archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,2.4861e-06,1.2013,1.0116,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,3.0905e-06,1.0644,0.8522,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.2538e-08,0.98963,0.82572,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,3.9717e-11,0.91991,0.89471,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.1789e-06,0.90901,0.69951,1,1
1,GO BLEB ASSEMBLY,3.6361e-10,0.87874,0.99781,1,1
1,GO RESPONSE TO INTERFERON ALPHA,8.0815e-10,0.85574,0.8851,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,5.4701e-07,0.81081,0.64467,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.6001e-09,0.79855,0.74308,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.2565e-10,0.78241,0.74756,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,3.4296e-07,0.78149,0.62021,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,4.0343e-10,0.78019,0.64487,1,1
1,GO RESPONSE TO INTERFERON BETA,3.5606e-08,0.7641,0.70694,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,4.1552e-07,0.76387,0.69865,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,3.4296e-07,0.76294,0.72305,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.7309e-08,0.73395,0.74173,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.2864e-09,0.7282,0.64304,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.1245e-09,0.7277,0.70653,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,1.1579e-08,0.71943,0.63766,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,6.0979e-10,0.71615,0.68006,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.5604e-09,0.71615,0.69919,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,5.3647e-09,0.71454,0.64386,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,2.634e-09,0.70732,0.66698,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.7909e-10,0.69843,0.67323,1,1
1,GO HYALURONAN CATABOLIC PROCESS,4.5526e-11,0.68333,0.72561,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,1.9563e-06,0.66669,0.56798,1,1
1,GO FIBRINOLYSIS,3.0296e-10,0.66339,0.6279,1,1
1,GO RESPONSE TO TYPE I INTERFERON,2.5359e-06,0.65482,0.51739,1,1
1,GO HEMIDESMOSOME ASSEMBLY,9.404e-07,0.6544,0.73944,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,9.1996e-11,0.65422,0.69523,1,1
1,GO NEUTROPHIL HOMEOSTASIS,4.4749e-10,0.64981,0.64797,1,1
1,GO MEMBRANE RAFT ORGANIZATION,2.4586e-08,0.63974,0.65216,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.094e-05,0.6375,0.45678,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,6.5125e-09,0.6344,0.57354,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,4.3082e-09,0.62964,0.6169,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.65e-07,0.62701,0.48973,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1.8419e-06,0.62207,0.5788,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,3.094e-05,0.61647,0.54315,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.6362e-08,0.61583,0.58525,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,9.03e-05,0.6148,0.46719,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,1.9064e-09,0.61055,0.64021,1,1
1,GO CYTOLYSIS,9.028e-08,0.60793,0.48166,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.155e-06,0.60244,0.47937,1,1
1,GO LEUKOCYTE AGGREGATION,1.9175e-06,0.59916,0.51275,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,5.0922e-10,0.59818,0.5887,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,4.31e-06,0.59535,0.47555,1,1
1,GO PROSTATIC BUD FORMATION,1.9749e-05,0.59483,0.49578,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.9602e-08,0.59099,0.5316,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.4877e-09,0.59036,0.51473,1,1
1,GO SKIN MORPHOGENESIS,3.247e-08,0.59022,0.62451,1,1
1,GO TOLERANCE INDUCTION,2.9332e-05,0.58871,0.451,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,4.4285e-07,0.58604,0.52209,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,1.0804e-10,0.57758,0.62169,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,6.0759e-07,0.57525,0.53275,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,5.6245e-08,0.57122,0.48947,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,5.1356e-08,0.57031,0.52977,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.8135e-09,0.56885,0.53804,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,4.3606e-10,0.56833,0.56189,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.3784e-07,0.56785,0.5806,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,7.4177e-11,0.56725,0.6162,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.1101e-09,0.56571,0.53473,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,1.0554e-07,0.56372,0.46683,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,1.9064e-09,0.5609,0.58921,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,7.1121e-10,0.55849,0.63132,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,6.4434e-08,0.55433,0.44902,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,7.0337e-07,0.55344,0.48136,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.9546e-09,0.55066,0.57014,1,1
1,GO DETECTION OF BIOTIC STIMULUS,3.1004e-08,0.55008,0.49877,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.8271e-07,0.54647,0.44248,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.0527e-08,0.54585,0.47786,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,3.8118e-09,0.53954,0.50643,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.342e-06,0.53527,0.53594,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.457e-10,0.53513,0.55452,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.188e-08,0.5334,0.48528,1,1
1,GO T CELL EXTRAVASATION,2.65e-07,0.53213,0.48214,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.5233e-07,0.53141,0.49285,1,1
1,GO ELASTIC FIBER ASSEMBLY,8.3066e-07,0.5311,0.65247,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.5756e-08,0.52735,0.50098,1,1
1,GO EPIBOLY,6.757e-10,0.52558,0.54642,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,8.6328e-08,0.52395,0.50847,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,3.8161e-07,0.52219,0.63026,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.3274e-07,0.51957,0.49176,1,1
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,2.2505e-06,0.5192,0.44544,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,1.1041e-08,0.5188,0.55369,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,8.2864e-09,0.51876,0.47948,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.7154e-07,0.51668,0.39341,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,8.6328e-08,0.51559,0.40754,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,2.65e-07,0.51488,0.52707,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.6907e-08,0.51309,0.44835,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.9546e-09,0.51146,0.53793,1,1
1,GO MUCUS SECRETION,3.5646e-05,0.50977,0.46774,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,3.7195e-09,0.50857,0.5642,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,9.5999e-07,0.50707,0.53938,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,1.3878e-06,0.5058,0.49159,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,2.6386e-06,0.50546,0.48713,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0028118,0.50513,0.33145,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,4.8416e-06,0.50492,0.552,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,6.2993e-08,0.50477,0.50455,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.6352e-05,0.50171,0.43792,1,1
1,GO ZYMOGEN ACTIVATION,2.8001e-06,0.50093,0.40939,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.3312e-10,0.49861,0.50282,1,1
1,GO ETHANOL OXIDATION,0.0041031,0.49769,0.32599,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,9.4407e-08,0.49644,0.48368,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.2775e-07,0.4959,0.4397,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.9558e-07,0.49441,0.35921,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,1.2604e-07,0.4942,0.52297,1,1
1,GO RESPONSE TO INTERLEUKIN 18,4.7172e-05,0.49255,0.5009,1,1
1,GO ENDODERM FORMATION,5.7923e-10,0.49199,0.5069,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,1.2027e-05,0.49053,0.43194,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3878e-06,0.49026,0.36509,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,6.545e-05,0.48947,0.52554,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,2.0364e-06,0.48921,0.45188,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.3174e-07,0.48882,0.44277,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,2.0881e-08,0.48837,0.47795,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,3.6435e-08,0.48563,0.4808,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.2585e-06,0.48524,0.34202,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,6.3359e-07,0.48359,0.39481,1,1
1,GO INTERLEUKIN 1 PRODUCTION,8.8282e-08,0.48,0.39157,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,1.2534e-06,0.4796,0.51281,1,1
1,GO APOPTOTIC CELL CLEARANCE,3.2764e-10,0.47931,0.50687,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.6914e-06,0.47759,0.32995,1,1
1,GO ZYMOGEN INHIBITION,7.1726e-09,0.47454,0.52959,1,1
1,GO PROTEIN OXIDATION,2.2416e-05,0.47324,0.4261,1,1
1,GO TYPE 2 IMMUNE RESPONSE,3.6435e-08,0.47078,0.44991,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,2.971e-06,0.46875,0.39705,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,3.0811e-07,0.46791,0.468,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,4.9694e-05,0.46527,0.34707,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.7536e-08,0.46503,0.41283,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,3.2859e-07,0.46399,0.44317,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,2.1064e-09,0.46299,0.50146,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9834e-06,0.46166,0.33338,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,4.4285e-07,0.46096,0.41494,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.7319e-10,0.45829,0.47653,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.1101e-09,0.45674,0.4381,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.7582e-06,0.45641,0.37155,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.6981e-08,0.45556,0.42011,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,3.9941e-08,0.45493,0.4542,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.892e-08,0.45125,0.35811,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.6321e-06,0.4498,0.3793,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,2.1338e-07,0.44933,0.4267,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.0522e-08,0.44828,0.39449,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,1.3948e-05,0.44807,0.40695,1,1
1,GO REGULATION OF FIBRINOLYSIS,4.6202e-07,0.44782,0.41634,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,2.3891e-06,0.44767,0.4364,1,1
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,4.3997e-05,0.44724,0.36937,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.65e-07,0.44601,0.50437,1,1
1,GO VAGINA DEVELOPMENT,9.3415e-09,0.44564,0.43203,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.9859e-05,0.44503,0.329,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.7442e-10,0.4448,0.52214,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,4.0314e-05,0.44466,0.42974,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.4285e-07,0.44459,0.38494,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.536e-06,0.44323,0.3425,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,7.8778e-10,0.44104,0.45786,1,1
1,GO PROTEIN ACTIVATION CASCADE,9.7991e-09,0.43739,0.42175,1,1
1,GO BONE TRABECULA MORPHOGENESIS,3.758e-05,0.43725,0.41439,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,5.0278e-07,0.43676,0.40253,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,4.0033e-09,0.43577,0.5707,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.8262e-08,0.43494,0.38091,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,3.2057e-05,0.43485,0.42805,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,2.1375e-08,0.43398,0.41623,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,2.4837e-07,0.43375,0.3786,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.5427e-10,0.43371,0.44455,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,1.0557e-05,0.43368,0.35099,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,1.6321e-06,0.43255,0.42054,1,1
1,GO DEFENSE RESPONSE TO VIRUS,7.4873e-07,0.43226,0.32651,1,1
1,GO TRABECULA FORMATION,2.4861e-06,0.43225,0.38857,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.152e-06,0.43215,0.30881,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,3.1494e-05,0.43187,0.3454,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.5412e-09,0.43025,0.45684,1,1
1,GO INTERLEUKIN 13 PRODUCTION,1.6761e-05,0.43007,0.37023,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,1.0964e-09,0.4295,0.45812,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00046872,0.4295,0.30353,1,1
1,GO ENDODERM DEVELOPMENT,9.658e-10,0.42907,0.44486,1,1
1,GO T CELL MEDIATED IMMUNITY,1.155e-06,0.42886,0.3401,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,2.342e-06,0.42822,0.44153,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.3747e-08,0.42781,0.39761,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.5359e-06,0.42754,0.37011,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,8.4262e-06,0.42741,0.2908,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.8856e-08,0.4272,0.43532,1,1
1,GO VASCULOGENESIS,2.1543e-10,0.42595,0.44208,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.00027716,0.42437,0.40996,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.2534e-06,0.42434,0.41054,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.3419e-09,0.42421,0.43505,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.2733e-08,0.42341,0.43682,1,1
1,GO PINOCYTOSIS,2.2926e-08,0.42327,0.38666,1,1
1,GO BIOLOGICAL PHASE,2.5884e-05,0.42287,0.40509,1,1
1,GO HIPPO SIGNALING,5.0278e-07,0.42267,0.41723,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.4305e-07,0.42248,0.3252,1,1
1,GO DNA DEAMINATION,2.2015e-05,0.42234,0.42557,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.3351e-08,0.42212,0.41983,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,3.0811e-07,0.42141,0.39787,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,4.3774e-08,0.42123,0.3698,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,5.1356e-08,0.42099,0.36692,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,1.6654e-06,0.42093,0.44524,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.402e-08,0.42041,0.38549,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,9.4959e-05,0.41823,0.26869,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.2058e-07,0.41807,0.38002,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.0169e-05,0.41789,0.36247,1,1
1,GO RETINAL METABOLIC PROCESS,5.7059e-05,0.41781,0.35192,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,5.9498e-07,0.41682,0.41466,1,1
1,GO POSITIVE REGULATION OF COAGULATION,3.2146e-06,0.41653,0.33855,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2271e-06,0.4164,0.28732,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,6.5906e-08,0.41631,0.38447,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00026438,0.41583,0.28873,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,8.8282e-08,0.41552,0.48448,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,6.8885e-07,0.41537,0.42122,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00068191,0.41522,0.2812,1,1
1,GO CERAMIDE CATABOLIC PROCESS,1.2954e-05,0.41514,0.3443,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.0323e-06,0.41396,0.31404,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,6.0205e-08,0.4137,0.56118,1,1
1,GO PLASMINOGEN ACTIVATION,1.0212e-06,0.4137,0.42475,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.152e-06,0.41353,0.45809,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,1.7693e-06,0.4129,0.33395,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,5.7051e-07,0.41167,0.36401,1,1
1,GO REGULATION OF PINOCYTOSIS,1.475e-06,0.41064,0.32238,1,1
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,3.3806e-05,0.41021,0.39396,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.3891e-06,0.40891,0.33124,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,6.545e-05,0.40874,0.32599,1,1
1,GO ENTRY INTO HOST,2.188e-08,0.4086,0.38498,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.0337e-07,0.4057,0.42008,1,1
1,GO INTERLEUKIN 8 PRODUCTION,1.6062e-07,0.4044,0.36217,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,5.02e-08,0.40439,0.48002,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,5.8262e-07,0.40401,0.4152,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.00032916,0.404,0.30994,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,2.6352e-05,0.40374,0.35175,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00023667,0.40232,0.29434,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,3.9822e-07,0.40144,0.42878,1,1
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.016027,0.40055,0.23569,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.996e-06,0.40042,0.43954,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,2.1196e-06,0.4,0.3887,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,5.4701e-07,0.39962,0.39805,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,6.7461e-07,0.39953,0.35916,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,3.0295e-08,0.39948,0.40174,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,2.8925e-08,0.39921,0.38672,1,1
1,GO GAP JUNCTION ASSEMBLY,1.6782e-07,0.39815,0.4244,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,2.2015e-05,0.39815,0.35566,1,1
1,GO SALIVARY GLAND DEVELOPMENT,9.028e-08,0.39747,0.44816,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,4.1552e-07,0.39741,0.47563,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.3174e-07,0.39712,0.34283,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.2328e-07,0.39538,0.36701,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,2.5359e-06,0.39449,0.42611,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.6581e-10,0.39349,0.45551,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.3599e-06,0.39334,0.31207,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.6782e-07,0.39332,0.33086,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,1.6321e-06,0.39288,0.37426,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,3.3214e-05,0.39226,0.28665,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,2.5868e-06,0.39215,0.35905,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.00088789,0.3914,0.24244,1,1
1,GO CELLULAR RESPONSE TO DSRNA,2.7676e-09,0.39077,0.39888,1,1
1,GO AMYLOID FIBRIL FORMATION,0.00015083,0.3904,0.35579,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,6.1583e-08,0.39038,0.50244,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,3.3713e-09,0.38995,0.42078,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00049053,0.38974,0.35871,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00022208,0.38972,0.33249,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,3.0395e-05,0.38898,0.4773,1,1
1,GO AMYLOID BETA CLEARANCE,4.0678e-07,0.38887,0.32295,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,2.6352e-05,0.38852,0.39159,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.3693e-05,0.38825,0.31315,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.2015e-05,0.38793,0.37053,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,5.7536e-08,0.38785,0.32856,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.0212e-06,0.38717,0.40608,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.856e-06,0.3864,0.31083,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00010673,0.38628,0.28111,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.2482e-05,0.38554,0.38695,1,1
1,GO VIRAL GENOME REPLICATION,7.0522e-08,0.38468,0.33961,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,1.1086e-06,0.38399,0.41426,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,7.9617e-06,0.38314,0.39647,1,1
1,GO MACROPHAGE PROLIFERATION,1.3196e-05,0.38297,0.37743,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,8.5858e-05,0.38178,0.30941,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,7.2414e-06,0.38064,0.37097,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,3.2784e-06,0.37959,0.33162,1,1
1,GO MYOBLAST PROLIFERATION,7.3739e-05,0.37936,0.28467,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,8.1138e-06,0.37927,0.38887,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,8.8389e-07,0.3792,0.367,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,6.5837e-06,0.37833,0.34918,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,5.0563e-05,0.37828,0.32968,1,1
1,GO RESPONSE TO INTERLEUKIN 12,1.5713e-07,0.37818,0.32164,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.3891e-06,0.37748,0.32397,1,1
1,GO T CELL APOPTOTIC PROCESS,9.8716e-08,0.37727,0.30057,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.6202e-07,0.37725,0.34224,1,1
1,GO REGULATION OF TRANSPOSITION,1.1588e-05,0.37674,0.37846,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,7.3739e-05,0.37662,0.32478,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,2.913e-06,0.37637,0.42313,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.4837e-07,0.37604,0.32247,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,2.6362e-08,0.37529,0.4226,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,8.0256e-05,0.37457,0.34822,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.2416e-05,0.37409,0.26206,1,1
1,GO INTERLEUKIN 2 PRODUCTION,2.9602e-08,0.37391,0.33279,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.1858e-08,0.37322,0.41519,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,3.9822e-07,0.3731,0.42829,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.9064e-09,0.37081,0.43084,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,8.4805e-07,0.37069,0.27494,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.0811e-07,0.37066,0.31862,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.2958e-06,0.3697,0.3806,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,5.8698e-06,0.36904,0.31028,1,1
1,GO HEME METABOLIC PROCESS,2.1375e-08,0.36867,0.34928,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.996e-06,0.36805,0.42598,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.6881e-08,0.36765,0.37768,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.6567e-07,0.36668,0.41482,1,1
1,GO SERTOLI CELL DEVELOPMENT,4.8416e-06,0.36576,0.35791,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,6.9323e-10,0.36571,0.39669,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.00020178,0.36488,0.27019,1,1
1,GO GENITALIA MORPHOGENESIS,6.8888e-05,0.36449,0.31239,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.6981e-08,0.3641,0.35301,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.3769e-07,0.36329,0.37142,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,1.1034e-07,0.36324,0.40357,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,1.7534e-07,0.36303,0.36746,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,2.7804e-05,0.36252,0.34439,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.5934e-07,0.36217,0.37987,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.9361e-06,0.36148,0.28515,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.0429e-07,0.36039,0.35046,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.1819e-07,0.36039,0.29055,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,8.4415e-08,0.35991,0.39649,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,1.1165e-05,0.35985,0.27615,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00015583,0.35984,0.28521,1,1
1,GO RESPONSE TO VIRUS,7.333e-07,0.35982,0.27844,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,3.357e-07,0.35971,0.40375,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,2.7804e-05,0.35899,0.25278,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,1.2032e-06,0.35857,0.3145,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5713e-07,0.3585,0.32503,1,1
1,GO CHEMOKINE PRODUCTION,1.1806e-05,0.35849,0.26952,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.5037e-07,0.35812,0.43341,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.9175e-06,0.35788,0.35148,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,9.2118e-07,0.3578,0.44172,1,1
1,GO PLATELET AGGREGATION,4.6881e-08,0.35755,0.35445,1,1
1,GO TROPHOBLAST CELL MIGRATION,2.4371e-06,0.35689,0.38792,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,3.0395e-05,0.35669,0.45205,1,1
1,GO T CELL CYTOKINE PRODUCTION,6.8396e-06,0.35632,0.27707,1,1
1,GO REGULATION OF COAGULATION,1.2886e-07,0.35577,0.38737,1,1
1,GO MUSCLE CELL FATE COMMITMENT,4.4285e-07,0.35522,0.3709,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,9.795e-06,0.35479,0.31024,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,2.402e-08,0.35418,0.36432,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.457e-10,0.35367,0.38844,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.00084997,0.35365,0.29849,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,8.1623e-05,0.35347,0.26864,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.6245e-08,0.35275,0.3865,1,1
1,GO HYALURONAN METABOLIC PROCESS,9.4157e-10,0.35268,0.363,1,1
1,GO INTERFERON BETA PRODUCTION,3.5461e-06,0.35204,0.27011,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00018323,0.35194,0.27511,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,8.1623e-05,0.35191,0.41177,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,9.9844e-05,0.35084,0.25048,1,1
1,GO CD40 SIGNALING PATHWAY,7.5451e-08,0.35071,0.37463,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,5.332e-06,0.35035,0.29273,1,1
1,GO COLLAGEN CATABOLIC PROCESS,5.4982e-08,0.34996,0.35834,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.0322e-07,0.34975,0.34841,1,1
1,GO PROSTANOID METABOLIC PROCESS,2.5868e-06,0.34947,0.29751,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00043435,0.34931,0.27901,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.9749e-05,0.34884,0.26375,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.0364e-06,0.34882,0.339,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0025961,0.34855,0.2569,1,1
1,GO PROSTATE GLAND DEVELOPMENT,1.5994e-06,0.3477,0.36842,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.7059e-05,0.34768,0.30865,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.2444e-07,0.34722,0.3301,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,1.0094e-07,0.34715,0.40708,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,2.0879e-07,0.34634,0.34605,1,1
1,GO RENAL FILTRATION,0.0001179,0.34606,0.3849,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,2.0364e-06,0.34576,0.31515,1,1
1,GO ENAMEL MINERALIZATION,6.1119e-05,0.34551,0.37478,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.5868e-06,0.34532,0.29887,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.8318e-07,0.3453,0.32532,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.5037e-07,0.34506,0.2975,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,1.5037e-07,0.34495,0.35912,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00022927,0.34469,0.24572,1,1
1,GO AORTIC VALVE DEVELOPMENT,8.8389e-07,0.34387,0.39924,1,1
1,GO PLATELET DEGRANULATION,1.8723e-07,0.34366,0.35774,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.004156,0.34352,0.24213,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,9.2118e-07,0.3435,0.27949,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.000286,0.34334,0.31378,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.6446e-07,0.34256,0.33264,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,5.1446e-05,0.34168,0.27299,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2281e-06,0.34152,0.29164,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,3.0905e-06,0.34138,0.25871,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,1.2032e-06,0.34125,0.32866,1,1
1,GO I KAPPAB PHOSPHORYLATION,2.3274e-07,0.34121,0.30172,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,2.4972e-05,0.3412,0.33863,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.475e-06,0.34086,0.26161,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.1282e-07,0.3408,0.28909,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,6.4699e-07,0.34078,0.36742,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,6.337e-06,0.34031,0.33331,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.7693e-06,0.33969,0.27557,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.3693e-05,0.3393,0.31762,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.3946e-06,0.33905,0.29475,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,9.5999e-07,0.33905,0.26863,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.9136e-07,0.33901,0.31044,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.1196e-06,0.33828,0.27835,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00034485,0.33805,0.2669,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.2958e-06,0.33803,0.35266,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,2.856e-06,0.33768,0.29789,1,1
1,GO GLAND MORPHOGENESIS,1.5674e-06,0.33718,0.35434,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,4.4787e-08,0.33704,0.38153,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,4.9694e-05,0.33678,0.29206,1,1
1,GO RESPONSE TO DSRNA,2.3784e-07,0.33621,0.2885,1,1
1,GO REGULATION OF MYOBLAST FUSION,6.4592e-06,0.33602,0.3632,1,1
1,GO PIGMENT ACCUMULATION,3.1494e-05,0.33571,0.31555,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.9014e-08,0.33553,0.31927,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.4528e-05,0.33551,0.26152,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.0025277,0.33498,0.25464,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,9.2321e-08,0.33483,0.38355,1,1
1,GO LYMPHANGIOGENESIS,1.9465e-08,0.33456,0.37191,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00013451,0.33452,0.37882,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.8001e-06,0.33409,0.25262,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0021798,0.33404,0.37043,1,1
1,GO MACROPHAGE CHEMOTAXIS,3.8161e-07,0.33342,0.30494,1,1
1,GO MACROPHAGE MIGRATION,2.9602e-08,0.33331,0.31823,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,4.8839e-05,0.33287,0.34595,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,6.5837e-06,0.33233,0.30424,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,8.8282e-08,0.33154,0.31893,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,5.8262e-07,0.33131,0.35722,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.9941e-08,0.33092,0.36833,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,6.7105e-06,0.33079,0.40666,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00023667,0.32953,0.23319,1,1
1,GO PERICARDIUM DEVELOPMENT,7.5001e-05,0.32953,0.3084,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,4.4807e-06,0.32947,0.29413,1,1
1,GO PHAGOCYTOSIS RECOGNITION,2.1624e-06,0.32914,0.35141,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,9.6538e-08,0.32907,0.38449,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,2.9514e-07,0.32861,0.29671,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00015838,0.32831,0.34211,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,3.094e-05,0.32818,0.30516,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,3.8983e-07,0.32797,0.34773,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,8.1361e-07,0.32733,0.26545,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,3.6162e-06,0.32666,0.36589,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,5.8856e-08,0.32599,0.29494,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.00013232,0.32588,0.25119,1,1
1,GO REGULATION OF STEROL TRANSPORT,1.3599e-06,0.32503,0.31079,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,6.4341e-05,0.32485,0.28226,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,1.0036e-08,0.32483,0.38772,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00016901,0.32418,0.25224,1,1
1,GO TRANSPOSITION,1.8701e-05,0.32359,0.32581,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.00049053,0.32356,0.33485,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.3056e-06,0.32346,0.27946,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00048316,0.32329,0.36197,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00020178,0.3229,0.25339,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.0881e-08,0.32279,0.28228,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.538e-07,0.32256,0.38924,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,2.1624e-06,0.32225,0.34074,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,2.2416e-05,0.32188,0.25311,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,1.7687e-09,0.32127,0.35196,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,6.1119e-05,0.32126,0.35781,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,5.7059e-05,0.32113,0.23806,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.7534e-07,0.32093,0.2929,1,1
1,GO OSTEOBLAST DEVELOPMENT,7.2414e-06,0.32077,0.29409,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.5038e-07,0.32038,0.25682,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,4.8839e-05,0.32021,0.32068,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.3355e-07,0.31989,0.28797,1,1
1,GO P38MAPK CASCADE,9.795e-06,0.31949,0.25336,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.8698e-06,0.31935,0.38156,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00045468,0.31897,0.2308,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.5412e-06,0.31878,0.28132,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,2.5164e-08,0.31795,0.27384,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,8.7237e-10,0.31794,0.34027,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00034485,0.31771,0.32808,1,1
1,GO EMBRYO IMPLANTATION,3.4296e-07,0.31711,0.31467,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.7452e-06,0.31644,0.2528,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,4.6359e-05,0.31629,0.25774,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.4837e-07,0.31625,0.33594,1,1
1,GO HYPOTONIC RESPONSE,2.011e-05,0.3161,0.28773,1,1
1,GO ODONTOGENESIS,9.1829e-05,0.31601,0.25261,1,1
1,GO FIBROBLAST MIGRATION,4.1815e-08,0.31573,0.33802,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,5.7059e-05,0.31556,0.26644,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.8419e-06,0.31543,0.24308,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,7.6657e-06,0.31492,0.35121,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,6.4592e-06,0.31469,0.30084,1,1
1,GO PROSTATE GLAND MORPHOGENESIS,0.00033432,0.31462,0.35333,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0025277,0.31439,0.35879,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,3.4409e-05,0.31422,0.28561,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,2.3467e-08,0.31407,0.33768,1,1
1,GO TRABECULA MORPHOGENESIS,2.4528e-05,0.31395,0.28676,1,1
1,GO REGULATION OF PLATELET ACTIVATION,0.00012594,0.31393,0.33407,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,6.2169e-06,0.31357,0.27776,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,5.8049e-05,0.31355,0.25331,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.6129e-08,0.31345,0.39497,1,1
1,GO RESPONSE TO ESTROGEN,3.8118e-09,0.31318,0.30803,1,1
1,GO FOCAL ADHESION ASSEMBLY,2.1338e-07,0.31291,0.35171,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,2.4305e-07,0.31247,0.33624,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.00041488,0.31176,0.27336,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.00039622,0.31169,0.23189,1,1
1,GO RESPONSE TO ANGIOTENSIN,2.0429e-07,0.31097,0.3177,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.152e-06,0.31071,0.24899,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.105e-06,0.31061,0.26686,1,1
1,GO CELL SUBSTRATE ADHESION,3.4796e-08,0.31016,0.34292,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,9.0235e-07,0.31002,0.3309,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.9617e-06,0.30977,0.38865,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.00019857,0.30945,0.3179,1,1
1,GO COPPER ION HOMEOSTASIS,3.5038e-07,0.30873,0.31465,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,0.00012804,0.30812,0.33964,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.00053704,0.30809,0.35866,1,1
1,GO LIVER REGENERATION,4.6356e-09,0.30798,0.30841,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.2444e-07,0.30785,0.32988,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0033361,0.30722,0.31324,1,1
1,GO PHOSPHOLIPID HOMEOSTASIS,0.0023009,0.30701,0.23172,1,1
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.00042777,0.307,0.32967,1,1
1,GO MEMBRANE INVAGINATION,9.4407e-08,0.30697,0.30086,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0001862,0.30677,0.35187,1,1
1,GO ARGININE METABOLIC PROCESS,1.8419e-06,0.30653,0.31202,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9102e-06,0.30602,0.28099,1,1
1,GO REGULATION OF PHAGOCYTOSIS,9.4407e-08,0.30588,0.33401,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,7.2497e-05,0.30582,0.32584,1,1
1,GO VIRAL LIFE CYCLE,5.4982e-08,0.30545,0.27379,1,1
1,GO VITAMIN D METABOLIC PROCESS,0.0020092,0.30542,0.23358,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,6.8885e-07,0.30537,0.28414,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,1.6782e-07,0.30524,0.28188,1,1
1,GO RESPONSE TO TUMOR CELL,0.0019285,0.30522,0.25385,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00033432,0.30505,0.20782,1,1
1,GO PROTEIN DEGLYCOSYLATION,1.1588e-05,0.30487,0.29848,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.001483,0.30485,0.31841,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,0.00016098,0.30332,0.31113,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0011021,0.30303,0.25023,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00019857,0.303,0.30035,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,1.0169e-05,0.30284,0.23847,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,3.3214e-05,0.30266,0.28425,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00025215,0.30081,0.26684,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0010259,0.30042,0.32445,1,1
1,GO RESPONSE TO CYTOKINE,9.5999e-07,0.30033,0.23899,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.9822e-07,0.3003,0.27367,1,1
1,GO RESPONSE TO HYDROPEROXIDE,0.024947,0.30025,0.20861,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.4972e-05,0.30021,0.24809,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,2.538e-07,0.30013,0.29554,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.1535e-07,0.29973,0.39795,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.4305e-07,0.29946,0.25777,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,8.6579e-07,0.29938,0.32463,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,2.1196e-06,0.29926,0.38374,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.0364e-06,0.29727,0.26407,1,1
1,GO INTERACTION WITH SYMBIONT,2.4837e-07,0.29709,0.24693,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.8701e-05,0.29707,0.26086,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.0478e-05,0.29677,0.22712,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,2.9859e-05,0.29644,0.24305,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,1.2792e-06,0.29643,0.29864,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.5868e-06,0.2964,0.36742,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.5994e-06,0.29629,0.31931,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,8.4805e-07,0.29627,0.29126,1,1
1,GO REGULATION OF VASCULOGENESIS,0.0016122,0.29601,0.26924,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,6.2993e-08,0.29588,0.2635,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,7.6446e-07,0.29574,0.27306,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.5372e-07,0.29564,0.25898,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.3599e-06,0.29549,0.29038,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.475e-06,0.29527,0.30907,1,1
1,GO LIPOPROTEIN LOCALIZATION,4.31e-06,0.29525,0.32174,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,1.5576e-05,0.29518,0.25758,1,1
1,GO INTERFERON ALPHA PRODUCTION,5.1446e-05,0.29487,0.26154,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00033955,0.29467,0.24127,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.001776,0.29452,0.35933,1,1
1,GO OSTEOCLAST DEVELOPMENT,2.8001e-06,0.2943,0.33344,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,5.9498e-07,0.29417,0.36006,1,1
1,GO CELLULAR RESPONSE TO IRON ION,6.4341e-05,0.2941,0.30483,1,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0034692,0.29355,0.21636,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.65e-07,0.29351,0.28309,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,6.8888e-05,0.29345,0.30738,1,1
1,GO REGULATION OF GASTRULATION,1.2886e-07,0.29341,0.28902,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,5.1304e-06,0.29276,0.24391,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.2328e-07,0.29276,0.33507,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,3.5646e-05,0.29276,0.29116,1,1
1,GO RESPONSE TO MANGANESE ION,9.028e-08,0.29252,0.26725,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00092737,0.29226,0.23564,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,1.6062e-07,0.29193,0.38157,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.00026438,0.29188,0.27858,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00070238,0.29176,0.23563,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0005789,0.29164,0.24169,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,3.8246e-05,0.29134,0.27298,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.010522,0.29106,0.25746,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,4.7999e-05,0.29041,0.23809,1,1
1,GO RESPONSE TO UV B,0.0038977,0.29034,0.24049,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,1.1034e-07,0.28999,0.34686,1,1
1,GO NATURAL KILLER CELL ACTIVATION,3.2784e-06,0.28962,0.2605,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00028155,0.2894,0.25512,1,1
1,GO WOUND HEALING,2.9514e-07,0.28887,0.28096,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00026024,0.28886,0.28679,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.001422,0.28872,0.24292,1,1
1,GO MYOBLAST DIFFERENTIATION,9.4407e-08,0.2887,0.2979,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00015331,0.28848,0.21628,1,1
1,GO BONE GROWTH,6.7105e-06,0.28846,0.35248,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,2.0853e-05,0.28824,0.22143,1,1
1,GO VIRAL RNA GENOME REPLICATION,2.2958e-06,0.28808,0.27046,1,1
1,GO COAGULATION,3.1479e-07,0.28803,0.26176,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,9.4959e-05,0.28794,0.30057,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.6435e-08,0.28775,0.27487,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.6578e-05,0.28774,0.44696,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,6.7461e-07,0.28765,0.29613,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0011341,0.28763,0.20949,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,1.6761e-05,0.28762,0.28026,1,1
1,GO CELL MATRIX ADHESION,3.6567e-07,0.28754,0.31059,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,1.8363e-05,0.28706,0.25435,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.0361e-05,0.28704,0.25224,1,1
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,6.6578e-05,0.2867,0.29079,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.3769e-07,0.2864,0.33879,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,6.7105e-06,0.28635,0.30327,1,1
1,GO REGULATION OF BONE MINERALIZATION,0.000662,0.28571,0.23315,1,1
1,GO ENDOTHELIAL CELL MIGRATION,2.65e-07,0.28567,0.31412,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00029052,0.28567,0.26775,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,3.3435e-06,0.28563,0.26888,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.00071283,0.28542,0.3408,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.1588e-05,0.28527,0.33278,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,6.4592e-06,0.28524,0.28462,1,1
1,GO RESPONSE TO X RAY,6.5906e-08,0.28467,0.33682,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,4.8198e-07,0.28437,0.29635,1,1
1,GO INTERACTION WITH HOST,2.2775e-07,0.28403,0.26339,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,4.5558e-05,0.284,0.27095,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,7.1819e-07,0.284,0.27115,1,1
1,GO SERTOLI CELL DIFFERENTIATION,5.8049e-05,0.28387,0.27454,1,1
1,GO AMINE CATABOLIC PROCESS,0.0016347,0.28387,0.19398,1,1
1,GO LYMPH VESSEL DEVELOPMENT,2.5424e-05,0.28385,0.3208,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,4.0314e-05,0.28385,0.22575,1,1
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0046018,0.28372,0.24993,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,4.9228e-07,0.28362,0.27574,1,1
1,GO NIK NF KAPPAB SIGNALING,1.2434e-08,0.28356,0.27867,1,1
1,GO MUSCLE CELL MIGRATION,5.2344e-05,0.28338,0.26302,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.1751e-05,0.28332,0.35191,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.7051e-07,0.28317,0.25067,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.001071,0.28294,0.22956,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00033432,0.28275,0.33724,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012804,0.28242,0.2168,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,8.2864e-09,0.28227,0.27883,1,1
1,GO RESPONSE TO RETINOIC ACID,2.342e-06,0.28218,0.25271,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0011503,0.28194,0.16882,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,1.6321e-06,0.28164,0.20972,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,1.8419e-06,0.28156,0.30679,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,3.0156e-07,0.28102,0.36593,1,1
1,GO TISSUE REGENERATION,6.0991e-06,0.28072,0.24107,1,1
1,GO RESPONSE TO INTERLEUKIN 1,1.0791e-07,0.28041,0.23911,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.3196e-05,0.27979,0.27115,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.357e-07,0.27943,0.36517,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,2.971e-06,0.27937,0.2929,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,3.628e-05,0.27923,0.25497,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,1.2027e-05,0.2792,0.29529,1,1
1,GO TISSUE MIGRATION,1.7693e-06,0.27898,0.28166,1,1
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0073682,0.2789,0.19014,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,5.3256e-05,0.27887,0.35492,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.8796e-05,0.27886,0.27985,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.3435e-06,0.27848,0.26029,1,1
1,GO RESPONSE TO VITAMIN,0.00012186,0.27832,0.21782,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,6.6066e-07,0.27826,0.27612,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.8814e-05,0.278,0.23831,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,7.6446e-07,0.27741,0.33598,1,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0048405,0.2773,0.25563,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,1.1165e-05,0.27702,0.267,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.001776,0.27683,0.26726,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.6924e-05,0.27636,0.23114,1,1
1,GO IMMUNE EFFECTOR PROCESS,2.8001e-06,0.27623,0.24651,1,1
1,GO CHONDROCYTE DEVELOPMENT,6.9711e-06,0.27573,0.31342,1,1
1,GO HAIR FOLLICLE MATURATION,0.00024045,0.2757,0.25246,1,1
1,GO POSITIVE REGULATION OF WOUND HEALING,0.0019023,0.27519,0.23413,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.7154e-07,0.27517,0.2736,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.9872e-06,0.27504,0.23598,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,7.4873e-07,0.27493,0.3035,1,1
1,GO MACROPHAGE DIFFERENTIATION,8.3066e-07,0.27473,0.28915,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,9.5999e-07,0.27445,0.30101,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,6.2169e-06,0.27393,0.3014,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.4454e-06,0.27392,0.28756,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,3.357e-07,0.27383,0.28121,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,8.2686e-06,0.27349,0.30826,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.0062108,0.27335,0.23351,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,1.0361e-05,0.2733,0.29152,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,2.0364e-06,0.27299,0.27935,1,1
1,GO MYOBLAST FUSION,5.5412e-06,0.27296,0.33548,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00016629,0.27292,0.30442,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,1.4454e-06,0.27253,0.27203,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.0072e-05,0.27248,0.2001,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.8305e-05,0.27205,0.31474,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,3.3435e-06,0.27186,0.22807,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.9166e-06,0.27181,0.22737,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.9102e-06,0.27142,0.2389,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,1.1588e-05,0.27083,0.25895,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00052901,0.27029,0.19791,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0034692,0.27012,0.20705,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0042636,0.27004,0.19295,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,3.6924e-05,0.26992,0.20975,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,3.0905e-06,0.26988,0.24482,1,1
1,GO REGULATION OF CELL SHAPE,2.011e-05,0.26979,0.22731,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,4.6359e-05,0.26916,0.25607,1,1
1,GO VASCULATURE DEVELOPMENT,2.4837e-07,0.26915,0.26959,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,1.9044e-05,0.26895,0.28062,1,1
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,9.03e-05,0.2689,0.22066,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.5934e-07,0.26885,0.27672,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00033432,0.26865,0.21808,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.2416e-05,0.26865,0.22047,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,3.5646e-05,0.26862,0.492,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,4.5822e-08,0.26829,0.27823,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,5.0563e-05,0.26824,0.27097,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,8.3066e-07,0.26814,0.25997,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,2.1624e-06,0.26809,0.26546,1,1
1,GO POSITIVE CHEMOTAXIS,0.00015083,0.26798,0.23729,1,1
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0001803,0.26752,0.23128,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.2032e-06,0.26732,0.28177,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,2.6352e-05,0.26718,0.33513,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.1351e-07,0.26665,0.25682,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00036686,0.26658,0.18931,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,5.2303e-06,0.26646,0.31521,1,1
1,GO REGULATION OF WOUND HEALING,8.5867e-06,0.26628,0.28218,1,1
1,GO PHAGOCYTOSIS,1.9136e-07,0.26602,0.28387,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,6.4434e-08,0.26597,0.27176,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,1.2253e-05,0.2657,0.31021,1,1
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,6.8396e-06,0.26549,0.33618,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.5794e-07,0.26535,0.25349,1,1
1,GO MESENCHYME MORPHOGENESIS,0.0011503,0.26526,0.23189,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,3.4098e-06,0.2652,0.27765,1,1
1,GO LIPID STORAGE,5.7582e-06,0.26481,0.22037,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.5022e-05,0.26466,0.19388,1,1
1,GO NECROTIC CELL DEATH,3.5646e-05,0.26456,0.24381,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,1.1375e-05,0.26383,0.27482,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,2.9859e-05,0.26364,0.25801,1,1
1,GO ERK1 AND ERK2 CASCADE,8.1361e-07,0.26318,0.24773,1,1
1,GO GALACTOSE METABOLIC PROCESS,7.2497e-05,0.26272,0.27592,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,3.247e-08,0.26261,0.30329,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,3.4409e-05,0.26251,0.26404,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.8793e-06,0.26244,0.25536,1,1
1,GO CARDIOBLAST DIFFERENTIATION,6.7724e-05,0.26173,0.28575,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,1.2032e-06,0.26129,0.25276,1,1
1,GO CERAMIDE TRANSPORT,2.1621e-05,0.2612,0.26337,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00040857,0.2603,0.29365,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,1.5576e-05,0.26022,0.31764,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0022095,0.25985,0.2946,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00091404,0.25979,0.31164,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.758e-05,0.25967,0.19526,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,8.7316e-05,0.25951,0.26223,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,2.1338e-07,0.25946,0.27729,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00022565,0.25938,0.29628,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,7.9617e-06,0.25925,0.27178,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0026663,0.2592,0.18757,1,1
1,GO RESPONSE TO SALT STRESS,7.8052e-07,0.25843,0.2713,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,1.6457e-05,0.25835,0.27998,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,9.6562e-05,0.25828,0.24262,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,7.6283e-05,0.25814,0.21494,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,9.795e-06,0.25803,0.25662,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.00044103,0.25765,0.21976,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.6782e-07,0.25708,0.25411,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,2.913e-06,0.25662,0.2997,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,8.4424e-05,0.25619,0.2533,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,2.4528e-05,0.25588,0.26012,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00015331,0.25562,0.18062,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,9.2585e-06,0.25551,0.23306,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,4.4807e-06,0.25542,0.2069,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00042128,0.25521,0.24092,1,1
1,GO REGULATION OF OSSIFICATION,0.0001862,0.25519,0.21614,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00015583,0.25456,0.3302,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.6654e-06,0.25439,0.24009,1,1
1,GO ARTERY DEVELOPMENT,0.00073415,0.25433,0.2209,1,1
1,GO PODOSOME ASSEMBLY,3.8924e-05,0.25416,0.31435,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.000662,0.25415,0.22349,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0011021,0.25388,0.21537,1,1
1,GO RESPONSE TO CORTICOSTEROID,1.0557e-05,0.25384,0.21659,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00025215,0.25374,0.18947,1,1
1,GO URETER DEVELOPMENT,0.00022208,0.25372,0.2406,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,3.6567e-07,0.25371,0.34138,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,5.1351e-07,0.2537,0.2459,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,2.1624e-06,0.25369,0.27587,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,5.5412e-06,0.25318,0.23734,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.011e-05,0.25283,0.20865,1,1
1,GO NEURAL CREST CELL MIGRATION,0.00033955,0.25277,0.24475,1,1
1,GO REGULATION OF LIPID STORAGE,3.758e-05,0.25252,0.21262,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.6457e-05,0.2521,0.22108,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0001862,0.25161,0.26675,1,1
1,GO FOREGUT MORPHOGENESIS,3.3214e-05,0.25159,0.27742,1,1
1,GO RIG I SIGNALING PATHWAY,2.7312e-05,0.2515,0.24127,1,1
1,GO OSTEOBLAST DIFFERENTIATION,8.4805e-07,0.25092,0.26538,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0024609,0.25086,0.26583,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,2.0879e-07,0.25014,0.24013,1,1
1,GO MUSCLE CELL PROLIFERATION,1.2604e-07,0.25012,0.26301,1,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.020385,0.2499,0.15662,1,1
1,GO SEQUESTERING OF METAL ION,9.4959e-05,0.24984,0.21247,1,1
1,GO KERATINOCYTE MIGRATION,3.5461e-06,0.24899,0.25199,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.4454e-06,0.24883,0.25018,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,3.1494e-05,0.24865,0.20552,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.0478e-05,0.24781,0.20558,1,1
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,9.6562e-05,0.24744,0.21809,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.0361e-05,0.24715,0.30056,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.017699,0.24705,0.20207,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,2.1621e-05,0.24678,0.28244,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,4.7488e-06,0.24651,0.3117,1,1
1,GO MICROVILLUS ASSEMBLY,0.014332,0.24645,0.16949,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,5.7059e-05,0.24609,0.25765,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,0.003607,0.24594,0.1792,1,1
1,GO STEROL TRANSPORT,9.1829e-05,0.2458,0.21221,1,1
1,GO GASTRULATION,3.0156e-07,0.24577,0.26723,1,1
1,GO ASTROCYTE DEVELOPMENT,6.7105e-06,0.24574,0.26502,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.00015331,0.24569,0.21226,1,1
1,GO GLIAL CELL ACTIVATION,0.00013451,0.24533,0.22866,1,1
1,GO RESPONSE TO VITAMIN D,0.044722,0.24521,0.15223,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,1.6158e-05,0.24498,0.26617,1,1
1,GO RECEPTOR CATABOLIC PROCESS,1.9749e-05,0.24418,0.26252,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.019523,0.24376,0.19327,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0039481,0.24292,0.22145,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.00023294,0.24225,0.20694,1,1
1,GO CHONDROCYTE DIFFERENTIATION,1.2534e-06,0.24196,0.28796,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,4.0657e-06,0.24165,0.28987,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,4.0314e-05,0.24165,0.27078,1,1
1,GO PLASMA MEMBRANE FUSION,0.01829,0.2416,0.18813,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.00034485,0.24156,0.2548,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00013016,0.24114,0.16879,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00055343,0.2406,0.26264,1,1
1,GO SYNCYTIUM FORMATION,4.5233e-07,0.2405,0.32259,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.9613e-05,0.24046,0.25331,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,3.5646e-05,0.2398,0.22617,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.9613e-05,0.23946,0.19324,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,6.0991e-06,0.23943,0.21139,1,1
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.0027381,0.23932,0.21472,1,1
1,GO ERBB2 SIGNALING PATHWAY,1.8701e-05,0.23901,0.22527,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.9056e-05,0.23889,0.30589,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.2784e-06,0.23843,0.26652,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0011341,0.23823,0.20014,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,3.628e-05,0.23808,0.23749,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00031414,0.23807,0.22409,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,4.2444e-07,0.23758,0.25556,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.7105e-06,0.23758,0.23116,1,1
1,GO TERPENOID METABOLIC PROCESS,0.003166,0.23686,0.14511,1,1
1,GO DECIDUALIZATION,0.0002117,0.2365,0.31015,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.00011033,0.23615,0.29919,1,1
1,GO CHOLESTEROL EFFLUX,7.7586e-05,0.23615,0.2193,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,8.7502e-06,0.23592,0.29332,1,1
1,GO BONE DEVELOPMENT,1.6761e-05,0.23588,0.22171,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.006444,0.2356,0.16082,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.00026858,0.23559,0.22381,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.011151,0.23552,0.20589,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,1.0169e-05,0.2354,0.2618,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,1.4472e-05,0.23474,0.226,1,1
1,GO ANIMAL ORGAN REGENERATION,1.0527e-08,0.23441,0.28506,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,6.2175e-05,0.23375,0.22979,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00030449,0.23374,0.23166,1,1
1,GO ERBB SIGNALING PATHWAY,4.8839e-05,0.23374,0.19409,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.9056e-05,0.23337,0.19467,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,1.0557e-05,0.23332,0.27313,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,3.5461e-06,0.23308,0.25943,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,4.2444e-07,0.23303,0.23751,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,2.4091e-05,0.23288,0.20975,1,1
1,GO REGENERATION,2.4305e-07,0.23285,0.2204,1,1
1,GO RESPONSE TO WOUNDING,9.7998e-07,0.23259,0.24657,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,3.5461e-06,0.23205,0.3209,1,1
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.013856,0.23185,0.16678,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,5.1446e-05,0.2318,0.23455,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.8416e-06,0.2318,0.20074,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.00019541,0.23169,0.21023,1,1
1,GO CELLULAR RESPONSE TO LIPID,1.0361e-05,0.23122,0.18783,1,1
1,GO PLATELET ACTIVATION,1.9749e-05,0.23118,0.24327,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,3.3214e-05,0.23117,0.24715,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,1.0361e-05,0.23105,0.23608,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00040857,0.23104,0.17783,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0018256,0.23083,0.20263,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.4771e-05,0.23061,0.21488,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,2.0853e-05,0.23055,0.25799,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,8.5867e-06,0.23037,0.19607,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,7.3803e-06,0.2302,0.20875,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,2.2958e-06,0.22958,0.27637,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,5.4184e-05,0.22957,0.22946,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,4.2271e-06,0.22956,0.23938,1,1
1,GO VESICLE CARGO LOADING,2.7312e-05,0.22942,0.22895,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,3.0395e-05,0.22914,0.17425,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,8.4424e-05,0.22907,0.21225,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,7.3739e-05,0.22839,0.20147,1,1
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00057029,0.22833,0.23187,1,1
1,GO ASTROCYTE ACTIVATION,6.2175e-05,0.22822,0.22181,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,7.6283e-05,0.22794,0.21229,1,1
1,GO UV PROTECTION,0.0021505,0.22784,0.21662,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0046604,0.22777,0.29698,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00024045,0.22744,0.18023,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00032408,0.22736,0.18673,1,1
1,GO FACE DEVELOPMENT,3.2631e-05,0.22717,0.25319,1,1
1,GO REGULATION OF LIPASE ACTIVITY,2.8001e-06,0.22707,0.22258,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.000286,0.22705,0.22895,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,2.342e-06,0.22689,0.22479,1,1
1,GO RETINOL METABOLIC PROCESS,0.00024819,0.22641,0.19396,1,1
1,GO RESPONSE TO VITAMIN A,0.00046165,0.22597,0.20737,1,1
1,GO BONE MORPHOGENESIS,1.9749e-05,0.22581,0.24695,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.00044103,0.22577,0.19252,1,1
1,GO MESENCHYME DEVELOPMENT,4.7172e-05,0.22563,0.20332,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,1.9393e-05,0.22551,0.21674,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00091404,0.2254,0.18776,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.00029976,0.22516,0.18519,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.3256e-05,0.22484,0.21206,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00039622,0.2247,0.24612,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0027381,0.22453,0.28889,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,9.819e-05,0.22448,0.19016,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,4.0314e-05,0.2244,0.31901,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,6.7105e-06,0.22406,0.23854,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00076726,0.22405,0.19069,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,4.3946e-06,0.22394,0.26045,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,2.5884e-05,0.22363,0.28719,1,1
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00042777,0.22335,0.2159,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,4.3997e-05,0.22289,0.18338,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00092737,0.22276,0.19719,1,1
1,GO ACUTE PHASE RESPONSE,0.012087,0.22253,0.14662,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,6.0079e-05,0.22202,0.3014,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,7.2497e-05,0.222,0.23847,1,1
1,GO IRON ION HOMEOSTASIS,1.2534e-06,0.22194,0.20476,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00039622,0.22188,0.20312,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,6.4434e-08,0.22181,0.25608,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,6.7105e-06,0.22154,0.24297,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,1.4472e-05,0.22057,0.24815,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00046165,0.22044,0.25881,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00047589,0.21923,0.27446,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,8.7316e-05,0.21841,0.28099,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.6994e-06,0.21835,0.2103,1,1
1,GO OSSIFICATION,4.1026e-05,0.21832,0.20663,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.6202e-07,0.21799,0.23029,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00013899,0.2178,0.27199,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00059648,0.21715,0.19951,1,1
1,GO BONE MATURATION,0.03006,0.21704,0.12006,1,1
1,GO CARNITINE METABOLIC PROCESS,0.0018006,0.21674,0.20382,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0014624,0.21623,0.2459,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.795e-06,0.21609,0.2343,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.8793e-06,0.21605,0.24923,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0012005,0.21549,0.17006,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0018764,0.21541,0.25999,1,1
1,GO TUBE MORPHOGENESIS,1.7385e-05,0.21472,0.2064,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00095459,0.21415,0.25044,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00044103,0.21385,0.2242,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.996e-06,0.21376,0.27437,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,9.4959e-05,0.21367,0.20173,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00037257,0.21367,0.22866,1,1
1,GO LIVER MORPHOGENESIS,0.01585,0.21354,0.17552,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00044781,0.21345,0.19396,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00082553,0.21333,0.18437,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,2.8305e-05,0.21331,0.24083,1,1
1,GO REGULATION OF BODY FLUID LEVELS,6.7724e-05,0.21301,0.18435,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,7.105e-06,0.21288,0.26787,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0007786,0.21255,0.14005,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,7.6283e-05,0.21244,0.22036,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0028872,0.2123,0.1997,1,1
1,GO REPLACEMENT OSSIFICATION,0.00040235,0.21211,0.26383,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0002443,0.21197,0.16411,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,1.4207e-05,0.2119,0.20626,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,7.2414e-06,0.21187,0.2236,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.1316e-06,0.21177,0.23642,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.011813,0.21163,0.1585,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00015838,0.2116,0.22205,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.9393e-05,0.21082,0.29737,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0005133,0.21081,0.22638,1,1
1,GO FLUID TRANSPORT,0.00037835,0.2108,0.19357,1,1
1,GO LAMELLIPODIUM ORGANIZATION,9.03e-05,0.21067,0.20005,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00020504,0.21022,0.17979,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,4.9694e-05,0.21014,0.194,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0002443,0.21009,0.17778,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0056255,0.2098,0.13796,1,1
1,GO REGULATION OF HEMOPOIESIS,2.8001e-06,0.20947,0.1917,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.00010323,0.20912,0.18507,1,1
1,GO NEGATIVE CHEMOTAXIS,0.0049019,0.20898,0.2178,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,5.7051e-07,0.20882,0.21516,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00020178,0.20872,0.16092,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0020929,0.20867,0.18791,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00025617,0.20854,0.22349,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0047198,0.20852,0.17289,1,1
1,GO ISOPRENOID METABOLIC PROCESS,0.0022095,0.20847,0.13233,1,1
1,GO PLACENTA DEVELOPMENT,0.00014839,0.20845,0.18313,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0087156,0.20799,0.17563,1,1
1,GO REGULATION OF HEART GROWTH,9.9844e-05,0.20778,0.19791,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,6.1119e-05,0.20778,0.20538,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,2.4972e-05,0.20749,0.23603,1,1
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.017315,0.20722,0.1815,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.31e-06,0.20721,0.2196,1,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.010645,0.20707,0.17445,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.4163e-06,0.20692,0.22224,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0007786,0.20677,0.17736,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.7172e-05,0.20671,0.19719,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.0361e-05,0.20645,0.20556,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.00027716,0.20645,0.19648,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0068504,0.20624,0.18042,1,1
1,GO ERAD PATHWAY,4.7999e-05,0.2058,0.15797,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00073415,0.20575,0.20421,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.003607,0.2056,0.20692,1,1
1,GO SYMBIOTIC PROCESS,2.2775e-07,0.20557,0.17385,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0010259,0.20546,0.17324,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,4.2487e-05,0.20522,0.21912,1,1
1,GO CARTILAGE DEVELOPMENT,1.9563e-06,0.20479,0.25421,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.0041031,0.20476,0.27026,1,1
1,GO MUSCLE FILAMENT SLIDING,1.3442e-05,0.20449,0.21944,1,1
1,GO REGULATION OF CELL FATE SPECIFICATION,0.040981,0.20428,0.17481,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0005133,0.20423,0.27195,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0022095,0.20392,0.18844,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,9.404e-07,0.20377,0.19339,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00012388,0.20368,0.23761,1,1
1,GO TRACHEA MORPHOGENESIS,1.9749e-05,0.20358,0.31232,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,9.03e-05,0.20336,0.16775,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0013633,0.20334,0.16658,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.00095459,0.20281,0.20531,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0054872,0.20281,0.14799,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,9.03e-05,0.20223,0.23411,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0043184,0.2018,0.18097,1,1
1,GO PROSTATE GLAND GROWTH,0.034984,0.20115,0.21959,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00044103,0.20106,0.15607,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.010041,0.20043,0.18224,1,1
1,GO HINDLIMB MORPHOGENESIS,0.0023637,0.19993,0.20132,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00030449,0.19954,0.19444,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00067188,0.19953,0.129,1,1
1,GO RESPONSE TO ANTIBIOTIC,4.1456e-06,0.19917,0.18903,1,1
1,GO RESPONSE TO UV C,0.0025961,0.1991,0.15576,1,1
1,GO AMELOGENESIS,0.019523,0.19895,0.16768,1,1
1,GO PEPTIDE CATABOLIC PROCESS,5.9834e-06,0.19884,0.24932,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0068504,0.19843,0.13227,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,0.00010152,0.19757,0.21973,1,1
1,GO BIOLOGICAL ADHESION,0.0021505,0.19754,0.15149,1,1
1,GO MYOTUBE DIFFERENTIATION,0.0032078,0.19713,0.14781,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.5884e-05,0.19712,0.17223,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,1.8701e-05,0.1971,0.22773,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00025215,0.1966,0.18994,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00010673,0.1965,0.19113,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,4.2271e-06,0.19592,0.29614,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.1304e-06,0.1958,0.24055,1,1
1,GO FATTY ACID BETA OXIDATION,0.0005211,0.19557,0.16025,1,1
1,GO BIOMINERALIZATION,0.0062877,0.19554,0.16172,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.1375e-05,0.19545,0.22749,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0010259,0.19508,0.18136,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0005618,0.19508,0.19979,1,1
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018693,0.19477,0.16041,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00067188,0.19465,0.18363,1,1
1,GO VIRAL TRANSLATION,0.0020092,0.19421,0.18662,1,1
1,GO GLIAL CELL MIGRATION,0.0028492,0.19409,0.17315,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,5.7582e-06,0.19402,0.19849,1,1
1,GO PROTEIN KINASE B SIGNALING,2.0853e-05,0.19376,0.18692,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.7312e-05,0.19361,0.19449,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.00019857,0.19298,0.18285,1,1
1,GO RECEPTOR RECYCLING,0.0010259,0.19294,0.14491,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.7385e-05,0.19293,0.2077,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.033948,0.19249,0.13735,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00013016,0.19241,0.19426,1,1
1,GO VIRAL GENE EXPRESSION,0.0050269,0.19208,0.13252,1,1
1,GO STRESS FIBER ASSEMBLY,0.00032408,0.19204,0.21861,1,1
1,GO ANIMAL ORGAN FORMATION,0.0013255,0.19194,0.18634,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00091404,0.19161,0.17151,1,1
1,GO PROTEIN KINASE A SIGNALING,0.0002117,0.19144,0.16482,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00064263,0.19133,0.22295,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00036686,0.19131,0.14598,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.013856,0.1912,0.14751,1,1
1,GO AUTOPHAGOSOME MATURATION,2.7312e-05,0.19093,0.1818,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00011218,0.1909,0.16665,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0005056,0.1906,0.18115,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0018006,0.19022,0.21271,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,6.2175e-05,0.18981,0.17303,1,1
1,GO DETOXIFICATION,0.00084997,0.18971,0.13878,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.037509,0.18971,0.13882,1,1
1,GO PLATELET MORPHOGENESIS,0.0010113,0.18963,0.20697,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0037985,0.18956,0.13723,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,6.7105e-06,0.18929,0.21517,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.00022565,0.18912,0.16716,1,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.011411,0.18909,0.1424,1,1
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.036409,0.18897,0.11921,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,0.0007786,0.18871,0.20842,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,7.6283e-05,0.18853,0.22406,1,1
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00094089,0.18837,0.17453,1,1
1,GO SELECTIVE AUTOPHAGY,3.2146e-06,0.18828,0.19109,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.002702,0.18826,0.16843,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0025617,0.18819,0.16806,1,1
1,GO RESPONSE TO LIPID,0.00014599,0.18815,0.16094,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,3.2146e-06,0.18784,0.16981,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.8983e-07,0.18783,0.18386,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.0060595,0.18779,0.1566,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.001422,0.18743,0.17822,1,1
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0052197,0.18739,0.15365,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,6.545e-05,0.18732,0.16185,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0013633,0.18675,0.1374,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.996e-06,0.18651,0.18399,1,1
1,GO LIPID OXIDATION,0.00045468,0.18611,0.15389,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0044298,0.18589,0.14997,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00012594,0.18582,0.15423,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,2.9859e-05,0.1856,0.22309,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.4207e-05,0.1851,0.22395,1,1
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0028872,0.18504,0.18751,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,4.2487e-05,0.18463,0.1865,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.1806e-05,0.1846,0.16118,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,7.2414e-06,0.18444,0.20086,1,1
1,GO RESPONSE TO IONIZING RADIATION,4.0314e-05,0.18402,0.16264,1,1
1,GO POSITIVE REGULATION OF OSSIFICATION,0.001442,0.18399,0.22238,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00010497,0.18349,0.15279,1,1
1,GO MESODERM MORPHOGENESIS,7.6657e-06,0.18319,0.2158,1,1
1,GO PRIMARY MIRNA PROCESSING,0.0029645,0.18315,0.15815,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,8.3013e-05,0.1829,0.13578,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.0011341,0.18289,0.1752,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.022686,0.18243,0.11838,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0012705,0.18243,0.16572,1,1
1,GO TOXIN TRANSPORT,0.0039992,0.18238,0.12952,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.2631e-05,0.18219,0.18386,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00020178,0.18205,0.22117,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00038422,0.18198,0.18818,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0047798,0.18187,0.14352,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0003557,0.1817,0.18807,1,1
1,GO HEAD MORPHOGENESIS,0.00060545,0.1817,0.23671,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00018323,0.18165,0.16533,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0005133,0.18146,0.17769,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,8.0256e-05,0.1814,0.17597,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0022095,0.18117,0.21136,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,1.1165e-05,0.18078,0.22082,1,1
1,GO RESPONSE TO AMYLOID BETA,0.056652,0.18072,0.10864,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.2281e-06,0.18063,0.21373,1,1
1,GO RESPONSE TO ISCHEMIA,0.00068191,0.18028,0.1735,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,9.6129e-06,0.18003,0.1569,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,1.0958e-05,0.17991,0.19978,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00025617,0.1799,0.22123,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00060545,0.1799,0.17547,1,1
1,GO PORE COMPLEX ASSEMBLY,0.0052854,0.17987,0.12532,1,1
1,GO MATURATION OF LSU RRNA,0.021053,0.17973,0.142,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,3.8246e-05,0.1797,0.17118,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0005133,0.17968,0.19736,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.00019541,0.17957,0.21078,1,1
1,GO REGULATION OF MRNA BINDING,0.019735,0.17876,0.1415,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00020835,0.1787,0.14516,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0094686,0.17817,0.17172,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00080175,0.17811,0.18146,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.012087,0.17808,0.13085,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,9.6562e-05,0.17801,0.16516,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00054518,0.17772,0.22869,1,1
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.021053,0.17764,0.17588,1,1
1,GO PENTOSE METABOLIC PROCESS,0.01251,0.1773,0.15014,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0018508,0.17727,0.18036,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.013243,0.17726,0.1335,1,1
1,GO REGULATION OF URINE VOLUME,2.2416e-05,0.17706,0.21795,1,1
1,GO FEMALE GENITALIA DEVELOPMENT,0.0070192,0.17649,0.18011,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.0003557,0.17643,0.1952,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,4.3997e-05,0.17634,0.16979,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00028155,0.17634,0.17329,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00016901,0.17591,0.16897,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00064263,0.17578,0.15643,1,1
1,GO REGULATION OF PROTEOLYSIS,1.6457e-05,0.17573,0.16691,1,1
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0022095,0.17554,0.15119,1,1
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0032078,0.17519,0.15372,1,1
1,GO PIGMENT METABOLIC PROCESS,0.00011986,0.17494,0.15822,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00096848,0.17476,0.15824,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,8.0256e-05,0.17461,0.18759,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,4.7999e-05,0.17433,0.21322,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.5014e-05,0.17428,0.20744,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,2.2015e-05,0.17416,0.185,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,8.2686e-06,0.17415,0.16189,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0003557,0.17415,0.14199,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00072342,0.17404,0.20969,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.00043435,0.17399,0.20923,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00062378,0.17378,0.1401,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0022396,0.17368,0.16691,1,1
1,GO REGULATION OF VASOCONSTRICTION,7.5001e-05,0.17365,0.21921,1,1
1,GO TUBE DEVELOPMENT,0.00021857,0.17363,0.17103,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.00048316,0.17328,0.16041,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00095459,0.17326,0.1833,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.027686,0.17319,0.15741,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0023321,0.17289,0.14252,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.03429,0.17277,0.12523,1,1
1,GO RESPONSE TO CORTICOSTERONE,0.031953,0.17247,0.1346,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0098086,0.1723,0.16909,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0023957,0.17202,0.15922,1,1
1,GO REGULATION OF FATTY ACID OXIDATION,0.0098086,0.17195,0.14357,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,4.7172e-05,0.17189,0.16548,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.00055343,0.17186,0.15259,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.4207e-05,0.17166,0.1679,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,2.6352e-05,0.17148,0.22077,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.0063654,0.17134,0.14132,1,1
1,GO REGULATION OF ORGAN GROWTH,9.6129e-06,0.1713,0.20681,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00087508,0.17091,0.26118,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0016806,0.1707,0.18175,1,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0047198,0.17066,0.21341,1,1
1,GO CELLULAR RESPONSE TO FATTY ACID,0.056128,0.17059,0.11454,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0087156,0.17047,0.15201,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0024609,0.17023,0.16025,1,1
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.027973,0.16999,0.11576,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0031247,0.16991,0.19339,1,1
1,GO MANGANESE ION TRANSPORT,0.0015038,0.16951,0.16699,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0001862,0.16942,0.15877,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00049802,0.1693,0.19896,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0020929,0.16921,0.15796,1,1
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0011503,0.16868,0.1641,1,1
1,GO ORGAN GROWTH,0.0001803,0.16852,0.18071,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.5646e-05,0.16816,0.2334,1,1
1,GO LAMELLIPODIUM ASSEMBLY,0.00017741,0.16803,0.18501,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0025617,0.16795,0.17356,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0024281,0.16792,0.21061,1,1
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0021215,0.16783,0.17535,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00055343,0.1677,0.15599,1,1
1,GO REGULATION OF CELL AGING,2.5424e-05,0.16707,0.17504,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00074504,0.16707,0.20451,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.6828e-05,0.16706,0.2175,1,1
1,GO MRNA TRANSCRIPTION,0.00030928,0.16702,0.21057,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.1165e-05,0.16672,0.18991,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00095459,0.16671,0.15689,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.02174,0.16638,0.13303,1,1
1,GO RESPONSE TO GAMMA RADIATION,0.00016629,0.16624,0.15973,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,8.3013e-05,0.16592,0.18108,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0011836,0.1659,0.13656,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0095807,0.16588,0.11023,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00082553,0.16586,0.17556,1,1
1,GO CELL MOTILITY,0.0021798,0.16582,0.13409,1,1
1,GO BONE REMODELING,0.00061456,0.1657,0.20829,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,2.3661e-05,0.16562,0.18084,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0013255,0.1656,0.12471,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.035336,0.16558,0.11178,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0053519,0.16555,0.15624,1,1
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.041789,0.16536,0.157,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00075607,0.16522,0.15159,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00024045,0.16519,0.17488,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.01995,0.16515,0.16638,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0098086,0.16492,0.1384,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.0054192,0.16462,0.12458,1,1
1,GO HISTONE H2B UBIQUITINATION,0.033271,0.16454,0.091089,1,1
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0019819,0.16417,0.18503,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.031953,0.16414,0.17453,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00052901,0.16413,0.15129,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00022208,0.16406,0.18935,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00032916,0.16367,0.18608,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0023957,0.16338,0.14614,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0031247,0.16336,0.18997,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0021505,0.16323,0.17718,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.002631,0.16317,0.21688,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,8.9166e-06,0.16308,0.16313,1,1
1,GO HISTONE PHOSPHORYLATION,0.0012177,0.16306,0.13283,1,1
1,GO RESPONSE TO NUTRIENT,0.00081356,0.16282,0.16288,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0059852,0.16278,0.24668,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,6.8396e-06,0.16259,0.1662,1,1
1,GO HEART MORPHOGENESIS,0.0032928,0.162,0.14478,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.012945,0.16166,0.14582,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00019857,0.16166,0.15974,1,1
1,GO MEMBRANE DISASSEMBLY,0.018091,0.16153,0.14285,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0059116,0.16102,0.14724,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00159,0.16067,0.11156,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0021215,0.16062,0.11985,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0086125,0.16051,0.1393,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0016575,0.1604,0.14178,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.9749e-05,0.16039,0.17874,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.00016098,0.16005,0.14318,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.0083098,0.16004,0.22695,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.011813,0.15968,0.10497,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00060545,0.15956,0.15404,1,1
1,GO CELL AGING,6.6578e-05,0.15954,0.14911,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.00026024,0.15915,0.16032,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0032928,0.15914,0.13831,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0080166,0.15899,0.17633,1,1
1,GO MUSCLE ADAPTATION,0.010279,0.15847,0.12686,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0011341,0.15826,0.10521,1,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0063654,0.15808,0.15611,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.012945,0.15792,0.18225,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.035691,0.15777,0.12155,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.02945,0.15758,0.12025,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0081133,0.15743,0.15727,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0030038,0.15732,0.11947,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00026438,0.15731,0.16279,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,4.5558e-05,0.15726,0.17525,1,1
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.043444,0.1572,0.15919,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.001235,0.15719,0.19873,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.9393e-05,0.15702,0.17943,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0032928,0.15692,0.13228,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0037016,0.15685,0.19962,1,1
1,GO REGULATION OF MAPK CASCADE,0.00013451,0.15666,0.16111,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0003557,0.15644,0.13722,1,1
1,GO STEM CELL DIFFERENTIATION,2.5424e-05,0.15643,0.15939,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0043184,0.15637,0.12493,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.4262e-06,0.15625,0.15939,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0016806,0.15621,0.12278,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00036686,0.15619,0.14345,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.001071,0.15609,0.12918,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.013394,0.15604,0.10496,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00069207,0.1558,0.14038,1,1
1,GO VESICLE TARGETING,0.0028118,0.15574,0.12313,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0005618,0.15562,0.15171,1,1
1,GO CELLULAR RESPONSE TO KETONE,0.019104,0.15538,0.1151,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0018764,0.15487,0.12132,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00014362,0.15484,0.16422,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00039622,0.15466,0.13118,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.001955,0.15466,0.15041,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.00022208,0.15465,0.14885,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0093576,0.1546,0.14151,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.0011341,0.15458,0.16785,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.01995,0.15457,0.12249,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00090088,0.15449,0.1514,1,1
1,GO PROTEIN PROCESSING,0.00033955,0.15417,0.15149,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.00031414,0.15411,0.13588,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.00030449,0.15385,0.24828,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.001071,0.15363,0.15053,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,3.628e-05,0.15344,0.21576,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.01829,0.1532,0.08894,1,1
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.015674,0.153,0.18968,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0010113,0.15295,0.12048,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.015501,0.15295,0.12069,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.027401,0.15291,0.12853,1,1
1,GO CELL CELL RECOGNITION,2.4528e-05,0.15286,0.14847,1,1
1,GO HEART TRABECULA FORMATION,0.010522,0.15255,0.21994,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,3.9872e-06,0.15242,0.17127,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0021505,0.15242,0.15424,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00087508,0.15241,0.18359,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0072795,0.15222,0.15096,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.011022,0.1518,0.10486,1,1
1,GO MEMBRANE BIOGENESIS,0.0085105,0.15165,0.17209,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00083767,0.15149,0.12736,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0005211,0.15145,0.13161,1,1
1,GO MYELOID CELL DEVELOPMENT,0.031953,0.1513,0.11378,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00020835,0.15087,0.14332,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00049053,0.1508,0.14364,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,2.8814e-05,0.15065,0.14439,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,2.011e-05,0.15061,0.14915,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.0071051,0.15055,0.13329,1,1
1,GO RESPONSE TO BMP,0.024947,0.15001,0.13084,1,1
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0029645,0.14992,0.1466,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,1.5865e-05,0.14986,0.15116,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0020929,0.14976,0.13429,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.00069207,0.14961,0.16722,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0075485,0.14956,0.16004,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00034485,0.14946,0.13569,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00031414,0.14931,0.15478,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0023637,0.14927,0.16502,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.00081356,0.14902,0.13442,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00029511,0.14894,0.13963,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.6283e-05,0.14882,0.17501,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0015463,0.14857,0.13509,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00019541,0.14857,0.16193,1,1
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.022686,0.1485,0.11594,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.0050904,0.14839,0.11883,1,1
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.03902,0.14817,0.12828,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00068191,0.14813,0.13057,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00026858,0.14777,0.14228,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.0098086,0.14773,0.15885,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0027381,0.14771,0.16482,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.014823,0.14763,0.13913,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.022209,0.14735,0.13165,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0069343,0.14726,0.17825,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0066039,0.14695,0.12448,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0050904,0.14658,0.11532,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.013394,0.14656,0.12894,1,1
1,GO LYSOSOMAL TRANSPORT,0.0014022,0.14638,0.13185,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0030038,0.14571,0.15339,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,9.03e-05,0.14555,0.18956,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0010865,0.14554,0.14594,1,1
1,GO RESPONSE TO ESTRADIOL,0.001955,0.14521,0.14341,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,6.4341e-05,0.14501,0.12335,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00058763,0.1449,0.1377,1,1
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.038258,0.14476,0.10883,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.010041,0.14473,0.15176,1,1
1,GO CELLULAR RESPONSE TO DRUG,0.0029645,0.14433,0.11515,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.027401,0.14416,0.1315,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.059331,0.14394,0.12811,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0035605,0.14348,0.12578,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.0005133,0.14335,0.15113,1,1
1,GO HEART GROWTH,0.00090088,0.14334,0.15668,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0016806,0.14323,0.12344,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.0018256,0.14306,0.12136,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00029976,0.14284,0.13794,1,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.033608,0.14275,0.14658,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0023321,0.1427,0.12366,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.0039481,0.14254,0.1374,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.002631,0.14241,0.11674,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00087508,0.1423,0.10262,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0044298,0.14214,0.11769,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.01251,0.14206,0.12848,1,1
1,GO JNK CASCADE,0.014658,0.14203,0.095648,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.0025961,0.14168,0.15491,1,1
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.02521,0.1416,0.11044,1,1
1,GO HISTONE H4 DEACETYLATION,0.025475,0.1413,0.15197,1,1
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.025743,0.14075,0.11497,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0096941,0.14064,0.11731,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.0027747,0.1405,0.15208,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.049212,0.1403,0.11353,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,7.5001e-05,0.14025,0.13996,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.002631,0.13985,0.12813,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.0065235,0.13981,0.15967,1,1
1,GO CYTOKINETIC PROCESS,0.00071283,0.13971,0.1575,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,8.2686e-06,0.13939,0.17357,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00017176,0.13928,0.14051,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0042636,0.13892,0.10899,1,1
1,GO REGULATION OF RESPONSE TO STRESS,8.1623e-05,0.13857,0.13215,1,1
1,GO RIBOSOME ASSEMBLY,0.035691,0.13854,0.10379,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0085105,0.13844,0.11277,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00021857,0.1384,0.18097,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0016347,0.13831,0.1297,1,1
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.011022,0.13774,0.1316,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00049802,0.13744,0.12108,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.001422,0.13713,0.1363,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00039018,0.13697,0.11561,1,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.050154,0.13696,0.10507,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0077327,0.13682,0.098771,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0032078,0.13676,0.093677,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,9.4959e-05,0.13667,0.14315,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0056958,0.13666,0.10608,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.023419,0.13658,0.10116,1,1
1,GO CAMP METABOLIC PROCESS,0.013093,0.13651,0.18751,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.014494,0.13649,0.15002,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.8701e-05,0.13648,0.16386,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0007786,0.13634,0.16714,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0016806,0.13628,0.153,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00065224,0.13582,0.14658,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00064263,0.13564,0.11933,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0005211,0.13535,0.12886,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.018091,0.13529,0.09615,1,1
1,GO RESPONSE TO KETONE,0.0054192,0.13511,0.12386,1,1
1,GO MULTI ORGANISM LOCALIZATION,0.00015838,0.13499,0.15349,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.055093,0.13478,0.090225,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0007901,0.13468,0.13963,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.2487e-05,0.13463,0.1462,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00062378,0.13459,0.12015,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.016568,0.13431,0.14564,1,1
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.027118,0.13427,0.13985,1,1
1,GO REGULATION OF CELL DEATH,0.00059648,0.1337,0.11625,1,1
1,GO CELLULAR PIGMENTATION,0.0050269,0.13321,0.11844,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0034243,0.13321,0.16947,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0066851,0.13315,0.12571,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,8.7316e-05,0.1331,0.13208,1,1
1,GO DNA LIGATION,0.046921,0.13285,0.093881,1,1
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.0027747,0.1328,0.12667,1,1
1,GO INACTIVATION OF MAPK ACTIVITY,0.0031247,0.13258,0.21323,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,3.628e-05,0.13229,0.14089,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0085105,0.13211,0.094127,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030928,0.13167,0.13422,1,1
1,GO RESPONSE TO HORMONE,0.0028492,0.1316,0.11149,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.0087156,0.13155,0.12793,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0087156,0.1314,0.15645,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0065235,0.13108,0.11019,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.0022396,0.13068,0.12647,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00015331,0.13053,0.1243,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0028872,0.13048,0.11067,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.01251,0.13047,0.10532,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.0075485,0.13033,0.14688,1,1
1,GO NEURAL TUBE FORMATION,0.015501,0.13024,0.11354,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00025215,0.13023,0.13414,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0069343,0.13009,0.14486,1,1
1,GO TRANSLATIONAL INITIATION,0.01995,0.13006,0.11135,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00011596,0.12992,0.1478,1,1
1,GO SULFATION,0.010279,0.12982,0.15908,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.027973,0.12965,0.10566,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00049053,0.12954,0.13684,1,1
1,GO MUSCLE TISSUE DEVELOPMENT,0.055093,0.12953,0.084577,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00087508,0.12921,0.13345,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.05063,0.12902,0.066023,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00073415,0.12895,0.16314,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0011341,0.1289,0.13036,1,1
1,GO AGING,0.00015331,0.12886,0.13321,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0033799,0.12841,0.10947,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.014494,0.12828,0.1399,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0054872,0.12821,0.1128,1,1
1,GO MAINTENANCE OF LOCATION,9.03e-05,0.12818,0.13968,1,1
1,GO EXOCYTOSIS,0.0025617,0.12813,0.12746,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0047198,0.12781,0.10571,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.015329,0.12744,0.12472,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0054872,0.12743,0.14968,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0063654,0.12732,0.21868,1,1
1,GO VACUOLAR ACIDIFICATION,0.046921,0.12722,0.090435,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0022095,0.12688,0.11645,1,1
1,GO RESPONSE TO UV,0.0010408,0.12602,0.11443,1,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0059116,0.1258,0.17475,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.0017517,0.12568,0.10708,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.001422,0.12558,0.13776,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,0.00065224,0.12547,0.13057,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.0033361,0.12519,0.11477,1,1
1,GO REGULATION OF GENE SILENCING,0.0074579,0.12518,0.094658,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.021973,0.12476,0.11938,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.001483,0.12443,0.16803,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0016347,0.1241,0.14434,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.031631,0.12392,0.10269,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.017506,0.12388,0.10454,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.014332,0.12362,0.093665,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0028118,0.1236,0.089402,1,1
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.038637,0.12261,0.11604,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00016629,0.12227,0.13536,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,7.6283e-05,0.12221,0.11175,1,1
1,GO LIPID CATABOLIC PROCESS,0.001568,0.12209,0.11387,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00020504,0.12206,0.10291,1,1
1,GO MATURATION OF 5 8S RRNA,0.058787,0.12202,0.092751,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.0074579,0.12197,0.074813,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00159,0.12179,0.10012,1,1
1,GO HEART DEVELOPMENT,0.0011503,0.12166,0.13953,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.018693,0.12152,0.079034,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.0018256,0.12099,0.14174,1,1
1,GO GOLGI VESICLE TRANSPORT,0.00019541,0.12087,0.11762,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.01251,0.12082,0.10487,1,1
1,GO GOLGI VESICLE BUDDING,0.0056255,0.12039,0.10624,1,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.010041,0.12037,0.12392,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0052854,0.12032,0.080057,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0005211,0.12015,0.11089,1,1
1,GO COPII COATED VESICLE BUDDING,0.0068504,0.11982,0.10291,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0007786,0.11969,0.13265,1,1
1,GO ENDOCYTOSIS,0.0030839,0.11968,0.10821,1,1
1,GO ENDOCYTIC RECYCLING,0.037882,0.11965,0.093414,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.0024609,0.11958,0.10742,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0005618,0.11957,0.18032,1,1
1,GO BODY FLUID SECRETION,0.0005618,0.11956,0.13451,1,1
1,GO VIRION ASSEMBLY,0.0045438,0.11882,0.10288,1,1
1,GO LIPID MODIFICATION,0.0065235,0.11857,0.099552,1,1
1,GO PROTEIN AUTOPHOSPHORYLATION,0.032607,0.11803,0.088608,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.016752,0.118,0.13415,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.009139,0.1173,0.13916,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.0023321,0.11729,0.11682,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.023919,0.11725,0.13999,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0013069,0.11709,0.12436,1,1
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.040582,0.11684,0.11033,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0001803,0.11669,0.15078,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.027401,0.1162,0.11212,1,1
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.040981,0.11614,0.1091,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00059648,0.11578,0.1201,1,1
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.027401,0.11524,0.097794,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0013633,0.11511,0.10601,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.014172,0.1151,0.092808,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0015249,0.11478,0.099792,1,1
1,GO VACUOLAR TRANSPORT,0.0034692,0.11446,0.10272,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0042636,0.11439,0.10368,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,0.0048405,0.11428,0.11314,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.013093,0.11423,0.11254,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.039406,0.11392,0.10061,1,1
1,GO DNA DEALKYLATION,0.02174,0.11352,0.11116,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00099681,0.1135,0.19015,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0076401,0.11344,0.099455,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,8.1623e-05,0.11342,0.15353,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00075607,0.1134,0.10142,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0062877,0.11338,0.10253,1,1
1,GO RNA DESTABILIZATION,0.006444,0.11336,0.12034,1,1
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0027381,0.11282,0.14066,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,7.5001e-05,0.11264,0.10887,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0032078,0.11255,0.11248,1,1
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0094686,0.11226,0.1408,1,1
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.01585,0.11201,0.091318,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0045438,0.11152,0.09426,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00023294,0.11072,0.10545,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.026286,0.11066,0.12992,1,1
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.020385,0.11024,0.10754,1,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.010522,0.11011,0.11184,1,1
1,GO REGULATION OF CATABOLIC PROCESS,0.00020835,0.10986,0.098122,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0026663,0.10981,0.077837,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0021505,0.10972,0.1065,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.015501,0.10969,0.10297,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.010645,0.10962,0.11577,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.0048405,0.10934,0.16797,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011151,0.10921,0.098538,1,1
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.028556,0.10915,0.094253,1,1
1,GO RESPONSE TO CAMP,0.016568,0.10894,0.12565,1,1
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.017894,0.10879,0.11935,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0071918,0.10869,0.099377,1,1
1,GO PROTEIN DESTABILIZATION,0.045155,0.10823,0.084306,1,1
1,GO MITOTIC CYTOKINESIS,0.036048,0.10777,0.082002,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.016027,0.10758,0.20832,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.018693,0.10737,0.12034,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,8.3013e-05,0.10639,0.11632,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.00099681,0.10615,0.11273,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.012227,0.10596,0.086188,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.003607,0.10534,0.10961,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00082553,0.10516,0.1458,1,1
1,GO MATURATION OF SSU RRNA,0.036409,0.10472,0.12238,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.023919,0.10429,0.048934,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0023009,0.10359,0.11903,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.004964,0.10306,0.09821,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.02174,0.10191,0.093695,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0030038,0.10176,0.10296,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.037139,0.10132,0.12784,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0031247,0.1008,0.08946,1,1
1,GO WHITE FAT CELL DIFFERENTIATION,0.046921,0.098864,0.098154,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.024947,0.098413,0.078281,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.021973,0.097073,0.11504,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,0.013546,0.096797,0.078763,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.033608,0.096433,0.079777,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.02521,0.096338,0.099459,1,1
1,GO BLASTOCYST FORMATION,0.01829,0.095974,0.085217,1,1
1,GO PEPTIDE METABOLIC PROCESS,0.0024609,0.09431,0.086053,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.015159,0.094128,0.16872,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0010259,0.093734,0.09261,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0034243,0.09284,0.14258,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.059331,0.092803,0.0955,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.009139,0.092253,0.13605,1,1
1,GO MITOPHAGY,0.031631,0.091996,0.1074,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.028264,0.091204,0.086818,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.019104,0.091171,0.052128,1,1
1,GO HORMONE METABOLIC PROCESS,0.033608,0.089974,0.085917,1,1
1,GO MODIFIED AMINO ACID TRANSPORT,0.046921,0.089758,0.091948,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.05063,0.089511,0.076946,1,1
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.048746,0.089476,0.095793,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.036048,0.088997,0.072305,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.016568,0.088575,0.079718,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.045591,0.088246,0.049797,1,1
1,GO RESPONSE TO HEAT,0.0087156,0.087508,0.090157,1,1
1,GO NCRNA PROCESSING,0.046031,0.087071,0.087281,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.016205,0.087037,0.088515,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0037498,0.086732,0.10784,1,1
1,GO SULFATE TRANSPORT,0.041789,0.086067,0.061825,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0021798,0.085929,0.079188,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.00072342,0.085899,0.088224,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0016122,0.085743,0.086112,1,1
1,GO RNA MODIFICATION,0.047372,0.083781,0.075161,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.024173,0.083619,0.083206,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0026663,0.083134,0.10091,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0077327,0.082487,0.099957,1,1
1,GO CELLULAR SENESCENCE,0.0026663,0.080169,0.11688,1,1
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.025743,0.079463,0.094651,1,1
1,GO RNA CATABOLIC PROCESS,0.008211,0.079154,0.087331,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0047798,0.07856,0.12122,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0089251,0.078326,0.079425,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0041031,0.078055,0.096533,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0055559,0.077779,0.079913,1,1
1,GO SPINDLE LOCALIZATION,0.061549,0.077776,0.081615,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.048285,0.077539,0.066446,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,0.001704,0.077234,0.082161,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.050154,0.077116,0.072802,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.060988,0.075706,0.059258,1,1
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.022686,0.073837,0.089924,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.060432,0.073634,0.03472,1,1
1,GO NUCLEAR TRANSPORT,0.049212,0.07299,0.04487,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.040582,0.072539,0.10639,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.039406,0.07175,0.072626,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.046921,0.071628,0.0642,1,1
1,GO NUCLEAR EXPORT,0.05357,0.071586,0.052474,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,0.0032501,0.071524,0.078156,1,1
1,GO ENDOSOMAL TRANSPORT,0.032938,0.071288,0.063717,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.042197,0.070898,0.10937,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.039406,0.069135,0.13882,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.050154,0.068655,0.07375,1,1
1,GO MEMBRANE ORGANIZATION,0.03006,0.068493,0.068547,1,1
1,GO PROTEIN FOLDING,0.048285,0.066629,0.088188,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.034636,0.066477,0.060874,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.041383,0.060824,0.056875,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.037882,0.060814,0.077811,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.021053,0.060771,0.060084,1,1
1,GO PROTEIN TARGETING,0.014494,0.060471,0.072545,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.059879,0.058338,0.037094,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.026286,0.055255,0.074983,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,1.2281e-06,1.2443,1.0153,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.1316e-06,1.1308,0.86079,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.1729e-08,0.85374,0.76605,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.1456e-06,0.83447,0.62634,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,3.9035e-08,0.82247,0.63923,1,1
2,GO ETHANOL OXIDATION,2.0509e-11,0.81594,0.81777,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.0979e-10,0.81216,0.73438,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.9185e-12,0.74363,0.70832,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,2.2912e-11,0.73251,0.64634,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,3.8149e-08,0.704,0.59307,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,1.9136e-07,0.70166,0.62766,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,2.2926e-08,0.70076,0.56347,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,4.9069e-08,0.69228,0.55458,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,5.6487e-06,0.68424,0.54168,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,2.1196e-06,0.67079,0.52026,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,1.9546e-09,0.66928,0.73024,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.3697e-11,0.66169,0.6384,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,9.2118e-07,0.65325,0.58052,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,2.7676e-09,0.61977,0.5623,1,1
2,GO MUCUS SECRETION,5.0278e-07,0.60833,0.60468,1,1
2,GO MYOBLAST MIGRATION,6.1119e-05,0.60232,0.47736,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,3.0811e-07,0.59536,0.5535,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,8.4805e-07,0.59258,0.52202,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2328e-07,0.57958,0.47746,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,3.2859e-07,0.57953,0.5391,1,1
2,GO RESPONSE TO INTERFERON BETA,0.0005056,0.57709,0.38013,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.6579e-07,0.571,0.52296,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,1.0554e-07,0.56979,0.56408,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,5.9056e-05,0.56895,0.42808,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,7.5266e-09,0.5671,0.61708,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,1.1794e-07,0.56703,0.51152,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.0868e-08,0.56225,0.53948,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,4.3946e-06,0.55605,0.40023,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.2281e-06,0.55461,0.43787,1,1
2,GO PROSTATE GLAND GROWTH,2.2926e-08,0.55415,0.58062,1,1
2,GO RESPONSE TO INTERLEUKIN 18,5.4701e-07,0.54153,0.58503,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,2.7078e-07,0.54023,0.50008,1,1
2,GO OTIC VESICLE DEVELOPMENT,1.8032e-05,0.53871,0.436,1,1
2,GO CYCLOOXYGENASE PATHWAY,6.7105e-06,0.53652,0.43955,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,2.6386e-06,0.5365,0.45112,1,1
2,GO TOLERANCE INDUCTION,3.628e-05,0.53201,0.42042,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.2131e-09,0.53013,0.49509,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00010852,0.52874,0.39172,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.5052e-06,0.52544,0.53692,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,2.4586e-08,0.52424,0.46404,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.8135e-09,0.52242,0.44862,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.1064e-09,0.51682,0.49492,1,1
2,GO ETHANOL METABOLIC PROCESS,3.7319e-10,0.51622,0.55044,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.3784e-07,0.51559,0.44136,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,9.404e-07,0.51436,0.39191,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,1.2281e-06,0.50787,0.49877,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,1.6761e-05,0.50639,0.38419,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,4.8198e-07,0.50297,0.40082,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.9393e-05,0.50166,0.46387,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,9.4157e-10,0.5013,0.51333,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.6162e-06,0.49973,0.42541,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.5868e-06,0.49769,0.37822,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,5.4967e-09,0.4967,0.54816,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,8.9047e-09,0.49594,0.43604,1,1
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,2.6352e-05,0.49242,0.37739,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.00013673,0.48886,0.37457,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.5934e-07,0.48805,0.3607,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.8124e-06,0.48707,0.35947,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.7536e-08,0.48664,0.47704,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.2926e-08,0.47985,0.38973,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,8.7502e-06,0.47928,0.461,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.0235e-07,0.47927,0.47247,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,6.337e-06,0.47603,0.34267,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,4.1552e-07,0.47349,0.42453,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1533e-09,0.47099,0.45565,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,1.6994e-06,0.46977,0.40376,1,1
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.00036686,0.46909,0.35518,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.8001e-06,0.46669,0.36658,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,5.1304e-06,0.46447,0.45399,1,1
2,GO ACTIN FILAMENT SEVERING,6.7724e-05,0.46013,0.40913,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.5027e-08,0.45894,0.41235,1,1
2,GO HEPATOCYTE DIFFERENTIATION,1.0361e-05,0.45862,0.39071,1,1
2,GO RETINAL METABOLIC PROCESS,0.00033432,0.45685,0.35298,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.1588e-05,0.45606,0.42151,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.5037e-07,0.45532,0.40717,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,2.1375e-08,0.45156,0.38731,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.2543e-08,0.45052,0.36597,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.0429e-07,0.44871,0.35456,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.0094e-07,0.448,0.39258,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,3.1729e-08,0.44374,0.43427,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,3.5461e-06,0.44201,0.42056,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,7.9617e-06,0.44041,0.39943,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.3325e-06,0.43564,0.38122,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.5646e-05,0.43417,0.38321,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00037835,0.43411,0.43267,1,1
2,GO TYPE 2 IMMUNE RESPONSE,1.064e-06,0.43347,0.36176,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.00016361,0.43137,0.29999,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.9069e-08,0.43114,0.39601,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010673,0.42991,0.35922,1,1
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00026858,0.42592,0.35729,1,1
2,GO PROSTANOID METABOLIC PROCESS,3.8118e-09,0.42553,0.4481,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.5293e-05,0.42449,0.38796,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,3.094e-05,0.42449,0.31044,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,5.0278e-07,0.42376,0.44051,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,2.7452e-06,0.42311,0.32526,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00025215,0.42279,0.34064,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,1.0094e-07,0.42158,0.42768,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.1375e-05,0.41958,0.3234,1,1
2,GO DENDRITIC CELL MIGRATION,8.0712e-08,0.41871,0.39561,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.6881e-08,0.41869,0.39767,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.7282e-08,0.41867,0.33876,1,1
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.052575,0.41855,0.3722,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,6.4592e-06,0.41757,0.36398,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00011596,0.41701,0.40725,1,1
2,GO BIOLOGICAL PHASE,1.3693e-05,0.41638,0.47516,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,4.8416e-06,0.41607,0.39062,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0014624,0.41594,0.31976,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,2.1234e-05,0.4142,0.34261,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.471e-07,0.41187,0.36749,1,1
2,GO T CELL MEDIATED IMMUNITY,8.6328e-08,0.41097,0.35091,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0099244,0.41029,0.24005,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.8983e-07,0.40896,0.35653,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.8262e-07,0.40728,0.35536,1,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.012798,0.40693,0.27621,1,1
2,GO PEPTIDE CROSS LINKING,4.3997e-05,0.40664,0.30663,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.8698e-06,0.40595,0.33826,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.00010673,0.40307,0.29994,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,2.7804e-05,0.40125,0.39428,1,1
2,GO LYSINE METABOLIC PROCESS,0.00013899,0.40119,0.41552,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00044781,0.40054,0.29139,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.5606e-08,0.39884,0.35772,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,1.9749e-05,0.39852,0.44651,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,6.3359e-07,0.39828,0.36849,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,7.0522e-08,0.39628,0.38779,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00026858,0.39569,0.38921,1,1
2,GO PSEUDOPODIUM ORGANIZATION,1.9393e-05,0.39557,0.40551,1,1
2,GO INTERLEUKIN 13 PRODUCTION,2.206e-06,0.39521,0.42665,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,7.6446e-07,0.39516,0.38218,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.0161e-09,0.39239,0.41771,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.012367,0.39103,0.20547,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,4.0314e-05,0.38894,0.4233,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,2.2926e-08,0.38826,0.38127,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,1.6457e-05,0.38267,0.3057,1,1
2,GO INTERLEUKIN 2 PRODUCTION,7.892e-08,0.38172,0.33845,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,5.8049e-05,0.38136,0.37995,1,1
2,GO T CELL APOPTOTIC PROCESS,9.404e-07,0.38104,0.28368,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.4773e-06,0.37975,0.29292,1,1
2,GO INTERLEUKIN 8 PRODUCTION,7.8052e-07,0.37972,0.34464,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0005133,0.37916,0.32748,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.01016,0.37855,0.22383,1,1
2,GO REGULATION OF CELL KILLING,1.5674e-06,0.37767,0.30713,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.2146e-06,0.37749,0.33412,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.2143e-08,0.37702,0.34146,1,1
2,GO NOTOCHORD DEVELOPMENT,9.795e-06,0.37665,0.43448,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00049802,0.3728,0.34504,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,5.9056e-05,0.37187,0.36578,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,9.7998e-07,0.37141,0.37664,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.4861e-06,0.3714,0.31539,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,1.7693e-06,0.37025,0.32107,1,1
2,GO FRUCTOSE METABOLIC PROCESS,3.9613e-05,0.36939,0.40852,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.0678e-07,0.36937,0.37808,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,9.5999e-07,0.3692,0.41013,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,6.7411e-08,0.3688,0.40708,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,7.3803e-06,0.36706,0.32425,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.4861e-06,0.36698,0.28876,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.014332,0.36594,0.19569,1,1
2,GO RESPONSE TO HYDROPEROXIDE,0.0043737,0.36449,0.26132,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,6.205e-09,0.36399,0.37938,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.00033432,0.36288,0.26893,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,4.2444e-07,0.36269,0.35328,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.332e-06,0.36243,0.31327,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,1.3442e-05,0.36201,0.43254,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,1.3693e-05,0.36193,0.29159,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.2253e-05,0.3607,0.28499,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,1.6654e-06,0.35853,0.29616,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.00086244,0.35842,0.21413,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.3661e-05,0.35779,0.27517,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,1.734e-06,0.35714,0.32263,1,1
2,GO LIMB BUD FORMATION,0.00087508,0.35677,0.41781,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00014599,0.35625,0.36579,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.0791e-07,0.35618,0.31948,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,3.3435e-06,0.35584,0.33223,1,1
2,GO LEUKOCYTE AGGREGATION,0.019523,0.35444,0.23095,1,1
2,GO MONOCYTE CHEMOTAXIS,4.3946e-06,0.35245,0.30582,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.0076401,0.35164,0.26983,1,1
2,GO AMINE CATABOLIC PROCESS,9.0235e-07,0.35091,0.34908,1,1
2,GO REGULATION OF DNA METHYLATION,5.8698e-06,0.34986,0.28257,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,1.3325e-06,0.34971,0.29945,1,1
2,GO RESPONSE TO TUMOR CELL,3.5461e-06,0.34834,0.32745,1,1
2,GO RETINOL METABOLIC PROCESS,9.2321e-08,0.34644,0.32352,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00029511,0.3455,0.27958,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,2.1196e-06,0.34498,0.32608,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.4091e-05,0.34367,0.30967,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00039622,0.33941,0.28815,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,1.8053e-06,0.33748,0.35807,1,1
2,GO INTERLEUKIN 1 PRODUCTION,2.5424e-05,0.3365,0.30813,1,1
2,GO CHONDROCYTE PROLIFERATION,5.1446e-05,0.33529,0.35968,1,1
2,GO OXYGEN TRANSPORT,0.0035605,0.33521,0.30177,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,5.7582e-06,0.33393,0.27524,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0028872,0.33344,0.27658,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.3228e-08,0.33287,0.32197,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.00016629,0.33273,0.29405,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00028155,0.33228,0.28543,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,4.5684e-06,0.33202,0.23952,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.00052901,0.33164,0.37144,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00036124,0.33112,0.31191,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.0657e-06,0.33096,0.27018,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00042128,0.33053,0.26328,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,6.1119e-05,0.33025,0.31986,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,9.086e-06,0.32907,0.25246,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.001955,0.32869,0.21331,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,5.0563e-05,0.32821,0.35148,1,1
2,GO ETHER METABOLIC PROCESS,2.7668e-07,0.32811,0.36159,1,1
2,GO RESPONSE TO INTERLEUKIN 15,8.1138e-06,0.32779,0.29377,1,1
2,GO NEURAL CREST FORMATION,0.00017176,0.32765,0.29946,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,5.8698e-06,0.32749,0.31496,1,1
2,GO HAIR FOLLICLE MATURATION,6.0079e-05,0.32699,0.31897,1,1
2,GO MATURE B CELL DIFFERENTIATION,3.4409e-05,0.32684,0.31455,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,1.7154e-07,0.3263,0.31553,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00010497,0.326,0.28791,1,1
2,GO GRANULOCYTE DIFFERENTIATION,9.4341e-06,0.32574,0.26568,1,1
2,GO EPIBOLY,0.0085105,0.3256,0.20893,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0021798,0.3253,0.21192,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.2445e-07,0.32446,0.33439,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.8262e-08,0.32406,0.35199,1,1
2,GO PSEUDOURIDINE SYNTHESIS,2.1624e-06,0.32343,0.28722,1,1
2,GO T CELL CHEMOTAXIS,8.6579e-07,0.32342,0.28178,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.206e-06,0.32317,0.28394,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.65e-07,0.32179,0.32616,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0012005,0.32096,0.22231,1,1
2,GO POSITIVE REGULATION OF COAGULATION,5.332e-06,0.32063,0.29392,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00012186,0.32048,0.256,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.3562e-07,0.31948,0.26962,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.4207e-05,0.31947,0.27449,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,1.5293e-05,0.31907,0.24508,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0029645,0.31897,0.27478,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,1.2716e-05,0.31885,0.30043,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.2162e-07,0.31836,0.29422,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,6.9711e-06,0.31808,0.27746,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,3.5022e-05,0.31795,0.23776,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.00025617,0.31757,0.31447,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,9.6129e-06,0.31752,0.26891,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,5.2303e-06,0.31738,0.2902,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.4472e-05,0.31708,0.25746,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.439e-07,0.31615,0.29546,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.6761e-05,0.3157,0.27192,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00014362,0.31516,0.28062,1,1
2,GO MONONUCLEAR CELL MIGRATION,5.0278e-07,0.31509,0.2987,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,7.5217e-06,0.31473,0.27995,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00084997,0.31442,0.23806,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,9.03e-05,0.31398,0.25035,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00038422,0.31395,0.29525,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,2.2505e-06,0.31353,0.29322,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0061347,0.31338,0.22451,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.206e-06,0.31282,0.3041,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00036124,0.31189,0.28782,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,1.9989e-07,0.31109,0.29554,1,1
2,GO NAD BIOSYNTHETIC PROCESS,0.00041488,0.31062,0.23759,1,1
2,GO I KAPPAB PHOSPHORYLATION,1.0756e-05,0.31056,0.26285,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.00022927,0.31018,0.31564,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,3.8161e-07,0.30935,0.28431,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,3.8347e-06,0.30878,0.39857,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00025215,0.30857,0.29981,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,3.758e-05,0.3081,0.26285,1,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.007921,0.30802,0.21189,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00019229,0.30752,0.33577,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00026858,0.30743,0.26041,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,6.3249e-05,0.30716,0.23873,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,5.8049e-05,0.30603,0.27979,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,2.0853e-05,0.3051,0.25758,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00012804,0.30485,0.36905,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,5.6487e-06,0.3048,0.28389,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.7051e-07,0.30468,0.26311,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,4.8416e-06,0.30435,0.32783,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,9.6562e-05,0.30433,0.31997,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.00023667,0.30407,0.24638,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00016098,0.30301,0.27606,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0003557,0.30247,0.2686,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,5.2303e-06,0.30171,0.34574,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.00012594,0.30159,0.23936,1,1
2,GO RESPONSE TO INTERLEUKIN 12,5.6487e-06,0.30123,0.26081,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.819e-05,0.30039,0.27462,1,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0012527,0.30018,0.27204,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,1.2954e-05,0.29997,0.37309,1,1
2,GO RIG I SIGNALING PATHWAY,5.2445e-07,0.29958,0.26798,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0028118,0.29918,0.27014,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.00023294,0.29901,0.2443,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,7.3803e-06,0.29873,0.27493,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.8419e-06,0.29857,0.29164,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,2.8001e-06,0.29847,0.30611,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,8.1623e-05,0.2977,0.30119,1,1
2,GO HIPPO SIGNALING,0.00095459,0.29769,0.28386,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.00013673,0.29717,0.30181,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00032408,0.2968,0.2637,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,7.0522e-08,0.29646,0.30808,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,8.1138e-06,0.29638,0.27554,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00083767,0.2959,0.27709,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.1794e-07,0.29548,0.27516,1,1
2,GO ZYMOGEN ACTIVATION,0.001422,0.29463,0.28057,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7804e-05,0.29439,0.26965,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,4.8416e-06,0.29421,0.27314,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,3.2162e-07,0.29376,0.25967,1,1
2,GO RESPONSE TO PROTOZOAN,3.8246e-05,0.29339,0.30804,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0068504,0.29302,0.2058,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,7.9617e-06,0.29216,0.27124,1,1
2,GO SEQUESTERING OF METAL ION,0.0011341,0.29213,0.23438,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00037257,0.29181,0.21311,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0002443,0.29148,0.24549,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.0094e-07,0.2912,0.28491,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,4.6359e-05,0.29115,0.23233,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0024281,0.29095,0.3049,1,1
2,GO PODOSOME ASSEMBLY,0.0005618,0.29072,0.27161,1,1
2,GO CHEMOKINE PRODUCTION,9.1829e-05,0.29062,0.2283,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,1.3056e-06,0.29039,0.28602,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.0012527,0.29027,0.23493,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.00032916,0.28923,0.20859,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,1.6761e-05,0.28904,0.21481,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00021511,0.28856,0.27364,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00013232,0.28822,0.30158,1,1
2,GO PORE COMPLEX ASSEMBLY,9.7991e-09,0.28708,0.28874,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,1.0036e-08,0.28706,0.3287,1,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.014494,0.28681,0.19883,1,1
2,GO T CELL PROLIFERATION,1.3442e-05,0.28641,0.23184,1,1
2,GO ETHANOL CATABOLIC PROCESS,0.00055343,0.28637,0.28279,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.011e-05,0.28615,0.2197,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00074504,0.28599,0.21288,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00053704,0.28562,0.25158,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,8.7316e-05,0.28528,0.25659,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0085105,0.28518,0.22031,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,9.6129e-06,0.28499,0.26587,1,1
2,GO VIRAL GENOME REPLICATION,0.0037016,0.28489,0.18375,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,6.5125e-09,0.28475,0.30051,1,1
2,GO REGULATION OF B CELL PROLIFERATION,2.9332e-05,0.28382,0.24859,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,7.5217e-06,0.28377,0.24702,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,6.4434e-08,0.28362,0.27125,1,1
2,GO RESPONSE TO ANGIOTENSIN,6.2175e-05,0.28328,0.25238,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.5837e-06,0.28291,0.24514,1,1
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.034984,0.28231,0.19,1,1
2,GO B CELL PROLIFERATION,2.0478e-05,0.28083,0.23922,1,1
2,GO BLASTODERM SEGMENTATION,0.0005789,0.28063,0.27014,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.0776e-06,0.28062,0.32065,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00040857,0.28038,0.31657,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00084997,0.28029,0.24117,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.00025617,0.28028,0.24423,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,1.5014e-05,0.28006,0.25491,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.913e-06,0.28003,0.28488,1,1
2,GO TRNA CATABOLIC PROCESS,0.038637,0.27951,0.18526,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,9.6129e-06,0.27807,0.25973,1,1
2,GO KERATINOCYTE PROLIFERATION,0.0084096,0.2767,0.23685,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,2.2824e-05,0.27657,0.23765,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.00010673,0.27628,0.22656,1,1
2,GO INTERACTION WITH SYMBIONT,6.8885e-07,0.27552,0.23448,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,2.3891e-06,0.27538,0.29991,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.5359e-06,0.27498,0.24235,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,8.2686e-06,0.27473,0.24362,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.00058763,0.27457,0.23575,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0021505,0.27457,0.19515,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0025617,0.27447,0.17937,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.8924e-05,0.27444,0.24746,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00057029,0.27437,0.24596,1,1
2,GO CHROMATIN DISASSEMBLY,0.00013899,0.27404,0.20691,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0012005,0.27383,0.25849,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,2.6828e-05,0.27373,0.24754,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,8.1361e-07,0.27369,0.2594,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,8.4262e-06,0.2736,0.29851,1,1
2,GO INNATE IMMUNE RESPONSE,4.3236e-05,0.27359,0.21846,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.758e-05,0.27307,0.24247,1,1
2,GO TONGUE MORPHOGENESIS,0.0062877,0.27302,0.24581,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,9.03e-05,0.27234,0.23192,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,4.4807e-06,0.27208,0.21549,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0031247,0.27185,0.20231,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,5.0323e-06,0.27179,0.26846,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0039992,0.27175,0.31156,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.011022,0.27171,0.21789,1,1
2,GO RESPONSE TO VIRUS,0.00091404,0.27166,0.18631,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00022208,0.27157,0.262,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,1.0424e-06,0.27142,0.26309,1,1
2,GO ERYTHROCYTE MATURATION,4.7999e-05,0.27127,0.29046,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00010152,0.27102,0.2169,1,1
2,GO FIBROBLAST ACTIVATION,8.6579e-07,0.27086,0.32149,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,8.1361e-07,0.27057,0.3057,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,1.0791e-07,0.27042,0.2739,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,2.8001e-06,0.27014,0.21571,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00022927,0.27011,0.24216,1,1
2,GO LAMELLIPODIUM ORGANIZATION,3.2162e-07,0.2701,0.25759,1,1
2,GO NIK NF KAPPAB SIGNALING,3.0905e-06,0.26973,0.21751,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,1.4207e-05,0.26947,0.24881,1,1
2,GO GAS TRANSPORT,0.00055343,0.26898,0.29312,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,1.9563e-06,0.26834,0.25011,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0012005,0.26816,0.23419,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,4.0314e-05,0.26801,0.21957,1,1
2,GO PIGMENT ACCUMULATION,0.0005618,0.26797,0.26515,1,1
2,GO PROTEIN DEMANNOSYLATION,0.00039622,0.26749,0.23058,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.00015838,0.26746,0.26418,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.00091404,0.26686,0.25941,1,1
2,GO CORNIFICATION,0.00020835,0.26663,0.32203,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0052197,0.26644,0.19208,1,1
2,GO TRACHEA DEVELOPMENT,0.00045468,0.2661,0.23981,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00020504,0.26538,0.26558,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.3661e-05,0.26479,0.26131,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.0050269,0.26467,0.23837,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,3.5461e-06,0.26461,0.32397,1,1
2,GO ALPHA BETA T CELL ACTIVATION,2.3661e-05,0.26453,0.24672,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.034984,0.26432,0.15617,1,1
2,GO PROTEIN ADP RIBOSYLATION,1.0169e-05,0.26388,0.24468,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.00013016,0.26316,0.21428,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.5127e-05,0.26315,0.25737,1,1
2,GO MICROVILLUS ORGANIZATION,0.00022565,0.26259,0.29056,1,1
2,GO NEUROBLAST DIVISION,0.00057029,0.26245,0.25272,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00029052,0.26225,0.2373,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,8.5867e-06,0.26188,0.25078,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,1.0424e-06,0.26151,0.22047,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00067188,0.26134,0.19612,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00092737,0.26129,0.21063,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,1.7071e-05,0.26104,0.24329,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0050269,0.26077,0.1946,1,1
2,GO MICROVILLUS ASSEMBLY,0.00042777,0.26063,0.26872,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,7.2414e-06,0.26061,0.2435,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0062877,0.26041,0.23082,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00013232,0.25958,0.22533,1,1
2,GO ERBB2 SIGNALING PATHWAY,5.7051e-07,0.25873,0.28141,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.1535e-07,0.25867,0.24882,1,1
2,GO ARACHIDONIC ACID SECRETION,1.1806e-05,0.25844,0.2501,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.0005618,0.25817,0.38597,1,1
2,GO RESPIRATORY BURST,0.00021511,0.25795,0.22953,1,1
2,GO RESPONSE TO INTERLEUKIN 1,1.2534e-06,0.25784,0.20983,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0050269,0.25749,0.24347,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,1.4741e-05,0.25724,0.24236,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.342e-06,0.25681,0.26613,1,1
2,GO BRONCHUS DEVELOPMENT,0.0063654,0.25665,0.22631,1,1
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.018693,0.25663,0.13739,1,1
2,GO T CELL CYTOKINE PRODUCTION,2.4861e-06,0.25639,0.26021,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.00024045,0.25615,0.26047,1,1
2,GO ARGININE METABOLIC PROCESS,0.00096848,0.25597,0.21737,1,1
2,GO ACETYL COA METABOLIC PROCESS,6.8888e-05,0.25586,0.24408,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.024687,0.25575,0.17564,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.00091404,0.25551,0.2617,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.2027e-05,0.25547,0.21805,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0016122,0.25515,0.18855,1,1
2,GO RESPONSE TO STEROL DEPLETION,2.4091e-05,0.25501,0.26387,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,7.8911e-05,0.25498,0.22901,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.3946e-06,0.2548,0.25667,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00023294,0.25406,0.22374,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.4424e-05,0.25387,0.20945,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,1.0557e-05,0.25368,0.25436,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,3.3435e-06,0.25326,0.22635,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0087156,0.25317,0.22795,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,4.2784e-08,0.25304,0.23037,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0028872,0.25296,0.20947,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00044781,0.25295,0.24542,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0022396,0.25208,0.25169,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.9056e-05,0.25183,0.2402,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,5.0278e-07,0.25162,0.25418,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.009139,0.25115,0.23335,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,3.2057e-05,0.25112,0.22816,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,8.8796e-05,0.25099,0.21659,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,5.2344e-05,0.25061,0.24286,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.1621e-05,0.25,0.21747,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00062378,0.24998,0.21275,1,1
2,GO INTERFERON BETA PRODUCTION,0.0005211,0.24948,0.20944,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.00026858,0.24921,0.22599,1,1
2,GO CYTOPLASM ORGANIZATION,5.4184e-05,0.24869,0.31881,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,4.3997e-05,0.24782,0.21018,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.1282e-07,0.24779,0.23969,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00055343,0.24745,0.21048,1,1
2,GO REGULATION OF GASTRULATION,0.012087,0.24734,0.14487,1,1
2,GO NEGATIVE T CELL SELECTION,0.00014599,0.24708,0.21841,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,4.7963e-08,0.24706,0.25334,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,6.3249e-05,0.24703,0.25614,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.628e-05,0.24703,0.24688,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,1.7071e-05,0.24698,0.22968,1,1
2,GO FOREGUT MORPHOGENESIS,0.00087508,0.24698,0.24747,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.052575,0.24697,0.14705,1,1
2,GO ERYTHROCYTE DEVELOPMENT,1.9749e-05,0.24695,0.21415,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.001442,0.24687,0.25726,1,1
2,GO SECRETION BY TISSUE,0.00011033,0.24664,0.22067,1,1
2,GO REGULATION OF FIBRINOLYSIS,0.0044864,0.2462,0.18692,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001568,0.24618,0.24182,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00049802,0.24547,0.23325,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,1.1034e-07,0.24546,0.23737,1,1
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0053519,0.245,0.2163,1,1
2,GO REGULATION OF T CELL ACTIVATION,4.2487e-05,0.24495,0.20907,1,1
2,GO URETER DEVELOPMENT,0.00071283,0.2449,0.22557,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,4.2271e-06,0.24462,0.32088,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.2497e-05,0.24425,0.21239,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.0089251,0.24425,0.16752,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.0041031,0.24401,0.18697,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.048746,0.2437,0.15249,1,1
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0058389,0.24322,0.19471,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0047798,0.24319,0.17063,1,1
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.001483,0.24302,0.2258,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,8.5858e-05,0.24254,0.24991,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.016568,0.24234,0.1549,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,1.7922e-07,0.24186,0.2478,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0020929,0.24171,0.20057,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0095807,0.2413,0.15432,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00033955,0.24122,0.19698,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00099681,0.24109,0.23955,1,1
2,GO NEPHRON TUBULE FORMATION,0.00014839,0.24069,0.31478,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,2.8001e-06,0.24023,0.22004,1,1
2,GO VIRAL LIFE CYCLE,0.00033955,0.24008,0.1779,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,6.7105e-06,0.24002,0.23363,1,1
2,GO CELLULAR RESPONSE TO VIRUS,9.819e-05,0.23968,0.21672,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.4972e-05,0.23955,0.22632,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00015838,0.23934,0.21848,1,1
2,GO MACROPHAGE MIGRATION,0.00045468,0.23896,0.20205,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.0003557,0.23848,0.21791,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.0020092,0.23841,0.38036,1,1
2,GO B CELL HOMEOSTASIS,0.00025617,0.2384,0.22593,1,1
2,GO LEUKOCYTE PROLIFERATION,1.6457e-05,0.23824,0.22242,1,1
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.024947,0.23822,0.21173,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,2.9859e-05,0.23815,0.23463,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00018323,0.23812,0.23421,1,1
2,GO ENAMEL MINERALIZATION,0.0029256,0.23807,0.3105,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.022446,0.23787,0.19659,1,1
2,GO TERPENOID METABOLIC PROCESS,0.00095459,0.23753,0.16858,1,1
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.032278,0.23751,0.14979,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00047589,0.23671,0.18905,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.002631,0.23654,0.1849,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00022565,0.23652,0.22153,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00031414,0.23595,0.21043,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,5.7582e-06,0.23581,0.26242,1,1
2,GO RESPONSE TO X RAY,1.3442e-05,0.23577,0.27603,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.010522,0.23562,0.25228,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,4.6881e-08,0.23559,0.23406,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.00031907,0.23558,0.19754,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,5.7059e-05,0.23549,0.23061,1,1
2,GO HISTONE H4 DEACETYLATION,0.00014839,0.23549,0.22405,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.00035024,0.23546,0.26903,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,7.5001e-05,0.23519,0.19948,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,3.1494e-05,0.23519,0.23545,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00063314,0.23503,0.21302,1,1
2,GO PENTOSE METABOLIC PROCESS,2.3891e-06,0.23487,0.32909,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.0011341,0.23448,0.1937,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.0314e-05,0.23419,0.20676,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0030839,0.23389,0.19424,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00015083,0.23371,0.19499,1,1
2,GO STEM CELL DIVISION,0.0013069,0.23367,0.21153,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,2.2015e-05,0.23367,0.21485,1,1
2,GO INTERFERON GAMMA PRODUCTION,2.7804e-05,0.23345,0.22906,1,1
2,GO VESICLE CARGO LOADING,6.1119e-05,0.23345,0.19904,1,1
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.002702,0.23325,0.25408,1,1
2,GO PLATELET MORPHOGENESIS,2.1234e-05,0.23266,0.2717,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,8.1623e-05,0.2326,0.23023,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.00018323,0.23225,0.21065,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0013633,0.23219,0.1807,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00018323,0.23206,0.28023,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.7316e-05,0.23148,0.22054,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,9.03e-05,0.23116,0.21284,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,2.2958e-06,0.23087,0.21737,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00011406,0.23079,0.29544,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.043866,0.23077,0.15741,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.8363e-05,0.23054,0.27291,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,3.094e-05,0.23039,0.22038,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.0015249,0.22995,0.21585,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0002117,0.2295,0.1999,1,1
2,GO RRNA MODIFICATION,1.3693e-05,0.22934,0.19663,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0037016,0.22931,0.21252,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0023637,0.22922,0.19466,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.011e-05,0.22892,0.20101,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00043435,0.22889,0.19987,1,1
2,GO L SERINE METABOLIC PROCESS,0.010895,0.22836,0.19498,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013633,0.22825,0.22797,1,1
2,GO BEHAVIORAL RESPONSE TO PAIN,0.031631,0.22822,0.18657,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00031907,0.22819,0.27005,1,1
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0024609,0.22798,0.19973,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,7.8911e-05,0.2278,0.191,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00049053,0.22775,0.27499,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,1.9175e-06,0.22712,0.26588,1,1
2,GO MUSCLE CELL MIGRATION,0.002631,0.22698,0.17386,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,0.0046604,0.22682,0.13954,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0043737,0.22669,0.17627,1,1
2,GO RENAL VESICLE DEVELOPMENT,0.00086244,0.22626,0.20048,1,1
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,1.2253e-05,0.22626,0.20334,1,1
2,GO REPLICATIVE SENESCENCE,0.034636,0.22613,0.13595,1,1
2,GO IMP METABOLIC PROCESS,0.0037498,0.22607,0.19902,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.00069207,0.22604,0.22884,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.0958e-05,0.22602,0.19484,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,9.3381e-05,0.22576,0.20577,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,9.4341e-06,0.22558,0.25812,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0010408,0.22537,0.16829,1,1
2,GO REPLACEMENT OSSIFICATION,0.018693,0.22512,0.18439,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,1.4472e-05,0.22498,0.22059,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,6.4592e-06,0.22495,0.1968,1,1
2,GO DETOXIFICATION,4.1456e-06,0.22435,0.22348,1,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0015249,0.2242,0.19375,1,1
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.032938,0.22415,0.21781,1,1
2,GO T CELL ACTIVATION,0.00010673,0.22407,0.20322,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0011668,0.22355,0.18195,1,1
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.017315,0.22323,0.18016,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,1.3948e-05,0.2228,0.23127,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00011033,0.22216,0.22588,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00030928,0.22186,0.18955,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0012177,0.2214,0.17662,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00024045,0.22114,0.18839,1,1
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00048316,0.22104,0.22376,1,1
2,GO ZINC ION HOMEOSTASIS,0.0055559,0.22068,0.21493,1,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0077327,0.22065,0.18232,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0034692,0.22055,0.16044,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,4.0314e-05,0.22039,0.22374,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.031631,0.22013,0.16404,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,2.3239e-05,0.22012,0.20196,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,3.9872e-06,0.22008,0.23635,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.0776e-06,0.22007,0.22566,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.011022,0.21992,0.19152,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.002702,0.21977,0.16605,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.536e-06,0.21967,0.24415,1,1
2,GO MRNA MODIFICATION,0.00035024,0.21939,0.19232,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.004156,0.21922,0.1836,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.00014129,0.21906,0.26193,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00064263,0.219,0.39455,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.00030928,0.21883,0.19855,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.0557e-05,0.21864,0.20989,1,1
2,GO LAMELLIPODIUM ASSEMBLY,7.3803e-06,0.21856,0.20631,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00023294,0.21833,0.20444,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.4972e-05,0.21808,0.19678,1,1
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.046921,0.21746,0.13028,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,6.8885e-07,0.21737,0.24513,1,1
2,GO REGULATION OF PROTEIN MATURATION,0.00071283,0.21722,0.17899,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0042095,0.21679,0.18142,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,2.3891e-06,0.21662,0.20043,1,1
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.030994,0.2164,0.16708,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00049053,0.2164,0.18003,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00080175,0.21639,0.24871,1,1
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0032078,0.21618,0.1668,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,7.0072e-05,0.21611,0.22174,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.094e-05,0.216,0.22025,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0014624,0.21546,0.27595,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00010497,0.21505,0.21088,1,1
2,GO INTERACTION WITH HOST,0.0002117,0.21483,0.18696,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.8924e-05,0.21452,0.19801,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0063654,0.21451,0.22816,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,2.6386e-06,0.21448,0.21327,1,1
2,GO CYTOKINE PRODUCTION,0.00014599,0.21445,0.19329,1,1
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0075485,0.21435,0.17998,1,1
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0046604,0.21416,0.18778,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0020092,0.21413,0.25951,1,1
2,GO RNA DECAPPING,2.1621e-05,0.21357,0.18832,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,1.2253e-05,0.21349,0.18712,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00010152,0.21347,0.21423,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00098255,0.21279,0.20724,1,1
2,GO B CELL APOPTOTIC PROCESS,0.0005056,0.21269,0.20317,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,7.6283e-05,0.21257,0.19864,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.001118,0.21236,0.17616,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.0022396,0.21234,0.27312,1,1
2,GO ALDITOL METABOLIC PROCESS,1.0958e-05,0.21232,0.28326,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,5.5412e-06,0.21231,0.21397,1,1
2,GO PIGMENT GRANULE ORGANIZATION,3.758e-05,0.21229,0.2484,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.00022208,0.21212,0.17062,1,1
2,GO LYMPH VESSEL DEVELOPMENT,0.0024941,0.21212,0.24441,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00014839,0.21187,0.19377,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,6.9711e-06,0.21183,0.28629,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0072795,0.21164,0.16786,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.016752,0.21133,0.14107,1,1
2,GO MITRAL VALVE DEVELOPMENT,0.0059852,0.21131,0.28148,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00012594,0.21087,0.19866,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,1.7922e-07,0.21005,0.23107,1,1
2,GO ICOSANOID METABOLIC PROCESS,3.6924e-05,0.21004,0.2132,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010152,0.21002,0.17799,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.02174,0.20987,0.17217,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00029052,0.20986,0.23858,1,1
2,GO REGULATION OF PROTEIN IMPORT,7.2414e-06,0.20982,0.22661,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,2.342e-06,0.20971,0.19613,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.2487e-05,0.20967,0.22282,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00010152,0.20962,0.20286,1,1
2,GO RNA INTERFERENCE,0.00027716,0.20947,0.18835,1,1
2,GO RESPONSE TO CYTOKINE,0.00027716,0.20925,0.17298,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00026024,0.20919,0.16371,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00013232,0.20917,0.22529,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0005211,0.20915,0.27563,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,6.545e-05,0.209,0.22068,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0028492,0.20852,0.18689,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.00013016,0.20839,0.23566,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.001704,0.20835,0.18087,1,1
2,GO OVULATION,9.9844e-05,0.20816,0.23507,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.00019857,0.20813,0.19614,1,1
2,GO SPROUTING ANGIOGENESIS,0.00071283,0.20802,0.18125,1,1
2,GO RESPONSE TO GONADOTROPIN,0.001442,0.2079,0.19333,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00010852,0.20779,0.21298,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0012705,0.20738,0.22961,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.00012388,0.20698,0.19597,1,1
2,GO FIBROBLAST PROLIFERATION,0.015501,0.20687,0.13834,1,1
2,GO LYMPHANGIOGENESIS,0.0025277,0.20669,0.2073,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0038977,0.20664,0.14988,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.010279,0.20658,0.14833,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0020646,0.20643,0.23024,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.001704,0.20627,0.18197,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0030436,0.20608,0.18,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,6.2169e-06,0.20605,0.21334,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0032928,0.20598,0.17754,1,1
2,GO PLASMA MEMBRANE FUSION,0.032607,0.20575,0.1552,1,1
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0053519,0.20551,0.17608,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.0011503,0.20491,0.19985,1,1
2,GO RESPONSE TO IONIZING RADIATION,2.8814e-05,0.20489,0.18766,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.00010323,0.20463,0.18841,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,5.0323e-06,0.20442,0.25166,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.014172,0.2044,0.15674,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00040235,0.20432,0.24447,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.003654,0.20431,0.15382,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00081356,0.20429,0.21673,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0013443,0.2042,0.25073,1,1
2,GO GTP METABOLIC PROCESS,4.8839e-05,0.20413,0.21522,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,2.7804e-05,0.20385,0.28813,1,1
2,GO RESPONSE TO ANTIBIOTIC,1.2716e-05,0.20329,0.20052,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.004156,0.20298,0.16431,1,1
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.01829,0.20264,0.18209,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.024947,0.20258,0.20181,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,1.2792e-06,0.20186,0.20759,1,1
2,GO REGULATION OF IMMUNE RESPONSE,2.5884e-05,0.20173,0.1957,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00046872,0.20161,0.17033,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.5359e-06,0.20134,0.19801,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0005056,0.20121,0.18328,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00021511,0.20093,0.18463,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,3.6162e-06,0.20076,0.19427,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,9.4341e-06,0.20076,0.19397,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.7999e-05,0.20059,0.21613,1,1
2,GO LIPID IMPORT INTO CELL,0.0032078,0.20023,0.17011,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0012005,0.2001,0.2225,1,1
2,GO RESPONSE TO BACTERIUM,0.00037257,0.20006,0.17144,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,7.8911e-05,0.1999,0.20941,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00015838,0.19982,0.21962,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0019285,0.19931,0.19591,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.0059852,0.19922,0.24842,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0013069,0.19899,0.16623,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0014624,0.1989,0.17215,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00016901,0.19854,0.18692,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.00026858,0.19851,0.17228,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00030449,0.19842,0.17017,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.042609,0.19837,0.16607,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00034485,0.19822,0.18622,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0016122,0.19811,0.16022,1,1
2,GO EPIDERMIS DEVELOPMENT,0.0010259,0.19802,0.18529,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00019229,0.1978,0.17163,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00024819,0.19735,0.16461,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.0030436,0.19732,0.16143,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0007901,0.19727,0.18512,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.00068191,0.19705,0.16611,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.000286,0.19698,0.16728,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,9.086e-06,0.19642,0.20306,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,8.9166e-06,0.19636,0.2081,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0018764,0.1963,0.15457,1,1
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.011949,0.19572,0.1715,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00016361,0.19555,0.2161,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0023637,0.19551,0.20277,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,9.4959e-05,0.19542,0.19489,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,8.1138e-06,0.19529,0.20554,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.0005211,0.19498,0.19266,1,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.004964,0.19494,0.16967,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,9.6562e-05,0.19475,0.17315,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,2.0853e-05,0.19452,0.1837,1,1
2,GO BLASTOCYST FORMATION,2.3784e-07,0.19445,0.21235,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00098255,0.19442,0.27918,1,1
2,GO MESODERMAL CELL DIFFERENTIATION,0.004964,0.1944,0.16064,1,1
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.012653,0.19414,0.17108,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.01128,0.19413,0.20568,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00043435,0.1941,0.15442,1,1
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.0052854,0.1941,0.16513,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.025475,0.1941,0.14574,1,1
2,GO PRIMARY MIRNA PROCESSING,9.086e-06,0.19407,0.25929,1,1
2,GO CARNITINE SHUTTLE,8.1623e-05,0.19403,0.23344,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,1.0958e-05,0.19394,0.19999,1,1
2,GO KERATINIZATION,0.0045438,0.19389,0.21575,1,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.016938,0.19385,0.10983,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.0756e-05,0.1936,0.198,1,1
2,GO ASYMMETRIC CELL DIVISION,0.0018006,0.19353,0.18436,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00040235,0.19338,0.18751,1,1
2,GO T HELPER CELL LINEAGE COMMITMENT,0.0089251,0.19328,0.15869,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00088789,0.19305,0.23921,1,1
2,GO FATTY ACID TRANSPORT,3.4773e-06,0.19303,0.18278,1,1
2,GO REGULATION OF HEMOPOIESIS,4.7999e-05,0.19294,0.18516,1,1
2,GO SKIN DEVELOPMENT,0.0025277,0.19288,0.18426,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.3196e-05,0.19276,0.17133,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0035605,0.19271,0.15572,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00043435,0.19235,0.1692,1,1
2,GO GASTRIC ACID SECRETION,2.3661e-05,0.19222,0.22542,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0067673,0.19172,0.17967,1,1
2,GO TISSUE REGENERATION,0.0014022,0.19168,0.17548,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,1.6761e-05,0.19141,0.19352,1,1
2,GO HYPOTONIC RESPONSE,0.016386,0.19131,0.16063,1,1
2,GO REGULATION OF CELL ACTIVATION,6.4341e-05,0.19129,0.1915,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00015083,0.19121,0.28712,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00057029,0.19086,0.17873,1,1
2,GO REGULATION OF CELL ADHESION,0.0017517,0.1908,0.16257,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.011678,0.19052,0.13914,1,1
2,GO MYOBLAST DIFFERENTIATION,0.0011503,0.19051,0.18039,1,1
2,GO ERBB SIGNALING PATHWAY,4.0314e-05,0.19042,0.18596,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0030038,0.1904,0.14111,1,1
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0014022,0.19039,0.21158,1,1
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.01849,0.19016,0.16067,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.00091404,0.18946,0.21916,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.020385,0.18934,0.15425,1,1
2,GO HISTONE H2B UBIQUITINATION,0.00047589,0.18927,0.15791,1,1
2,GO T CELL DIFFERENTIATION,8.8796e-05,0.18908,0.19874,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.2716e-05,0.1881,0.19776,1,1
2,GO GLYCINE METABOLIC PROCESS,0.001704,0.18785,0.18826,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0005211,0.18778,0.17196,1,1
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.053071,0.18775,0.15438,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0020929,0.18733,0.1999,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.0046604,0.18731,0.15711,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00088789,0.18686,0.22627,1,1
2,GO AMINO ACID ACTIVATION,8.8796e-05,0.18677,0.18232,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00034485,0.18654,0.18481,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0083098,0.18629,0.14272,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.001442,0.18621,0.22565,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0018006,0.18611,0.193,1,1
2,GO PHAGOCYTOSIS RECOGNITION,0.0020367,0.18602,0.20423,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00011986,0.18573,0.19638,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,9.819e-05,0.1853,0.17516,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.2057e-05,0.18522,0.22162,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,9.9844e-05,0.18511,0.21717,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,8.7316e-05,0.1851,0.16607,1,1
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.054582,0.18478,0.15354,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0037985,0.18477,0.14523,1,1
2,GO GRANULOCYTE MIGRATION,0.001235,0.18467,0.1776,1,1
2,GO SOMATIC STEM CELL DIVISION,0.016386,0.18453,0.26924,1,1
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.056128,0.18423,0.17688,1,1
2,GO MRNA TRANSCRIPTION,0.00052901,0.18368,0.18671,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.0012886,0.18354,0.16732,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,1.6761e-05,0.1832,0.17588,1,1
2,GO ARTERY MORPHOGENESIS,0.007921,0.18316,0.16725,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0043737,0.18305,0.15042,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00057029,0.18287,0.19659,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,8.1623e-05,0.18274,0.20718,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,2.3239e-05,0.18267,0.21334,1,1
2,GO FATTY ACID METABOLIC PROCESS,2.5424e-05,0.18265,0.15765,1,1
2,GO V D J RECOMBINATION,0.012227,0.1826,0.17597,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.00017176,0.18249,0.18893,1,1
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.032607,0.18238,0.19088,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.00022565,0.18229,0.20301,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00042128,0.18221,0.16076,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0104,0.18209,0.24181,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.7071e-05,0.18143,0.20225,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0047198,0.18134,0.15625,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00032916,0.18095,0.13116,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0001862,0.18081,0.16251,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,2.5884e-05,0.18069,0.16511,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.6877e-06,0.18048,0.20515,1,1
2,GO RESPONSE TO UV C,0.0069343,0.18041,0.19162,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,2.2824e-05,0.18027,0.18741,1,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.017315,0.18023,0.16787,1,1
2,GO RESPONSE TO ESTROGEN,0.0016806,0.18019,0.17593,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00031907,0.18017,0.18996,1,1
2,GO REGULATION OF HAIR CYCLE,0.0017517,0.17987,0.20826,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,4.5233e-07,0.17957,0.1878,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00062378,0.17945,0.14767,1,1
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.011022,0.1793,0.14488,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0010259,0.17913,0.21534,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0053519,0.17906,0.12694,1,1
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0104,0.17888,0.21734,1,1
2,GO LIPID HOMEOSTASIS,0.00061456,0.17861,0.14873,1,1
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.017125,0.17822,0.16746,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0052197,0.17816,0.16584,1,1
2,GO NUCLEAR PORE ORGANIZATION,6.545e-05,0.17792,0.20868,1,1
2,GO TOXIN TRANSPORT,0.00023294,0.17785,0.17086,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00032408,0.17762,0.1855,1,1
2,GO NADP METABOLIC PROCESS,0.0017277,0.17756,0.16507,1,1
2,GO PIGMENT METABOLIC PROCESS,8.5858e-05,0.17734,0.15875,1,1
2,GO SYMBIOTIC PROCESS,1.5293e-05,0.17718,0.15388,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.0096941,0.17713,0.16104,1,1
2,GO B CELL DIFFERENTIATION,0.00011986,0.17704,0.20215,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,1.5576e-05,0.17686,0.20441,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0019819,0.1763,0.22803,1,1
2,GO COLLAGEN CATABOLIC PROCESS,0.011022,0.17609,0.15457,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0016122,0.17605,0.16588,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0037985,0.17589,0.17672,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.019312,0.17589,0.1575,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.00015083,0.17588,0.18223,1,1
2,GO ACUTE PHASE RESPONSE,0.0005789,0.17585,0.17321,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,6.4341e-05,0.1757,0.19588,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0022396,0.17556,0.13168,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0016122,0.17545,0.16285,1,1
2,GO AMELOGENESIS,0.015674,0.17542,0.19817,1,1
2,GO HISTONE H3 K9 ACETYLATION,0.00031907,0.17515,0.17937,1,1
2,GO LEUKOCYTE HOMEOSTASIS,0.0039481,0.17494,0.15442,1,1
2,GO MAINTENANCE OF CELL NUMBER,6.3249e-05,0.17489,0.1803,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00029511,0.17481,0.14443,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0098086,0.1748,0.13789,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.0019285,0.1746,0.17722,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,1.8363e-05,0.17447,0.15494,1,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.059879,0.17413,0.0969,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0063654,0.174,0.15145,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.5558e-05,0.17383,0.17859,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00034485,0.17373,0.16147,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,4.3946e-06,0.17343,0.17808,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,1.5293e-05,0.17343,0.18384,1,1
2,GO GLAND MORPHOGENESIS,0.032278,0.17321,0.17322,1,1
2,GO PERICARDIUM DEVELOPMENT,0.033271,0.17317,0.1557,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.00025617,0.17303,0.17649,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0089251,0.17303,0.12043,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0056255,0.17301,0.14734,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0030038,0.17299,0.15655,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0031247,0.1729,0.2424,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.00019229,0.17262,0.1655,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.037509,0.17247,0.13048,1,1
2,GO LUNG MORPHOGENESIS,0.02128,0.17244,0.18926,1,1
2,GO AXIS ELONGATION,0.0010113,0.17231,0.26375,1,1
2,GO RESPONSE TO VITAMIN A,0.0069343,0.17204,0.17439,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00011406,0.17197,0.22557,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0013443,0.17144,0.15131,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,3.9102e-06,0.17141,0.22323,1,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.028852,0.17123,0.19828,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.017125,0.17122,0.13811,1,1
2,GO LYMPHOCYTE ACTIVATION,0.0002117,0.17115,0.17748,1,1
2,GO LIPID OXIDATION,0.00064263,0.17075,0.14258,1,1
2,GO REGULATORY T CELL DIFFERENTIATION,0.0042095,0.17064,0.20368,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.015329,0.17064,0.15387,1,1
2,GO REGULATION OF GENE SILENCING,1.6158e-05,0.17013,0.15421,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,8.4424e-05,0.17005,0.14919,1,1
2,GO GOLGI LOCALIZATION,0.00049802,0.17,0.17349,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.0029256,0.16984,0.13232,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.996e-06,0.16976,0.1765,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.001442,0.16968,0.1973,1,1
2,GO SYNCYTIUM FORMATION,0.0084096,0.16927,0.15156,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.017506,0.16899,0.14622,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.00032408,0.16898,0.27689,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.00030449,0.16896,0.15993,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.011e-05,0.16872,0.15798,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,3.094e-05,0.16822,0.18807,1,1
2,GO RESPONSE TO GAMMA RADIATION,1.0361e-05,0.16789,0.2125,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.012945,0.16783,0.14506,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.0033799,0.16776,0.17992,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.001235,0.16768,0.18609,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.003607,0.16755,0.13804,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.03006,0.167,0.13135,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0078263,0.16691,0.15291,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00020835,0.16677,0.17299,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00029511,0.1666,0.18917,1,1
2,GO AMP METABOLIC PROCESS,0.0015463,0.16656,0.22715,1,1
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.006444,0.16649,0.19924,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.001776,0.16601,0.19463,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.018693,0.16595,0.11346,1,1
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.042197,0.16587,0.15018,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0093576,0.16569,0.15439,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.002631,0.16546,0.16328,1,1
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.012367,0.16529,0.17488,1,1
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.008211,0.16501,0.16957,1,1
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.036409,0.16494,0.13506,1,1
2,GO TRNA PROCESSING,0.00024819,0.16485,0.13948,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00014839,0.16483,0.18271,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00013451,0.16466,0.16394,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,7.5217e-06,0.16466,0.18172,1,1
2,GO MIRNA METABOLIC PROCESS,0.0007786,0.16456,0.14846,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.002702,0.16453,0.16967,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00027284,0.16449,0.2163,1,1
2,GO MANGANESE ION TRANSPORT,0.050154,0.1644,0.097281,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.003607,0.16431,0.13681,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0046018,0.16431,0.14767,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0016122,0.16424,0.13775,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.00045468,0.16421,0.18433,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.027401,0.16416,0.13733,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.00031414,0.16409,0.1749,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0057669,0.16404,0.15388,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.052083,0.16399,0.12614,1,1
2,GO B CELL ACTIVATION,0.00028155,0.16387,0.18037,1,1
2,GO TRNA METABOLIC PROCESS,0.00014839,0.16376,0.14584,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00065224,0.16374,0.14766,1,1
2,GO RESPONSE TO SALT STRESS,0.0043737,0.16334,0.17815,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,5.4184e-05,0.16328,0.16167,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.030368,0.16326,0.11936,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.027973,0.16312,0.11891,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,6.545e-05,0.16303,0.13926,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00047589,0.16268,0.17366,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.0071051,0.16263,0.1316,1,1
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0050269,0.16262,0.19478,1,1
2,GO RESPONSE TO RETINOIC ACID,0.012653,0.16262,0.14389,1,1
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.001422,0.16243,0.18578,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0015463,0.16242,0.18732,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00018323,0.16218,0.19897,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.001955,0.16213,0.15878,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00038422,0.16207,0.15349,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,9.819e-05,0.16166,0.17306,1,1
2,GO RRNA METHYLATION,0.0001179,0.16161,0.17418,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00033955,0.16138,0.15754,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00033432,0.16121,0.17882,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00023294,0.16119,0.14467,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0012886,0.16088,0.16421,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.00092737,0.16061,0.132,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00061456,0.16057,0.17109,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0038977,0.16054,0.13925,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0104,0.16052,0.14005,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.023173,0.1605,0.11461,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0073682,0.16029,0.11471,1,1
2,GO SPLEEN DEVELOPMENT,0.0021798,0.16014,0.13932,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0080166,0.15977,0.11628,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0024941,0.15964,0.15603,1,1
2,GO LYMPH VESSEL MORPHOGENESIS,0.016386,0.15961,0.17701,1,1
2,GO PROTEIN NITROSYLATION,0.0053519,0.15954,0.1867,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0025617,0.15952,0.15888,1,1
2,GO PLACENTA DEVELOPMENT,0.0045438,0.15926,0.13371,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0048405,0.15879,0.13517,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00082553,0.15865,0.15707,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.0086125,0.15853,0.17223,1,1
2,GO TISSUE MIGRATION,0.0054192,0.15824,0.15288,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,9.3381e-05,0.15816,0.15165,1,1
2,GO BILE ACID METABOLIC PROCESS,0.0013826,0.15802,0.16967,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.008211,0.15784,0.13699,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.00044781,0.15778,0.20164,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.00016629,0.15742,0.1599,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0059852,0.15711,0.1491,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.001118,0.15707,0.16852,1,1
2,GO REGULATION OF CELL MATURATION,0.0047798,0.157,0.13758,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.00095459,0.15672,0.16127,1,1
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0012177,0.15629,0.1445,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00084997,0.1561,0.17306,1,1
2,GO REGULATION OF CELL SHAPE,0.0014624,0.15583,0.17256,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,0.0019285,0.15556,0.17933,1,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0047198,0.15555,0.16789,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0039481,0.15554,0.12073,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.01499,0.1555,0.15625,1,1
2,GO ASTROCYTE DEVELOPMENT,0.030368,0.15547,0.13289,1,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.011678,0.15546,0.12911,1,1
2,GO LIPID MODIFICATION,0.0010558,0.15545,0.12316,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00021857,0.15536,0.14234,1,1
2,GO THIOESTER METABOLIC PROCESS,9.819e-05,0.15526,0.19262,1,1
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.026013,0.15518,0.1285,1,1
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.057179,0.15488,0.09203,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0104,0.15465,0.13184,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,1.6761e-05,0.15432,0.1591,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.00016901,0.15376,0.15342,1,1
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.021509,0.15349,0.10494,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.00037257,0.15323,0.18075,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00028155,0.15277,0.15964,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.1588e-05,0.15275,0.1902,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.01128,0.15272,0.14114,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00016629,0.1525,0.13889,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.0013069,0.15241,0.12601,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00022927,0.15234,0.15809,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0065235,0.15219,0.12364,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.040582,0.15207,0.11911,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,4.8839e-05,0.15187,0.15946,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.7059e-05,0.15114,0.18026,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.00035024,0.15096,0.13613,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.4262e-06,0.15093,0.15685,1,1
2,GO PROTEIN KINASE B SIGNALING,0.0054872,0.15086,0.12014,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00058763,0.15075,0.14673,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,2.8305e-05,0.15066,0.15059,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057669,0.15063,0.14571,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.0169e-05,0.15057,0.15687,1,1
2,GO BLOOD VESSEL MORPHOGENESIS,0.041383,0.15027,0.11441,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00027284,0.15026,0.17588,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.017125,0.15017,0.10404,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00067188,0.15008,0.16628,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.010041,0.14998,0.1432,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0040509,0.14986,0.23288,1,1
2,GO GOLGI RIBBON FORMATION,0.00069207,0.14975,0.17124,1,1
2,GO MAST CELL MEDIATED IMMUNITY,0.052575,0.14971,0.13072,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.020166,0.14954,0.15543,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.016027,0.14947,0.13122,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,2.7312e-05,0.14946,0.15946,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.016568,0.14904,0.12401,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001568,0.14871,0.12893,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0046604,0.14856,0.13703,1,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.014823,0.1481,0.094697,1,1
2,GO EMBRYONIC HEMOPOIESIS,0.031311,0.14798,0.12814,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0016806,0.14768,0.17126,1,1
2,GO P BODY ASSEMBLY,0.0037985,0.14733,0.11262,1,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.006444,0.14731,0.11581,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00014129,0.14728,0.16197,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,9.9844e-05,0.14721,0.13696,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.00010852,0.14717,0.1662,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.0023009,0.14713,0.15896,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0014624,0.14702,0.1875,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0034692,0.14698,0.1395,1,1
2,GO ALCOHOL METABOLIC PROCESS,1.7071e-05,0.14692,0.15843,1,1
2,GO OXIDATIVE DEMETHYLATION,0.010522,0.14678,0.094131,1,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.0092477,0.14678,0.14491,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.021509,0.14673,0.12261,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.059879,0.14648,0.12113,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00037835,0.14644,0.13468,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00016629,0.14634,0.14559,1,1
2,GO VASCULATURE DEVELOPMENT,0.023173,0.14609,0.12426,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00067188,0.14602,0.16534,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.052575,0.14572,0.1065,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00068191,0.14571,0.12237,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.2344e-05,0.14545,0.16274,1,1
2,GO GOLGI VESICLE BUDDING,0.00044781,0.14543,0.13123,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.03006,0.14534,0.12902,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0021505,0.14508,0.16324,1,1
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.027401,0.14507,0.14684,1,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.018091,0.14497,0.12272,1,1
2,GO HISTONE DEUBIQUITINATION,0.0011503,0.14489,0.13907,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0074579,0.1448,0.11799,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.060432,0.14472,0.098584,1,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.021053,0.14469,0.12772,1,1
2,GO STEM CELL DIFFERENTIATION,0.0024609,0.14458,0.12273,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0005618,0.14457,0.14513,1,1
2,GO BONE MORPHOGENESIS,0.01829,0.14444,0.14598,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,1.5576e-05,0.14442,0.17805,1,1
2,GO BONE GROWTH,0.0083098,0.14415,0.19261,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00031414,0.14406,0.13496,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.7316e-05,0.144,0.15069,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.00024045,0.1438,0.16994,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00084997,0.14375,0.15075,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.0002117,0.14352,0.16267,1,1
2,GO RNA DESTABILIZATION,0.0023957,0.14295,0.1467,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0066851,0.14236,0.14903,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0089251,0.14208,0.15122,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.0031247,0.1419,0.1299,1,1
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.032278,0.1418,0.20618,1,1
2,GO MAMMARY GLAND DEVELOPMENT,0.040187,0.14177,0.10973,1,1
2,GO LIPID METABOLIC PROCESS,0.00055343,0.1417,0.11962,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.016752,0.14153,0.16768,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.048285,0.1415,0.12861,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.5014e-05,0.14126,0.1458,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0013069,0.14109,0.12213,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.010279,0.141,0.10637,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00049802,0.14077,0.16557,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00012388,0.14063,0.13508,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0087156,0.14015,0.13145,1,1
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.042609,0.14005,0.08107,1,1
2,GO LIVER MORPHOGENESIS,0.0071051,0.13987,0.16779,1,1
2,GO DETERMINATION OF ADULT LIFESPAN,0.01016,0.13984,0.16522,1,1
2,GO RESPONSE TO SALT,2.6352e-05,0.1398,0.20252,1,1
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.043025,0.13973,0.093115,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.00088789,0.13961,0.14428,1,1
2,GO MULTI ORGANISM LOCALIZATION,8.7316e-05,0.13922,0.14328,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.0073682,0.13922,0.19162,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00020835,0.1392,0.18269,1,1
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.016205,0.13917,0.11522,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.9044e-05,0.13905,0.15492,1,1
2,GO MALE SEX DIFFERENTIATION,0.012653,0.13902,0.11867,1,1
2,GO MUSCLE CELL PROLIFERATION,0.013856,0.13885,0.12161,1,1
2,GO COPII COATED VESICLE BUDDING,0.00043435,0.13866,0.12863,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.026838,0.13863,0.10273,1,1
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0012705,0.13835,0.12265,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,0.012945,0.13786,0.14209,1,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.011411,0.13782,0.11529,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.001955,0.1378,0.11034,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0083098,0.13772,0.15981,1,1
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.023919,0.13768,0.11472,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.030368,0.1376,0.13252,1,1
2,GO REGULATION OF GTP BINDING,0.041789,0.1374,0.14217,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.027973,0.13729,0.11236,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.0007786,0.13724,0.15494,1,1
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.037139,0.1371,0.14509,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.026838,0.13677,0.14168,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.011022,0.13657,0.16751,1,1
2,GO PROTEIN O LINKED GLYCOSYLATION,0.038258,0.13654,0.10143,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.0010408,0.13635,0.12117,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.017125,0.13625,0.11954,1,1
2,GO RESPONSE TO UV,0.0019023,0.13595,0.12381,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.00030928,0.13579,0.13284,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011411,0.13522,0.15674,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.011411,0.13516,0.16032,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0001803,0.13513,0.17567,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.0062108,0.1349,0.11612,1,1
2,GO STEROL METABOLIC PROCESS,0.00026858,0.13467,0.15362,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.025743,0.13457,0.092967,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0024281,0.13451,0.11485,1,1
2,GO STEROID METABOLIC PROCESS,0.00076726,0.13437,0.12641,1,1
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.041789,0.13422,0.12325,1,1
2,GO CELL CELL RECOGNITION,6.1119e-05,0.13415,0.15182,1,1
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.01128,0.13415,0.11651,1,1
2,GO CELLULAR RESPONSE TO UV,0.001483,0.13402,0.13132,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.0027381,0.13394,0.10986,1,1
2,GO HISTONE MONOUBIQUITINATION,0.025475,0.13374,0.085476,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00036124,0.13347,0.13285,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0015038,0.13323,0.17417,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0023009,0.13317,0.11572,1,1
2,GO RNA POLYADENYLATION,0.0071918,0.13316,0.11055,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.00036124,0.13304,0.1515,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00070238,0.13293,0.1356,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.027401,0.13287,0.091067,1,1
2,GO TRNA TRANSPORT,8.7316e-05,0.13276,0.16199,1,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.021509,0.13268,0.11122,1,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.021973,0.13267,0.12963,1,1
2,GO TISSUE HOMEOSTASIS,0.012653,0.13266,0.10066,1,1
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0037985,0.13233,0.1422,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0071051,0.13232,0.14365,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00016098,0.13216,0.11471,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.041383,0.13204,0.1302,1,1
2,GO CELLULAR PIGMENTATION,0.014494,0.13201,0.12906,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.02128,0.13191,0.11076,1,1
2,GO POSITIVE REGULATION OF URINE VOLUME,0.01585,0.13183,0.18805,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.00074504,0.13181,0.15785,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.00064263,0.13164,0.11568,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.00046165,0.13158,0.1492,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,3.628e-05,0.13152,0.15782,1,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.03068,0.13149,0.12086,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.02521,0.13129,0.12375,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.1165e-05,0.13129,0.15775,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0007901,0.13128,0.12901,1,1
2,GO RESPONSE TO STEROID HORMONE,0.021973,0.13118,0.10257,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.017315,0.13116,0.12208,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.001071,0.13052,0.13807,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.038637,0.13029,0.10071,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.010895,0.13018,0.12093,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.001071,0.12986,0.13517,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00018323,0.1293,0.12381,1,1
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.039406,0.12914,0.094946,1,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.0032928,0.12909,0.13067,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0022701,0.12908,0.12552,1,1
2,GO ACTIN NUCLEATION,0.00034485,0.12905,0.14077,1,1
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.031311,0.12899,0.1333,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.011813,0.12853,0.13999,1,1
2,GO LIPID STORAGE,0.052575,0.1285,0.099156,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.013243,0.12844,0.11038,1,1
2,GO RESPONSE TO LIPID,0.014823,0.128,0.10407,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.01128,0.12791,0.11523,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.001955,0.12767,0.15429,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.016752,0.12732,0.13607,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,5.7059e-05,0.12731,0.11901,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.011813,0.12721,0.28879,1,1
2,GO THYROID HORMONE METABOLIC PROCESS,0.048746,0.12717,0.083106,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,3.094e-05,0.12701,0.14458,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,7.5001e-05,0.12686,0.11971,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0137,0.12682,0.12571,1,1
2,GO RESPONSE TO OXYGEN LEVELS,0.0069343,0.12668,0.098187,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,6.3249e-05,0.12667,0.13508,1,1
2,GO SPERM EGG RECOGNITION,0.0024941,0.12657,0.10922,1,1
2,GO GMP METABOLIC PROCESS,0.0137,0.12625,0.12518,1,1
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.041383,0.1259,0.14539,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00054518,0.12568,0.12041,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0040509,0.12546,0.153,1,1
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.0137,0.12544,0.14879,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.00022927,0.12542,0.13499,1,1
2,GO COCHLEA MORPHOGENESIS,0.01995,0.12513,0.13157,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0094686,0.12495,0.13275,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.026013,0.12468,0.12895,1,1
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.010279,0.12464,0.12434,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0044864,0.12463,0.13214,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0023321,0.12454,0.12743,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.0065235,0.12446,0.12059,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.059331,0.12441,0.11042,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0057669,0.12434,0.10362,1,1
2,GO MRNA CLEAVAGE,0.00038422,0.12427,0.12378,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0029645,0.12408,0.12141,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.002631,0.12405,0.10689,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00067188,0.12404,0.12949,1,1
2,GO VITAMIN METABOLIC PROCESS,0.013546,0.12388,0.098435,1,1
2,GO MYOTUBE DIFFERENTIATION,0.040582,0.12379,0.10368,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.03429,0.12373,0.10674,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.03006,0.12334,0.094203,1,1
2,GO PROTEIN SUMOYLATION,0.00069207,0.12319,0.12426,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.008211,0.12313,0.14805,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION,0.043444,0.12307,0.10281,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,5.0563e-05,0.12278,0.1459,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.6085e-05,0.12271,0.13835,1,1
2,GO RUFFLE ORGANIZATION,0.019312,0.12255,0.10541,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.00036124,0.12231,0.11949,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.014658,0.12219,0.13994,1,1
2,GO RESPONSE TO INTERLEUKIN 4,0.00087508,0.12207,0.16134,1,1
2,GO REGULATION OF PROTEOLYSIS,0.0083098,0.12172,0.11278,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.041383,0.12165,0.11044,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0031247,0.12161,0.12871,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.0031247,0.1214,0.1395,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0035146,0.12123,0.1604,1,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.059879,0.12118,0.11634,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0021798,0.12115,0.098075,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00081356,0.12105,0.17969,1,1
2,GO REGULATION OF URINE VOLUME,0.0035605,0.12102,0.15928,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0080166,0.12099,0.12197,1,1
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.037882,0.12075,0.13235,1,1
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.042609,0.12068,0.10226,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.017125,0.12067,0.16996,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.00091404,0.12046,0.12912,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.025743,0.12037,0.14199,1,1
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.00159,0.12036,0.12872,1,1
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.055093,0.12023,0.11736,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00010152,0.11988,0.12083,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.02128,0.11961,0.13513,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.0010558,0.11916,0.1286,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.03068,0.11916,0.11121,1,1
2,GO ANION HOMEOSTASIS,0.0063654,0.11915,0.13936,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.05357,0.11869,0.085986,1,1
2,GO DIGESTION,0.0042636,0.11865,0.11781,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.018693,0.11864,0.086016,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.047372,0.11855,0.094366,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.052083,0.11792,0.098522,1,1
2,GO REGULATION OF CELL MATRIX ADHESION,0.047372,0.11781,0.12839,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00080175,0.11772,0.16389,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011678,0.1177,0.097471,1,1
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.049212,0.11751,0.097344,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.015501,0.11701,0.11887,1,1
2,GO NCRNA CATABOLIC PROCESS,0.0086125,0.11642,0.13131,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.052083,0.11617,0.087766,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.046474,0.11607,0.098436,1,1
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.027973,0.11591,0.11164,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00011406,0.11587,0.13808,1,1
2,GO THYMUS DEVELOPMENT,0.0007901,0.11562,0.15791,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.036048,0.11561,0.088291,1,1
2,GO LIPID PHOSPHORYLATION,0.024173,0.1156,0.099759,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00064263,0.11545,0.11323,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.0049019,0.11525,0.09317,1,1
2,GO LIPID CATABOLIC PROCESS,0.0043184,0.11512,0.10967,1,1
2,GO GENITALIA DEVELOPMENT,0.058247,0.11498,0.087251,1,1
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.017315,0.11479,0.10759,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0016806,0.1145,0.14523,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0010113,0.11436,0.11657,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.002631,0.11436,0.16144,1,1
2,GO DNA METHYLATION,0.00033955,0.1141,0.13291,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0031247,0.11392,0.11169,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.030368,0.1138,0.085177,1,1
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.047827,0.1138,0.14818,1,1
2,GO RESPONSE TO TESTOSTERONE,0.01849,0.11373,0.12416,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.017125,0.11369,0.13996,1,1
2,GO RESPONSE TO KETONE,0.033608,0.11365,0.095042,1,1
2,GO FOCAL ADHESION ASSEMBLY,0.01995,0.11346,0.16458,1,1
2,GO IMPORT INTO NUCLEUS,0.0087156,0.11332,0.10269,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0013443,0.11326,0.11371,1,1
2,GO EPITHELIAL TUBE FORMATION,0.020166,0.11306,0.11708,1,1
2,GO TUBE FORMATION,0.023668,0.11291,0.11345,1,1
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011022,0.11284,0.092406,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0066851,0.11267,0.09573,1,1
2,GO RESPONSE TO CHEMOKINE,0.0043737,0.11262,0.1255,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0033799,0.11254,0.11326,1,1
2,GO FEVER GENERATION,0.016027,0.11227,0.13217,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0005056,0.11211,0.13111,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.00087508,0.11196,0.13113,1,1
2,GO GENE SILENCING,0.00026858,0.11177,0.10843,1,1
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.052575,0.11125,0.092037,1,1
2,GO HISTONE DEACETYLATION,0.023419,0.1112,0.072643,1,1
2,GO HYPEROSMOTIC RESPONSE,0.018898,0.11119,0.10963,1,1
2,GO RESPONSE TO NUTRIENT,0.05063,0.11117,0.097656,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.00070238,0.11107,0.16713,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0025961,0.11082,0.14786,1,1
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.025743,0.11079,0.12041,1,1
2,GO TELOMERE ORGANIZATION,0.0013255,0.11075,0.1147,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0077327,0.11054,0.10007,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00049802,0.11022,0.10302,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.0045438,0.11016,0.10502,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.056128,0.10983,0.10177,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00014839,0.10973,0.12775,1,1
2,GO FATTY ACYL COA METABOLIC PROCESS,0.0032928,0.10969,0.16991,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.02521,0.10964,0.11284,1,1
2,GO REGULATION OF CELL DEATH,0.011411,0.10947,0.09343,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00032916,0.10938,0.12941,1,1
2,GO MOLTING CYCLE,0.056128,0.10916,0.11627,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00011986,0.10905,0.13102,1,1
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.050154,0.10854,0.10221,1,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.012367,0.10851,0.11513,1,1
2,GO HISTONE UBIQUITINATION,0.047372,0.10848,0.064577,1,1
2,GO RESPONSE TO DRUG,0.024687,0.10848,0.094335,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00048316,0.10848,0.13442,1,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.027686,0.10848,0.1071,1,1
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0056958,0.10843,0.11691,1,1
2,GO PROTEIN IMPORT,0.0019023,0.10837,0.10931,1,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.03902,0.10834,0.10332,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.012367,0.10827,0.082576,1,1
2,GO MACROPHAGE ACTIVATION,0.0048405,0.1082,0.14288,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.020605,0.10799,0.098256,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0025961,0.1079,0.11333,1,1
2,GO MRNA METHYLATION,0.033608,0.10708,0.12598,1,1
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.033948,0.10698,0.086408,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.0024609,0.10656,0.10976,1,1
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.053071,0.10633,0.084111,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.022686,0.10625,0.093909,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0045438,0.10609,0.17581,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.039795,0.10606,0.11218,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.046474,0.10594,0.10697,1,1
2,GO RNA CATABOLIC PROCESS,0.00013016,0.10582,0.11103,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00084997,0.10515,0.10603,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.01849,0.10507,0.11261,1,1
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.017699,0.10462,0.12758,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.048746,0.10456,0.1293,1,1
2,GO REGULATION OF ORGAN GROWTH,0.036048,0.10436,0.10331,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00019857,0.10417,0.12539,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.003166,0.10392,0.15327,1,1
2,GO DNA GEOMETRIC CHANGE,0.003654,0.10373,0.10512,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.00032408,0.1037,0.11743,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.013394,0.10369,0.12461,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00159,0.10364,0.11111,1,1
2,GO TRACHEA MORPHOGENESIS,0.036772,0.10339,0.11991,1,1
2,GO RESPONSE TO NITRIC OXIDE,0.058787,0.10311,0.073843,1,1
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.05063,0.10293,0.089969,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0021505,0.1029,0.095181,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0018764,0.10275,0.10552,1,1
2,GO RESPONSE TO ALCOHOL,0.021973,0.10269,0.089804,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0026663,0.10252,0.14468,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0090315,0.1021,0.10893,1,1
2,GO REGULATION OF LIPID STORAGE,0.045591,0.10209,0.10506,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.013243,0.10207,0.11111,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0099244,0.10175,0.12295,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.003654,0.10165,0.10569,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0098086,0.10136,0.09687,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.016386,0.10111,0.088601,1,1
2,GO RESPONSE TO ACTIVITY,0.014332,0.10065,0.093981,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0043184,0.10061,0.088762,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.034636,0.10007,0.11982,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0089251,0.099686,0.097901,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.023419,0.099444,0.14264,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0072795,0.099351,0.10174,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0005211,0.099142,0.11107,1,1
2,GO PROTEIN DESTABILIZATION,0.01849,0.099071,0.1067,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0029645,0.098871,0.095362,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.00028155,0.098572,0.11634,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.03006,0.098486,0.090302,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.038637,0.098481,0.11462,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.012087,0.098381,0.095785,1,1
2,GO NODAL SIGNALING PATHWAY,0.02128,0.098205,0.10671,1,1
2,GO RNA PROCESSING,0.00098255,0.098189,0.10926,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0034243,0.098128,0.11418,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.03429,0.097941,0.092989,1,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.056652,0.097889,0.088797,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0013826,0.097798,0.10116,1,1
2,GO MRNA 3 END PROCESSING,0.010895,0.097143,0.10092,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.01128,0.096567,0.10921,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00058763,0.096183,0.11155,1,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0012886,0.096123,0.11641,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.041789,0.096059,0.094413,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.056128,0.095851,0.091203,1,1
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.054074,0.095851,0.091675,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0024609,0.095835,0.098675,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.037139,0.095814,0.068607,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.001442,0.095801,0.10782,1,1
2,GO MULTIVESICULAR BODY ORGANIZATION,0.030994,0.095507,0.096172,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0076401,0.095374,0.083646,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0066039,0.095298,0.080156,1,1
2,GO RNA 3 END PROCESSING,0.010279,0.094921,0.088149,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0027747,0.094368,0.10418,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.013093,0.094199,0.099362,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0038478,0.094187,0.087244,1,1
2,GO CELLULAR RESPONSE TO RADIATION,0.015501,0.093963,0.091862,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00063314,0.093906,0.10759,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.043025,0.093855,0.084191,1,1
2,GO RNA LOCALIZATION,0.0022095,0.093387,0.10762,1,1
2,GO HORMONE METABOLIC PROCESS,0.042609,0.093302,0.078481,1,1
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0039992,0.092838,0.1642,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001704,0.092553,0.10252,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.0032501,0.092037,0.10976,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0059852,0.091616,0.11272,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.0076401,0.091568,0.093508,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0020929,0.091336,0.10736,1,1
2,GO DNA MODIFICATION,0.0061347,0.091331,0.094589,1,1
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0016347,0.091036,0.14055,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00033432,0.090962,0.11559,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.03006,0.090679,0.080467,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.015501,0.09024,0.14076,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0071051,0.0901,0.080675,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.053071,0.090088,0.074802,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0019285,0.089914,0.10495,1,1
2,GO PIGMENT GRANULE LOCALIZATION,0.038258,0.088699,0.11476,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0044298,0.088605,0.088251,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.017315,0.088318,0.083292,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.026561,0.088219,0.076671,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.039406,0.087799,0.079332,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.052575,0.08756,0.097774,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0024941,0.087519,0.096286,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0069343,0.087402,0.09454,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.022686,0.08704,0.085872,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00099681,0.086512,0.10431,1,1
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0066039,0.08643,0.11365,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.017699,0.086246,0.085391,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.0022095,0.086045,0.090605,1,1
2,GO MRNA METABOLIC PROCESS,0.0024281,0.085985,0.090686,1,1
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.046474,0.085701,0.13559,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.003607,0.085207,0.084989,1,1
2,GO PROTEOLYSIS,0.035336,0.084417,0.075083,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.044292,0.084413,0.069012,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.018693,0.084318,0.12614,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.010895,0.084201,0.14612,1,1
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.019312,0.083731,0.12654,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0035605,0.083726,0.099312,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.01849,0.083148,0.091678,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.01128,0.083052,0.088584,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.040582,0.082925,0.082714,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.055093,0.082821,0.088437,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.03006,0.08276,0.070469,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.016568,0.082712,0.076595,1,1
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.026838,0.081637,0.090728,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.033271,0.081518,0.11062,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.054582,0.081228,0.077734,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0088198,0.08096,0.099636,1,1
2,GO HISTONE H3 ACETYLATION,0.0085105,0.080085,0.080785,1,1
2,GO APOPTOTIC PROCESS,0.047827,0.079846,0.072477,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0052197,0.079683,0.099399,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.01995,0.078919,0.096683,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.03429,0.078621,0.072034,1,1
2,GO CELL AGING,0.012798,0.077787,0.097313,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0023637,0.077424,0.10464,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.0084096,0.077273,0.075485,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0020646,0.076595,0.10494,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.027973,0.076343,0.074777,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.030994,0.07569,0.090047,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.013546,0.074808,0.13517,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.046031,0.074719,0.092964,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0013255,0.074538,0.10425,1,1
2,GO PROTEIN MONOUBIQUITINATION,0.023668,0.074256,0.066173,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.012945,0.073682,0.091684,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.051111,0.071267,0.066789,1,1
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.032607,0.071151,0.065737,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.041383,0.069726,0.071787,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0019285,0.069221,0.098428,1,1
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.040187,0.068915,0.11374,1,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.035691,0.068794,0.073385,1,1
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0063654,0.068589,0.081523,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0070192,0.068242,0.085155,1,1
2,GO CHROMATIN REMODELING,0.011411,0.068231,0.077212,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.019312,0.067772,0.077494,1,1
2,GO MRNA PROCESSING,0.038258,0.067588,0.071603,1,1
2,GO METHYLATION,0.010279,0.066418,0.075617,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.038258,0.065998,0.084246,1,1
2,GO MRNA TRANSPORT,0.0081133,0.065838,0.096035,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.059331,0.065801,0.069874,1,1
2,GO DNA METABOLIC PROCESS,0.024947,0.065778,0.059877,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0094686,0.065484,0.097142,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.016027,0.064742,0.10785,1,1
2,GO RESPONSE TO RADIATION,0.037139,0.064509,0.06469,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0044298,0.064496,0.089198,1,1
2,GO BLASTOCYST DEVELOPMENT,0.046474,0.064202,0.056497,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.059879,0.063875,0.059793,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.037509,0.063445,0.061854,1,1
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.061549,0.062847,0.077104,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.061549,0.06093,0.058373,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.0062108,0.060886,0.085027,1,1
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.039795,0.060524,0.074566,1,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.042197,0.060439,0.066787,1,1
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.046921,0.060386,0.087691,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.02174,0.059306,0.075285,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.009139,0.058584,0.069452,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.051595,0.057008,0.061888,1,1
2,GO ENDOSOME ORGANIZATION,0.046921,0.055639,0.080248,1,1
2,GO MITOCHONDRIAL TRANSPORT,0.058787,0.055451,0.064629,1,1
2,GO RNA SPLICING,0.043866,0.054956,0.071799,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.029754,0.054746,0.066713,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.036048,0.054287,0.081081,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.026561,0.053665,0.063701,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.03902,0.053321,0.055429,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.012798,0.050871,0.082054,1,1
2,GO MACROAUTOPHAGY,0.014332,0.049852,0.072909,1,1
2,GO DNA METHYLATION OR DEMETHYLATION,0.014332,0.047323,0.093427,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0061347,0.047048,0.078884,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.059331,0.043012,0.099767,1,1
2,GO NCRNA TRANSCRIPTION,0.054582,0.042752,0.065831,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.041383,0.04249,0.058373,1,1
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.058247,0.041574,0.074063,1,1
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.050154,0.033208,0.064611,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.0437e-10,0.94793,0.89569,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.8118e-09,0.82367,0.76157,1,1
3,GO SYNAPSE MATURATION,8.3066e-07,0.60479,0.53275,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,4.2784e-08,0.59681,0.71706,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,1.6514e-08,0.5772,0.552,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,6.5837e-06,0.57716,0.52987,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,1.155e-06,0.55921,0.48753,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,4.4787e-08,0.5563,0.56012,1,1
3,GO REGULATION OF SYNAPSE MATURATION,2.3661e-05,0.54817,0.43776,1,1
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,2.3891e-06,0.54062,0.47435,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,7.0337e-07,0.54047,0.53144,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.856e-06,0.5356,0.43406,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,2.8886e-07,0.5246,0.49893,1,1
3,GO RESPONSE TO L GLUTAMATE,5.4967e-09,0.51224,0.48125,1,1
3,GO NEURON CELLULAR HOMEOSTASIS,8.7237e-10,0.50929,0.49989,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,6.9711e-06,0.49992,0.40188,1,1
3,GO DENSE CORE GRANULE TRANSPORT,2.5424e-05,0.49672,0.43062,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,4.9228e-07,0.44706,0.3842,1,1
3,GO POSTSYNAPSE ASSEMBLY,1.1086e-06,0.44362,0.4895,1,1
3,GO SYNAPTIC VESICLE MATURATION,2.971e-06,0.42834,0.43758,1,1
3,GO GLYCINE TRANSPORT,0.00099681,0.42547,0.32992,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,3.9822e-07,0.4222,0.51165,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,2.2505e-06,0.41687,0.47472,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,2.0398e-08,0.41566,0.44855,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,1.8793e-06,0.40191,0.3195,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.6457e-05,0.399,0.43255,1,1
3,GO CYTOPLASMIC TRANSLATION,2.971e-06,0.39893,0.3258,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,4.7172e-05,0.39866,0.35687,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,4.3946e-06,0.3979,0.33975,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,1.1789e-06,0.39179,0.38478,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,5.1446e-05,0.39157,0.41705,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,2.6386e-06,0.39123,0.40795,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00059648,0.38668,0.33541,1,1
3,GO SYNAPTIC MEMBRANE ADHESION,0.0010865,0.38275,0.31764,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,2.2397e-08,0.38257,0.43039,1,1
3,GO DENTATE GYRUS DEVELOPMENT,2.8001e-06,0.38012,0.43184,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,4.4807e-06,0.37872,0.35447,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,1.439e-07,0.3776,0.40629,1,1
3,GO MYOBLAST PROLIFERATION,8.0712e-08,0.37653,0.35587,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.001118,0.3748,0.29343,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,9.1829e-05,0.37181,0.31187,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.8888e-05,0.37126,0.32152,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,1.8701e-05,0.36892,0.35532,1,1
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00083767,0.36427,0.31702,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00032408,0.36395,0.3343,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,7.0072e-05,0.36352,0.31559,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.7071e-05,0.36135,0.37852,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00042128,0.35873,0.332,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.069e-09,0.35748,0.36415,1,1
3,GO SYNAPTIC VESICLE CLUSTERING,0.0011836,0.3572,0.38439,1,1
3,GO IMP METABOLIC PROCESS,1.1806e-05,0.35647,0.37257,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.0395e-05,0.3558,0.32497,1,1
3,GO SUCKLING BEHAVIOR,1.536e-06,0.35507,0.37864,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00083767,0.35385,0.35713,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0050269,0.35052,0.23758,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,1.3878e-06,0.3502,0.29695,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.9514e-07,0.3472,0.38478,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.0361e-05,0.34409,0.32341,1,1
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.00012594,0.34347,0.30979,1,1
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,3.6877e-06,0.34346,0.30318,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,4.9361e-06,0.34094,0.37444,1,1
3,GO TRANSLATIONAL INITIATION,3.0395e-05,0.34035,0.27869,1,1
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,9.795e-06,0.33832,0.31244,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001071,0.33772,0.2631,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00031414,0.33749,0.29827,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,1.6514e-08,0.33426,0.317,1,1
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00019857,0.33219,0.41567,1,1
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.0323e-06,0.33205,0.29645,1,1
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.1815e-08,0.33163,0.38507,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.001071,0.33097,0.30538,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0030839,0.33055,0.35553,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.5684e-06,0.32954,0.41574,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00060545,0.32914,0.3312,1,1
3,GO L GLUTAMATE IMPORT,0.0002443,0.32698,0.21632,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.00057029,0.32619,0.40663,1,1
3,GO MATURATION OF LSU RRNA,4.5684e-06,0.32595,0.33385,1,1
3,GO NEUROTRANSMITTER REUPTAKE,3.9102e-06,0.32363,0.30504,1,1
3,GO UV PROTECTION,8.9166e-06,0.3233,0.32379,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00043435,0.32325,0.29837,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.3803e-06,0.32109,0.35733,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.0156e-07,0.31903,0.33102,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,1.3056e-06,0.31669,0.30858,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.2784e-06,0.31255,0.34613,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,7.3739e-05,0.31196,0.35775,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.001422,0.3118,0.29787,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,5.7051e-07,0.3109,0.32715,1,1
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.004964,0.31033,0.251,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,6.4341e-05,0.30878,0.314,1,1
3,GO REGULATION OF VESICLE FUSION,5.332e-06,0.30679,0.32973,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,7.8124e-06,0.30495,0.29364,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,9.3381e-05,0.30424,0.2563,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.9749e-05,0.30354,0.32199,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,6.8396e-06,0.30211,0.30746,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,4.4787e-08,0.30175,0.28811,1,1
3,GO RIBOSOME ASSEMBLY,1.3442e-05,0.30149,0.30724,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,1.5994e-06,0.30046,0.36988,1,1
3,GO GLYCINE METABOLIC PROCESS,0.0044298,0.29865,0.20009,1,1
3,GO REGULATION OF MRNA BINDING,1.0557e-05,0.29533,0.2836,1,1
3,GO DIVALENT METAL ION EXPORT,6.7105e-06,0.29514,0.35919,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00030928,0.29464,0.268,1,1
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,6.7105e-06,0.29443,0.28144,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00031414,0.29417,0.29674,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,3.2057e-05,0.29382,0.27283,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,6.8396e-06,0.2932,0.28035,1,1
3,GO PHAGOCYTOSIS RECOGNITION,5.5127e-05,0.29263,0.25105,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,6.545e-05,0.2926,0.28563,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0002117,0.29252,0.2578,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.2926e-08,0.292,0.36048,1,1
3,GO NEURON PROJECTION ORGANIZATION,1.8053e-06,0.29185,0.27072,1,1
3,GO REGULATION OF NEURON MIGRATION,0.0034243,0.29166,0.19266,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0010558,0.29028,0.25351,1,1
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00014362,0.29012,0.36389,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,2.0478e-05,0.28791,0.35714,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,2.2824e-05,0.28754,0.33858,1,1
3,GO OXYGEN TRANSPORT,0.016386,0.28705,0.28345,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001422,0.28161,0.25364,1,1
3,GO ADULT HEART DEVELOPMENT,8.0256e-05,0.27979,0.32806,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.014658,0.27885,0.22041,1,1
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,6.3249e-05,0.27851,0.26411,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00017741,0.27832,0.27166,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0002443,0.27794,0.25306,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.0016575,0.27627,0.24672,1,1
3,GO CGMP METABOLIC PROCESS,0.0014022,0.27425,0.28054,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,4.5684e-06,0.27407,0.26018,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.00071283,0.27224,0.27399,1,1
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.1789e-06,0.27045,0.31878,1,1
3,GO TELOMERASE RNA LOCALIZATION,5.8049e-05,0.26961,0.26241,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,3.3806e-05,0.26911,0.21826,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,9.9844e-05,0.26893,0.2648,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.011022,0.26878,0.27109,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00059648,0.26818,0.2643,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,2.2416e-05,0.26811,0.2697,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,1.5576e-05,0.26686,0.28018,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,1.1165e-05,0.26669,0.31182,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0013443,0.26612,0.20396,1,1
3,GO ELASTIC FIBER ASSEMBLY,0.011949,0.26454,0.25592,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00090088,0.26367,0.26422,1,1
3,GO AMP METABOLIC PROCESS,0.0018764,0.26201,0.20436,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.0038977,0.26158,0.19822,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.012653,0.25724,0.20805,1,1
3,GO VIRAL TRANSLATION,5.8049e-05,0.25599,0.25136,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.042609,0.25541,0.14392,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,3.758e-05,0.25529,0.2637,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,6.7105e-06,0.25501,0.25595,1,1
3,GO NEUROTRANSMITTER UPTAKE,1.2027e-05,0.25494,0.24763,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,7.3739e-05,0.25458,0.20427,1,1
3,GO SIALYLATION,0.00086244,0.25456,0.33356,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1588e-05,0.25362,0.32229,1,1
3,GO PENTOSE METABOLIC PROCESS,0.00039622,0.2531,0.19799,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0021798,0.25218,0.24257,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00049053,0.25214,0.35551,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,3.3435e-06,0.25213,0.25698,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.011678,0.2521,0.20787,1,1
3,GO MATURATION OF SSU RRNA,4.3997e-05,0.25207,0.2678,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.001776,0.24994,0.20181,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00011033,0.24915,0.25375,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,9.795e-06,0.2487,0.24128,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0025277,0.24863,0.18945,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00019857,0.24847,0.26839,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,9.9844e-05,0.24843,0.19001,1,1
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.014494,0.24773,0.16512,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,2.7312e-05,0.24764,0.2018,1,1
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.023668,0.24712,0.19216,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,3.2057e-05,0.24701,0.26448,1,1
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00029511,0.24693,0.24556,1,1
3,GO NEURON REMODELING,8.0256e-05,0.24593,0.25498,1,1
3,GO REGULATION OF RNA BINDING,4.0314e-05,0.2453,0.22662,1,1
3,GO HEART VALVE FORMATION,0.00086244,0.2451,0.25995,1,1
3,GO GLUTAMATE SECRETION,1.5014e-05,0.24502,0.26724,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00015838,0.24492,0.26229,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.105e-06,0.24323,0.22928,1,1
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0010558,0.24276,0.25706,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00021511,0.24263,0.26719,1,1
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0010113,0.24241,0.21451,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0018764,0.24119,0.19079,1,1
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00091404,0.24055,0.23384,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00046872,0.24034,0.28624,1,1
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.00055343,0.24023,0.26213,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.086e-06,0.24015,0.19943,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00036686,0.24011,0.22577,1,1
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0046018,0.23969,0.19173,1,1
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.00076726,0.23952,0.2754,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00042777,0.23769,0.22728,1,1
3,GO PROTEIN TRIMERIZATION,5.7059e-05,0.23732,0.24358,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00026438,0.23714,0.23351,1,1
3,GO LONG TERM MEMORY,2.4528e-05,0.23646,0.24125,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00059648,0.2361,0.19656,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00026438,0.23606,0.28501,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,9.1829e-05,0.23568,0.26907,1,1
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0067673,0.23305,0.30183,1,1
3,GO GTP METABOLIC PROCESS,2.9859e-05,0.23303,0.2277,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0019285,0.23159,0.21184,1,1
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,7.0072e-05,0.23065,0.22954,1,1
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,9.03e-05,0.23042,0.26723,1,1
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.033948,0.22774,0.17139,1,1
3,GO GAS TRANSPORT,0.0038977,0.22462,0.25574,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.3435e-06,0.22457,0.23396,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00030449,0.22432,0.23085,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.006444,0.22332,0.18734,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00047589,0.22308,0.1865,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00030449,0.2229,0.18903,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00017176,0.22236,0.24068,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0011668,0.22175,0.2087,1,1
3,GO VOCALIZATION BEHAVIOR,0.024687,0.22156,0.24725,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00010497,0.2213,0.19495,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00075607,0.22068,0.21401,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.012945,0.22067,0.13309,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.059331,0.22058,0.19263,1,1
3,GO NAD METABOLIC PROCESS,1.7693e-06,0.22049,0.28163,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.05063,0.2197,0.13973,1,1
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0011503,0.21875,0.18839,1,1
3,GO ARGININE METABOLIC PROCESS,0.0015038,0.21847,0.23033,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.00067188,0.21843,0.26154,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.00042128,0.21832,0.20387,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.01016,0.21756,0.20766,1,1
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,6.8396e-06,0.21664,0.26383,1,1
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.05063,0.21643,0.14479,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.00063314,0.21561,0.25121,1,1
3,GO CHEMOSENSORY BEHAVIOR,4.6359e-05,0.2153,0.20593,1,1
3,GO LEARNING,0.00015838,0.21523,0.20029,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00067188,0.21459,0.21671,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0084096,0.21423,0.17987,1,1
3,GO VIRAL GENE EXPRESSION,0.00057029,0.21417,0.19236,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0054192,0.21345,0.17744,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.023419,0.21296,0.16327,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,8.4262e-06,0.21246,0.25062,1,1
3,GO SYNAPSE ORGANIZATION,0.00031414,0.21225,0.17526,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0012177,0.21219,0.19426,1,1
3,GO MECHANOSENSORY BEHAVIOR,0.0084096,0.21211,0.33796,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00011406,0.21206,0.21096,1,1
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00010673,0.21194,0.20851,1,1
3,GO STRESS GRANULE ASSEMBLY,0.00040857,0.21173,0.16975,1,1
3,GO MATURATION OF 5 8S RRNA,0.00068191,0.21149,0.22144,1,1
3,GO LONG TERM SYNAPTIC DEPRESSION,0.00057029,0.21115,0.21933,1,1
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.00035024,0.21107,0.20822,1,1
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.819e-05,0.21057,0.24141,1,1
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0019023,0.20962,0.22799,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.016027,0.20923,0.24769,1,1
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.00044103,0.20923,0.18331,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.5293e-05,0.20869,0.26246,1,1
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00015583,0.20862,0.24157,1,1
3,GO SYNAPTIC VESICLE EXOCYTOSIS,3.2057e-05,0.20784,0.24491,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.014823,0.20784,0.14411,1,1
3,GO PEPTIDYL ARGININE METHYLATION,2.3661e-05,0.20768,0.22797,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00030449,0.20682,0.18975,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0056958,0.20681,0.15919,1,1
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00090088,0.20641,0.32746,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00011986,0.20627,0.19572,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0025961,0.20573,0.26249,1,1
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.001776,0.20449,0.19141,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00082553,0.20437,0.19954,1,1
3,GO CGMP MEDIATED SIGNALING,0.00036124,0.20427,0.19379,1,1
3,GO TRNA MODIFICATION,0.00010497,0.20381,0.19736,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0040509,0.20237,0.1938,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0044864,0.20142,0.19437,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0013069,0.20017,0.1875,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0028118,0.19998,0.17236,1,1
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0047798,0.19918,0.15994,1,1
3,GO TRANSLATIONAL ELONGATION,5.9056e-05,0.19918,0.18994,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0012177,0.19832,0.1753,1,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.042609,0.19764,0.10197,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.001071,0.19751,0.18077,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0012527,0.19737,0.20368,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.030994,0.19708,0.16537,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.024173,0.197,0.13514,1,1
3,GO MITOCHONDRION LOCALIZATION,5.7059e-05,0.19665,0.17782,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,9.4341e-06,0.19656,0.22769,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,7.5001e-05,0.1959,0.20264,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,5.1304e-06,0.19583,0.23227,1,1
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00011986,0.19575,0.1919,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,4.7172e-05,0.19541,0.18961,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,1.536e-06,0.19461,0.2112,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0048405,0.19393,0.20445,1,1
3,GO MEMBRANE REPOLARIZATION,0.00028155,0.19352,0.18161,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00011986,0.19346,0.16657,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00023294,0.19305,0.19396,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0055559,0.19177,0.1595,1,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.017506,0.19072,0.17676,1,1
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,2.6352e-05,0.19065,0.17312,1,1
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00040235,0.18993,0.17415,1,1
3,GO REGULATION OF AXONOGENESIS,0.0020929,0.1893,0.16733,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.001071,0.18921,0.14321,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0023321,0.18874,0.17454,1,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.032938,0.18866,0.19611,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.6487e-06,0.18861,0.20042,1,1
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00048316,0.18831,0.2257,1,1
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,7.2497e-05,0.18812,0.17592,1,1
3,GO REGULATION OF CATION CHANNEL ACTIVITY,5.3256e-05,0.18788,0.19655,1,1
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.020166,0.18758,0.17443,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0018006,0.1868,0.18075,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00049802,0.18668,0.19406,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,3.758e-05,0.18622,0.20106,1,1
3,GO NEUROTRANSMITTER TRANSPORT,0.00039018,0.18621,0.2046,1,1
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.01016,0.18547,0.18708,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0088198,0.18405,0.15325,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00018923,0.18394,0.21132,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0096941,0.18387,0.15061,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0054872,0.1838,0.15212,1,1
3,GO ACIDIC AMINO ACID TRANSPORT,3.3214e-05,0.18353,0.19202,1,1
3,GO LIPID IMPORT INTO CELL,0.032938,0.18324,0.12001,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0044864,0.18297,0.19683,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00053704,0.18245,0.20501,1,1
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.0023321,0.18148,0.16404,1,1
3,GO SNORNA 3 END PROCESSING,9.6562e-05,0.18113,0.28441,1,1
3,GO NEURON RECOGNITION,0.0022396,0.18111,0.21181,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00052901,0.18026,0.23236,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00015583,0.17811,0.1709,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0029645,0.17756,0.13941,1,1
3,GO SHORT TERM MEMORY,0.0095807,0.17752,0.26052,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,1.4472e-05,0.17679,0.18259,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,2.1621e-05,0.17664,0.17973,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.013394,0.17599,0.13034,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0032501,0.1759,0.17142,1,1
3,GO HEPARIN METABOLIC PROCESS,0.020605,0.1758,0.18837,1,1
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0012705,0.17563,0.18874,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0014624,0.17561,0.17643,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0022095,0.17561,0.18979,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0034243,0.17509,0.17528,1,1
3,GO AEROBIC RESPIRATION,0.0023637,0.17482,0.13692,1,1
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.036409,0.17438,0.1204,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00011033,0.17373,0.15941,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,9.6562e-05,0.1737,0.19712,1,1
3,GO WALKING BEHAVIOR,6.4592e-06,0.17293,0.26574,1,1
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.014494,0.17252,0.16589,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.044722,0.17218,0.1305,1,1
3,GO AMINO ACID IMPORT,0.014332,0.17138,0.14025,1,1
3,GO NEUROTRANSMITTER SECRETION,0.0010865,0.17092,0.20015,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0020929,0.17081,0.19351,1,1
3,GO TRANSLATIONAL TERMINATION,0.0032928,0.17057,0.16328,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00069207,0.17055,0.18783,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.00033432,0.1705,0.20997,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0043737,0.17007,0.20891,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0011021,0.17002,0.1785,1,1
3,GO POSTSYNAPSE ORGANIZATION,6.545e-05,0.16991,0.21524,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.0044298,0.16969,0.10698,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0078263,0.16968,0.14161,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0010408,0.16915,0.19265,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00090088,0.16893,0.21377,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0018508,0.16871,0.27359,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.024173,0.16851,0.13593,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00011596,0.1682,0.14169,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0037985,0.16819,0.14285,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.0085105,0.16814,0.14813,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00012594,0.16797,0.18572,1,1
3,GO AXON EXTENSION,0.001071,0.16676,0.16449,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0076401,0.16675,0.1553,1,1
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0050269,0.16666,0.21329,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0014022,0.16652,0.14908,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00032408,0.16602,0.177,1,1
3,GO SYNAPTIC VESICLE LOCALIZATION,0.022686,0.16525,0.15375,1,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.025743,0.16512,0.12449,1,1
3,GO RIBOSOME BIOGENESIS,0.00020504,0.16477,0.21864,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00099681,0.16445,0.18771,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.0005789,0.16409,0.16016,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,3.3806e-05,0.16383,0.18625,1,1
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0032928,0.16381,0.17571,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0005056,0.16307,0.20833,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00083767,0.16307,0.14383,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0005211,0.16285,0.1424,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0029645,0.16263,0.12892,1,1
3,GO FATTY ACID HOMEOSTASIS,0.0030038,0.16232,0.21835,1,1
3,GO NADH METABOLIC PROCESS,5.2344e-05,0.16223,0.23471,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0038977,0.16184,0.17467,1,1
3,GO NEURON PROJECTION GUIDANCE,0.012798,0.16184,0.13982,1,1
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.021509,0.16133,0.19332,1,1
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00067188,0.1605,0.16105,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.0031247,0.16047,0.19715,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.001955,0.16008,0.17305,1,1
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.02521,0.15919,0.12285,1,1
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00022565,0.15888,0.16377,1,1
3,GO RRNA TRANSCRIPTION,0.00015583,0.15853,0.18635,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0043184,0.15851,0.16142,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0043737,0.15807,0.15647,1,1
3,GO REGULATION OF TUBULIN DEACETYLATION,0.036048,0.15746,0.15298,1,1
3,GO RELAXATION OF MUSCLE,0.0052854,0.15699,0.15141,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0030436,0.15669,0.16021,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.0067673,0.15658,0.10753,1,1
3,GO DENDRITE MORPHOGENESIS,0.0071051,0.15638,0.14659,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.02945,0.15609,0.16645,1,1
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0023009,0.15594,0.15721,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0015463,0.15536,0.13773,1,1
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.030994,0.15504,0.13499,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0035146,0.15498,0.16894,1,1
3,GO MRNA MODIFICATION,0.00060545,0.15496,0.20589,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0019023,0.15465,0.15605,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00022208,0.15462,0.17481,1,1
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.022928,0.15361,0.15562,1,1
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0067673,0.15351,0.1507,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00069207,0.15304,0.12446,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0092477,0.15279,0.13757,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0073682,0.15223,0.12881,1,1
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.012367,0.15201,0.17624,1,1
3,GO RRNA METABOLIC PROCESS,0.00022565,0.1516,0.20017,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00039622,0.15137,0.12866,1,1
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00033432,0.15049,0.20351,1,1
3,GO NEURON PROJECTION EXTENSION,0.0005789,0.15045,0.16081,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.033948,0.15026,0.18423,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00057029,0.14996,0.14153,1,1
3,GO ASSOCIATIVE LEARNING,0.00083767,0.14981,0.15276,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00159,0.14976,0.17484,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00015331,0.14976,0.14676,1,1
3,GO RESPONSE TO AMINE,0.0083098,0.14969,0.12278,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00016098,0.14967,0.15018,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0025617,0.14951,0.1536,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00013016,0.14932,0.17293,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,4.7488e-06,0.14913,0.17911,1,1
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0096941,0.14909,0.15732,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0010113,0.14885,0.22135,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.004156,0.1488,0.14264,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,0.0001803,0.14828,0.19324,1,1
3,GO L AMINO ACID TRANSPORT,0.00092737,0.14798,0.17295,1,1
3,GO TRNA METHYLATION,0.00084997,0.14767,0.17442,1,1
3,GO CRISTAE FORMATION,0.007921,0.14711,0.17852,1,1
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00075607,0.14693,0.15461,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0013826,0.14685,0.16255,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,4.4771e-05,0.14635,0.16719,1,1
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.003654,0.14604,0.13906,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00099681,0.14589,0.14558,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.013093,0.14537,0.13419,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.003654,0.14422,0.16445,1,1
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0084096,0.14388,0.16846,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,0.00023294,0.14382,0.20007,1,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.019735,0.14308,0.092611,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0104,0.14279,0.21248,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0035146,0.14253,0.14379,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00010673,0.14243,0.16796,1,1
3,GO DENDRITE DEVELOPMENT,0.0035146,0.14207,0.13994,1,1
3,GO ONE CARBON METABOLIC PROCESS,0.0096941,0.14147,0.12057,1,1
3,GO CARDIAC CONDUCTION,0.0029256,0.14127,0.1449,1,1
3,GO FOREBRAIN CELL MIGRATION,0.0020367,0.14031,0.16332,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00068191,0.13985,0.11235,1,1
3,GO DEVELOPMENTAL CELL GROWTH,0.0017517,0.13967,0.13128,1,1
3,GO GLUTAMINE METABOLIC PROCESS,6.1119e-05,0.13946,0.1937,1,1
3,GO IMPORT INTO CELL,7.8911e-05,0.13923,0.16171,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0052197,0.13884,0.15024,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0085105,0.13867,0.14903,1,1
3,GO AXON DEVELOPMENT,0.0057669,0.13812,0.13957,1,1
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.007921,0.13739,0.17593,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.046921,0.13727,0.14297,1,1
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.013546,0.13703,0.11739,1,1
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.047372,0.137,0.13545,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0020646,0.13635,0.1221,1,1
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.01251,0.1361,0.13471,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.00041488,0.13531,0.11636,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0037016,0.13454,0.16855,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.01585,0.13453,0.1139,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00073415,0.13436,0.19993,1,1
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0024281,0.13432,0.1547,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.00016361,0.13428,0.11714,1,1
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0063654,0.13359,0.15368,1,1
3,GO DENDRITIC SPINE MAINTENANCE,0.035336,0.13353,0.13289,1,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.026013,0.1335,0.14678,1,1
3,GO SNORNA METABOLIC PROCESS,0.00011033,0.13333,0.28274,1,1
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.031631,0.1329,0.12856,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.024687,0.13266,0.23125,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0046018,0.13243,0.16199,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,3.3806e-05,0.13243,0.14116,1,1
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.031311,0.13243,0.11021,1,1
3,GO RRNA MODIFICATION,0.0035605,0.13235,0.19523,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.022928,0.13179,0.12908,1,1
3,GO NUCLEOTIDE SALVAGE,0.031311,0.1314,0.18303,1,1
3,GO TRANSEPITHELIAL TRANSPORT,0.0027747,0.13123,0.12456,1,1
3,GO RNA POLYADENYLATION,0.0043184,0.13097,0.10954,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.012227,0.12938,0.11279,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00096848,0.1293,0.13038,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0023957,0.12859,0.13465,1,1
3,GO RNA SURVEILLANCE,0.0089251,0.12831,0.13219,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.026838,0.12824,0.12609,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0071918,0.12816,0.15095,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0046018,0.12752,0.16472,1,1
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016568,0.12688,0.11195,1,1
3,GO AXO DENDRITIC TRANSPORT,0.022209,0.12645,0.10253,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00039018,0.12608,0.12949,1,1
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.032938,0.12585,0.10865,1,1
3,GO CELLULAR RESPIRATION,0.001483,0.12581,0.12977,1,1
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0052197,0.12571,0.14752,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0030839,0.12411,0.14904,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.038258,0.12314,0.15893,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.040981,0.12245,0.10209,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.013546,0.1224,0.12136,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.037882,0.12233,0.11821,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0077327,0.12228,0.13041,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00094089,0.12146,0.1677,1,1
3,GO NCRNA PROCESSING,0.00072342,0.121,0.16863,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.016205,0.11924,0.13575,1,1
3,GO SYNAPTIC SIGNALING,0.0035605,0.1187,0.13916,1,1
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.028264,0.11852,0.13649,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0005211,0.11851,0.1291,1,1
3,GO BONE GROWTH,0.057179,0.11721,0.13654,1,1
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0022095,0.11532,0.12605,1,1
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.016386,0.11437,0.099064,1,1
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.011411,0.1142,0.13638,1,1
3,GO AMINO ACID TRANSPORT,0.00019857,0.11408,0.15251,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0012177,0.11402,0.1399,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0057669,0.11358,0.095175,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.023173,0.11315,0.15887,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.055609,0.11312,0.11689,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.0019819,0.11258,0.097746,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00024045,0.11192,0.15094,1,1
3,GO TUBULIN DEACETYLATION,0.023919,0.11086,0.1543,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0062877,0.11065,0.14865,1,1
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0088198,0.1096,0.10826,1,1
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0046018,0.10935,0.13592,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.023668,0.10868,0.103,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.027973,0.10852,0.1035,1,1
3,GO MEMBRANE HYPERPOLARIZATION,0.039406,0.10787,0.14377,1,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0051547,0.10692,0.1214,1,1
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0014022,0.1068,0.10896,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0078263,0.10667,0.13393,1,1
3,GO REGULATION OF MEMBRANE POTENTIAL,0.013093,0.10663,0.11645,1,1
3,GO COCHLEA DEVELOPMENT,0.022446,0.10613,0.10556,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.012945,0.10565,0.099129,1,1
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.019104,0.10544,0.090809,1,1
3,GO CERAMIDE TRANSPORT,0.014658,0.10518,0.12744,1,1
3,GO CELLULAR RESPONSE TO PH,0.010041,0.1047,0.10083,1,1
3,GO PROTEIN TARGETING,0.00015331,0.10423,0.10867,1,1
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.0046604,0.10401,0.12063,1,1
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0093576,0.10396,0.11398,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.040582,0.1039,0.10984,1,1
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0071051,0.10359,0.13701,1,1
3,GO TRNA PROCESSING,0.0014022,0.10318,0.15178,1,1
3,GO MRNA METHYLATION,0.037882,0.10279,0.13391,1,1
3,GO RNA METHYLATION,0.0055559,0.10199,0.12392,1,1
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0037016,0.10159,0.084806,1,1
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.012798,0.10082,0.13156,1,1
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0047198,0.099909,0.11394,1,1
3,GO STRIATED MUSCLE CONTRACTION,0.044292,0.099809,0.084131,1,1
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.020385,0.099807,0.085835,1,1
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0038478,0.099347,0.12333,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.036409,0.09932,0.1773,1,1
3,GO PRESYNAPTIC ENDOCYTOSIS,0.042197,0.099191,0.11172,1,1
3,GO RNA CATABOLIC PROCESS,0.0030839,0.098794,0.10639,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.012087,0.098576,0.10845,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0015249,0.097699,0.10363,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.023668,0.097607,0.12176,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.050154,0.096388,0.1069,1,1
3,GO SKELETAL MUSCLE CONTRACTION,0.010279,0.0958,0.13646,1,1
3,GO RESPONSE TO AMYLOID BETA,0.010769,0.095579,0.12321,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.018898,0.094643,0.12746,1,1
3,GO NCRNA METABOLIC PROCESS,0.0023009,0.093617,0.1417,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.01995,0.093316,0.084551,1,1
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0089251,0.092511,0.17303,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.017506,0.091914,0.082731,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.013243,0.091483,0.10253,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0020929,0.089074,0.11437,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.015674,0.089051,0.098154,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.012087,0.088621,0.10566,1,1
3,GO CELL RECOGNITION,0.0063654,0.088376,0.10273,1,1
3,GO TRNA 5 END PROCESSING,0.016938,0.087996,0.13094,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0030436,0.087544,0.089881,1,1
3,GO RNA 5 END PROCESSING,0.0088198,0.086892,0.16606,1,1
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0035146,0.08612,0.11091,1,1
3,GO PROTEIN TETRAMERIZATION,0.0051547,0.085451,0.095473,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.017894,0.085321,0.094385,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0031247,0.084634,0.11337,1,1
3,GO RRNA METHYLATION,0.027686,0.084319,0.13326,1,1
3,GO MRNA METABOLIC PROCESS,0.0031247,0.084215,0.087569,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.026286,0.083937,0.073863,1,1
3,GO REGULATION OF CELL SIZE,0.017894,0.082711,0.10064,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.0073682,0.082565,0.096887,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00038422,0.081828,0.12093,1,1
3,GO COGNITION,0.0084096,0.08141,0.11837,1,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.004156,0.081292,0.1248,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.034636,0.081087,0.10723,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.048746,0.080546,0.096944,1,1
3,GO RECEPTOR INTERNALIZATION,0.018091,0.080252,0.10511,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.004156,0.08019,0.08373,1,1
3,GO PROTEIN NITROSYLATION,0.059331,0.080055,0.12607,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0073682,0.079939,0.11589,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.014172,0.079721,0.11303,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0072795,0.079548,0.11195,1,1
3,GO ATP METABOLIC PROCESS,0.0029256,0.079302,0.092352,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0037016,0.079265,0.087485,1,1
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.014172,0.078407,0.13811,1,1
3,GO RNA 3 END PROCESSING,0.041383,0.077498,0.064902,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0033799,0.076384,0.074196,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.05063,0.075522,0.066975,1,1
3,GO RNA PROCESSING,0.0053519,0.074425,0.095293,1,1
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.019312,0.074275,0.087172,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0041031,0.073202,0.12789,1,1
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.019735,0.071752,0.091949,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.015329,0.07011,0.087191,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.020166,0.069013,0.08728,1,1
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0073682,0.067994,0.11282,1,1
3,GO MEMORY,0.042197,0.066017,0.094069,1,1
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.013856,0.063196,0.079158,1,1
3,GO RNA MODIFICATION,0.0069343,0.06175,0.11843,1,1
3,GO CATECHOLAMINE SECRETION,0.042197,0.059232,0.18623,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.059331,0.054455,0.054175,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.011813,0.048769,0.11416,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.015501,0.048189,0.076129,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1.1588e-05,0.70576,0.74612,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,6.3359e-07,0.62532,0.60025,1,1
4,GO HISTAMINE SECRETION,1.6321e-06,0.60845,0.5042,1,1
4,GO HISTAMINE TRANSPORT,3.9822e-07,0.52796,0.47793,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,1.2886e-07,0.51046,0.57356,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,7.1726e-09,0.50996,0.50441,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,9.2321e-08,0.50612,0.49491,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,6.6717e-09,0.49774,0.53368,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00075607,0.48753,0.42793,1,1
4,GO REFLEX,2.3239e-05,0.47881,0.39321,1,1
4,GO REGULATION OF PLATELET AGGREGATION,3.5794e-07,0.47817,0.48277,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,4.3355e-07,0.47269,0.47256,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,5.1101e-09,0.46065,0.46501,1,1
4,GO O GLYCAN PROCESSING,3.4003e-08,0.45906,0.39383,1,1
4,GO INTESTINAL LIPID ABSORPTION,1.996e-06,0.45716,0.49602,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,4.0343e-10,0.45453,0.4491,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.7582e-06,0.45346,0.42367,1,1
4,GO RESPONSE TO TYPE I INTERFERON,0.00047589,0.44607,0.32181,1,1
4,GO INTESTINAL ABSORPTION,5.6317e-09,0.44279,0.46034,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,1.2032e-06,0.43458,0.49518,1,1
4,GO REGULATION OF ANOIKIS,4.3355e-07,0.43111,0.42978,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00025617,0.42923,0.39786,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00029511,0.42807,0.3109,1,1
4,GO TOXIN METABOLIC PROCESS,2.3784e-07,0.4252,0.39414,1,1
4,GO MUCUS SECRETION,0.001235,0.42406,0.37735,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00063314,0.41816,0.3617,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,5.4184e-05,0.41632,0.38236,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.0712e-08,0.4161,0.43297,1,1
4,GO STABILIZATION OF MEMBRANE POTENTIAL,7.3739e-05,0.41551,0.37333,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,9.5999e-07,0.41175,0.51069,1,1
4,GO REGULATION OF PLATELET ACTIVATION,2.1196e-06,0.4107,0.37534,1,1
4,GO ADRENAL GLAND DEVELOPMENT,6.2993e-08,0.40923,0.40961,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,3.628e-05,0.40798,0.40687,1,1
4,GO RENAL ABSORPTION,2.8305e-05,0.40795,0.40693,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,5.0563e-05,0.40735,0.37405,1,1
4,GO RESPONSE TO INTERFERON BETA,0.0021505,0.40569,0.2859,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.00012186,0.39703,0.31393,1,1
4,GO CELLULAR RESPONSE TO ZINC ION,0.0050904,0.39492,0.37886,1,1
4,GO LIPOXYGENASE PATHWAY,0.00022565,0.39334,0.35039,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,3.0156e-07,0.39306,0.46449,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00026024,0.39288,0.31077,1,1
4,GO RESPONSE TO MAGNESIUM ION,1.734e-06,0.38825,0.4066,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0035146,0.38563,0.27347,1,1
4,GO DETECTION OF OTHER ORGANISM,0.00037835,0.38436,0.32138,1,1
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.043866,0.38022,0.46029,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,6.0991e-06,0.3789,0.33934,1,1
4,GO TOLERANCE INDUCTION,0.001071,0.37845,0.33037,1,1
4,GO CELLULAR RESPONSE TO COPPER ION,0.009139,0.37834,0.33976,1,1
4,GO ADHESION OF SYMBIONT TO HOST,2.5868e-06,0.37779,0.3966,1,1
4,GO REGULATION OF VASCULOGENESIS,2.2015e-05,0.37774,0.34618,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,1.5014e-05,0.37733,0.41554,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0084096,0.37642,0.22531,1,1
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.6994e-06,0.37457,0.39479,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00014362,0.37304,0.30668,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.1375e-05,0.37224,0.31799,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.00016629,0.36804,0.30904,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,5.7582e-06,0.3667,0.37933,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,9.7991e-09,0.36614,0.41623,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.1751e-05,0.36595,0.38331,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.00018923,0.3659,0.30936,1,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00031414,0.36576,0.33028,1,1
4,GO RESPONSE TO PAIN,4.0868e-08,0.36005,0.36009,1,1
4,GO MECHANOSENSORY BEHAVIOR,0.019312,0.35972,0.24826,1,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,8.5858e-05,0.35959,0.35471,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.971e-06,0.35101,0.4159,1,1
4,GO GERMINAL CENTER FORMATION,0.00033955,0.35055,0.29922,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00020178,0.34568,0.36092,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,3.8246e-05,0.34437,0.29427,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.5884e-05,0.34315,0.40832,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.8701e-05,0.3419,0.34306,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00010323,0.34128,0.29388,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.019312,0.34115,0.21391,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,2.8814e-05,0.34079,0.33337,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,1.5293e-05,0.34013,0.34563,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,1.4207e-05,0.33931,0.32372,1,1
4,GO MEMBRANE RAFT ORGANIZATION,0.00043435,0.33836,0.31647,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,4.0657e-06,0.33725,0.44722,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,3.6877e-06,0.33432,0.30952,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.0011836,0.33351,0.28581,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.0004e-06,0.33271,0.39734,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.001483,0.33255,0.2869,1,1
4,GO RESPONSE TO DIETARY EXCESS,3.0905e-06,0.33232,0.3234,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.001235,0.33207,0.26631,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,9.0235e-07,0.33109,0.32924,1,1
4,GO NEURONAL ACTION POTENTIAL,1.0004e-06,0.33105,0.39554,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,1.9563e-06,0.33102,0.30209,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,3.3228e-08,0.33063,0.30231,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.00040235,0.32865,0.26012,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00057029,0.32549,0.29421,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,4.8673e-09,0.32477,0.35887,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00015331,0.32475,0.3102,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,6.0991e-06,0.32385,0.26043,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00048316,0.32317,0.32458,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0011021,0.32248,0.33809,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.00021857,0.32218,0.33174,1,1
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.02174,0.32204,0.23599,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00057029,0.32174,0.30628,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.4262e-06,0.31917,0.32742,1,1
4,GO REGULATION OF DENDRITE EXTENSION,5.1351e-07,0.31861,0.35102,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,1.5372e-07,0.31827,0.37478,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,4.6578e-06,0.31745,0.31199,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,9.7998e-07,0.31696,0.31288,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00040857,0.31636,0.27916,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,2.9859e-05,0.31629,0.31194,1,1
4,GO CORNIFICATION,5.3256e-05,0.31582,0.2748,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0020929,0.31448,0.24875,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00036686,0.31446,0.27252,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,1.9175e-06,0.31311,0.37993,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0050904,0.31253,0.20481,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00016361,0.31029,0.24666,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0033799,0.30936,0.24106,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00021511,0.30899,0.35162,1,1
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,5.8049e-05,0.30876,0.35274,1,1
4,GO PLASMA MEMBRANE FUSION,0.00010152,0.30817,0.29518,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00015083,0.30772,0.2846,1,1
4,GO REGULATION OF DOPAMINE SECRETION,7.105e-06,0.30766,0.42208,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,1.3948e-05,0.30679,0.37845,1,1
4,GO EOSINOPHIL CHEMOTAXIS,6.545e-05,0.30652,0.35291,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00022208,0.30541,0.25861,1,1
4,GO KERATINIZATION,5.8698e-06,0.30527,0.2757,1,1
4,GO RESPONSE TO COLD,7.0337e-07,0.30501,0.28892,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,3.094e-05,0.30446,0.29599,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,3.9872e-06,0.30403,0.37404,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,4.8416e-06,0.30399,0.36205,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,7.5217e-06,0.30274,0.2756,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.6761e-05,0.30194,0.29965,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,8.1138e-06,0.30158,0.26622,1,1
4,GO RESPONSE TO COPPER ION,0.00018323,0.30152,0.33004,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.00061456,0.30101,0.30606,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,1.1086e-06,0.30016,0.35159,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,6.337e-06,0.29872,0.32835,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,1.5052e-06,0.29854,0.29815,1,1
4,GO SEQUESTERING OF ACTIN MONOMERS,0.00049053,0.29826,0.31765,1,1
4,GO RESPONSE TO REDOX STATE,1.3325e-06,0.29817,0.29133,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0050269,0.298,0.20439,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.0256e-05,0.29688,0.25677,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00022565,0.2967,0.31762,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.003607,0.29648,0.2196,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.0010408,0.29633,0.20849,1,1
4,GO RESPONSE TO FORSKOLIN,0.0011503,0.29629,0.25715,1,1
4,GO REGULATION OF RESPIRATORY BURST,1.1041e-08,0.29563,0.36063,1,1
4,GO ACTIN FILAMENT SEVERING,0.0001179,0.29524,0.29657,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0002117,0.29369,0.23756,1,1
4,GO CELLULAR DEFENSE RESPONSE,1.8363e-05,0.2934,0.23706,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0021215,0.29277,0.29002,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.011544,0.29178,0.26924,1,1
4,GO ANOIKIS,7.969e-07,0.29166,0.33155,1,1
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.0022701,0.2916,0.26411,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00016901,0.29109,0.24981,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00017176,0.2882,0.38012,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,4.2487e-05,0.28793,0.27149,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,6.2046e-07,0.28721,0.27776,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.7693e-06,0.28674,0.26599,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0012886,0.28574,0.23518,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.00067188,0.28559,0.27309,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00020178,0.28552,0.30231,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,1.5576e-05,0.28515,0.27812,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.0010408,0.28509,0.25671,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,6.6578e-05,0.28454,0.27981,1,1
4,GO LIPID TRANSLOCATION,5.4701e-07,0.2844,0.30354,1,1
4,GO DOPAMINE TRANSPORT,2.0364e-06,0.2843,0.38746,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00084997,0.28381,0.29238,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0020367,0.28374,0.22421,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,2.5868e-06,0.28267,0.27374,1,1
4,GO DETECTION OF CALCIUM ION,7.3803e-06,0.28227,0.355,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00015083,0.28208,0.2545,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.0051547,0.2816,0.22312,1,1
4,GO EOSINOPHIL MIGRATION,0.00018923,0.28071,0.32265,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,6.7461e-07,0.28034,0.32448,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0044864,0.27921,0.20168,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0075485,0.27817,0.25347,1,1
4,GO B CELL APOPTOTIC PROCESS,1.4741e-05,0.27799,0.26526,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00016629,0.27624,0.26249,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0023321,0.27581,0.26669,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,0.00024819,0.27541,0.29809,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0020646,0.27488,0.18969,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.0004e-06,0.27385,0.29096,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00094089,0.27292,0.20872,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00045468,0.27284,0.2639,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,9.4341e-06,0.27144,0.26651,1,1
4,GO VASODILATION,6.8888e-05,0.271,0.20762,1,1
4,GO REGULATION OF NEURON MATURATION,0.00019541,0.27075,0.24392,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0042636,0.26941,0.2437,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,1.1375e-05,0.26931,0.30409,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0032078,0.26877,0.25088,1,1
4,GO ZYMOGEN ACTIVATION,0.00027284,0.26793,0.25201,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0001803,0.26786,0.35333,1,1
4,GO RESPONSE TO EPINEPHRINE,0.00010152,0.2676,0.34669,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,6.545e-05,0.26648,0.23194,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00029511,0.26579,0.26432,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0026663,0.26562,0.27258,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00033432,0.26558,0.2073,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.0005789,0.26548,0.24451,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,7.3739e-05,0.26524,0.30352,1,1
4,GO REGULATION OF VESICLE FUSION,0.0029645,0.2652,0.21813,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00013232,0.26436,0.26018,1,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.00015838,0.26426,0.37241,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00016629,0.26371,0.28626,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0022396,0.26281,0.23643,1,1
4,GO RESPIRATORY BURST,1.0756e-05,0.26274,0.26279,1,1
4,GO MYELIN MAINTENANCE,0.001071,0.26241,0.27861,1,1
4,GO PANCREATIC JUICE SECRETION,0.00073415,0.26236,0.18496,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,3.357e-07,0.26231,0.29682,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0047198,0.26214,0.16236,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.014658,0.26143,0.15204,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.0051547,0.26085,0.19668,1,1
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0030038,0.26082,0.27236,1,1
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.0063654,0.26058,0.20878,1,1
4,GO REGULATION OF TISSUE REMODELING,1.2954e-05,0.26036,0.24749,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,9.6129e-06,0.2591,0.23834,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.0079e-05,0.25904,0.3429,1,1
4,GO BLOOD VESSEL REMODELING,0.0005056,0.25837,0.21451,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.00083767,0.25798,0.24062,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.019312,0.25795,0.2072,1,1
4,GO NEPHRIC DUCT DEVELOPMENT,0.003654,0.25781,0.21982,1,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.0012886,0.25695,0.1798,1,1
4,GO REGULATION OF BONE REMODELING,8.1138e-06,0.25659,0.25354,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,5.5127e-05,0.2564,0.23547,1,1
4,GO REGULATION OF CELL KILLING,0.0012005,0.25632,0.18724,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.001704,0.25566,0.20859,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,6.8888e-05,0.25524,0.24082,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00022927,0.25519,0.23169,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00016361,0.25471,0.27781,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00011218,0.25471,0.22801,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.8053e-06,0.2547,0.26806,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.002631,0.2544,0.21347,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,3.3435e-06,0.25428,0.31057,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.7693e-06,0.25325,0.27027,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,1.5576e-05,0.25317,0.24003,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00030449,0.25263,0.24117,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,3.9102e-06,0.25259,0.24338,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,5.0563e-05,0.25208,0.2662,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00010323,0.25179,0.22419,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00083767,0.25162,0.22121,1,1
4,GO RESPONSE TO LITHIUM ION,2.971e-06,0.25127,0.32154,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.014172,0.25122,0.17456,1,1
4,GO NEURON CELL CELL ADHESION,0.015159,0.25087,0.23135,1,1
4,GO PHAGOSOME ACIDIFICATION,3.6435e-08,0.25057,0.25674,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0056958,0.25032,0.21844,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,4.4285e-07,0.24988,0.27322,1,1
4,GO RESPONSE TO STEROL DEPLETION,1.9175e-06,0.24955,0.2776,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.00090088,0.2495,0.19642,1,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00080175,0.24917,0.26917,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0062108,0.24897,0.1866,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0029256,0.24821,0.28184,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.026013,0.24744,0.17229,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00041488,0.24693,0.22109,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.2604e-07,0.24654,0.29363,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00055343,0.2464,0.25567,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.0012705,0.24608,0.24368,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.0563e-05,0.24586,0.23917,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0054192,0.24569,0.16955,1,1
4,GO RESPONSE TO GONADOTROPIN,4.1026e-05,0.24553,0.21302,1,1
4,GO DOPAMINE METABOLIC PROCESS,2.4861e-06,0.24544,0.29353,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.00014129,0.24491,0.21423,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.0056958,0.24461,0.20672,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,3.6924e-05,0.24378,0.21783,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,4.7172e-05,0.24295,0.24661,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00095459,0.24273,0.21148,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.0012705,0.24252,0.19167,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00015083,0.2425,0.20286,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.0069343,0.24241,0.26574,1,1
4,GO APICAL JUNCTION ASSEMBLY,1.5576e-05,0.24193,0.24917,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0030436,0.24189,0.23958,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.0001179,0.2418,0.24705,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.5038e-07,0.2416,0.28074,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.5646e-05,0.24152,0.26601,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.012227,0.24132,0.19421,1,1
4,GO CATECHOLAMINE UPTAKE,8.1623e-05,0.24099,0.27861,1,1
4,GO REGULATION OF ICOSANOID SECRETION,4.1552e-07,0.24057,0.26803,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.0032078,0.24025,0.22303,1,1
4,GO REGULATION OF COAGULATION,0.00053704,0.24023,0.21577,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.00063314,0.23994,0.1843,1,1
4,GO INTERLEUKIN 12 PRODUCTION,0.00025617,0.23967,0.2083,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,2.1621e-05,0.23843,0.23642,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,2.4528e-05,0.23833,0.26685,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0088198,0.23786,0.211,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.00068191,0.23712,0.19464,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0007786,0.23701,0.19938,1,1
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0032078,0.23643,0.32278,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,3.628e-05,0.23582,0.25683,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.1086e-06,0.23578,0.23252,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0020367,0.23564,0.22134,1,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0033799,0.23505,0.18231,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.010522,0.23504,0.19236,1,1
4,GO SUPEROXIDE ANION GENERATION,0.0005789,0.23458,0.2203,1,1
4,GO N GLYCAN PROCESSING,0.0019023,0.23327,0.24687,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.2253e-05,0.23273,0.21981,1,1
4,GO MAST CELL ACTIVATION,1.9393e-05,0.23245,0.26343,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,1.536e-06,0.23177,0.23491,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00013451,0.23166,0.20748,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.3256e-05,0.23161,0.23083,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0024609,0.23157,0.2498,1,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.015159,0.23146,0.18376,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0037498,0.23138,0.15364,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.000662,0.23097,0.25306,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.055093,0.23082,0.11957,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.0958e-05,0.23061,0.2288,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00084997,0.23055,0.24942,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0019285,0.23039,0.16368,1,1
4,GO T CELL MEDIATED IMMUNITY,0.0081133,0.23014,0.13873,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.4972e-05,0.2297,0.25859,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,2.6828e-05,0.22956,0.19636,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,4.6359e-05,0.22946,0.20975,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.3381e-05,0.22878,0.18077,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00044781,0.22872,0.21514,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00084997,0.22866,0.20303,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.00046872,0.22786,0.25127,1,1
4,GO STEROID ESTERIFICATION,0.0104,0.2278,0.15512,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.015159,0.22776,0.23855,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00068191,0.22739,0.18568,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0099244,0.22693,0.12831,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.061549,0.22679,0.14635,1,1
4,GO RESPONSE TO INTERLEUKIN 2,1.4207e-05,0.22643,0.23411,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,4.3236e-05,0.22589,0.21005,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00027284,0.22578,0.17882,1,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0046604,0.22553,0.2211,1,1
4,GO DIGESTIVE SYSTEM PROCESS,1.5052e-06,0.22475,0.21376,1,1
4,GO PROTEIN DEMANNOSYLATION,9.4959e-05,0.22463,0.2387,1,1
4,GO MAGNESIUM ION TRANSPORT,1.4207e-05,0.22415,0.24847,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,2.2824e-05,0.224,0.32797,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,6.337e-06,0.22293,0.23338,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00018923,0.22287,0.23276,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.0020092,0.22274,0.2376,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0054872,0.22262,0.27298,1,1
4,GO MYOBLAST FUSION,0.00065224,0.22261,0.19981,1,1
4,GO POSITIVE REGULATION OF HEART CONTRACTION,1.1806e-05,0.2226,0.238,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00064263,0.22215,0.25158,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.6321e-06,0.22173,0.30545,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.001568,0.22137,0.21853,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00074504,0.22131,0.21889,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,5.4184e-05,0.22102,0.23856,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.027118,0.22101,0.1173,1,1
4,GO CELL KILLING,0.00065224,0.22042,0.16921,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00012388,0.2203,0.18941,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00046165,0.22007,0.18953,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0073682,0.21996,0.1836,1,1
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00052901,0.21989,0.19902,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0012705,0.21932,0.24595,1,1
4,GO VACUOLAR ACIDIFICATION,1.536e-06,0.21931,0.20594,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0016122,0.21931,0.23376,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.1789e-06,0.21897,0.2094,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.0089251,0.2188,0.1585,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0013069,0.21843,0.19648,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.0005211,0.21838,0.17344,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.00046872,0.21818,0.19767,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.00011218,0.21817,0.19944,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,2.4091e-05,0.21797,0.23406,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.014332,0.21779,0.13543,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00065224,0.21777,0.15683,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.043866,0.21748,0.10244,1,1
4,GO MEMBRANE DEPOLARIZATION,8.8796e-05,0.21737,0.20836,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.0028492,0.21733,0.21268,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0861e-06,0.21705,0.24792,1,1
4,GO PHOSPHOLIPID TRANSPORT,4.31e-06,0.21693,0.21677,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0081133,0.21598,0.16169,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,1.4741e-05,0.21593,0.23089,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0066039,0.21548,0.22329,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,7.7586e-05,0.21531,0.1944,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00044103,0.21529,0.21645,1,1
4,GO INOSITOL METABOLIC PROCESS,0.00029511,0.21521,0.19835,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00021857,0.2152,0.25171,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,7.9617e-06,0.21514,0.24646,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00021511,0.21433,0.20298,1,1
4,GO REGULATION OF MYOBLAST FUSION,0.00029976,0.21428,0.23142,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00029511,0.21388,0.21574,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.032938,0.21374,0.21031,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0022701,0.21348,0.22111,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.00012594,0.21288,0.23522,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,5.4356e-06,0.21287,0.24723,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00099681,0.21266,0.17469,1,1
4,GO ETHER METABOLIC PROCESS,0.00044781,0.21199,0.17523,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0056255,0.2117,0.22375,1,1
4,GO REGULATION OF B CELL PROLIFERATION,8.1623e-05,0.21135,0.21583,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.000286,0.21134,0.23191,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00025215,0.21134,0.23844,1,1
4,GO SECRETION BY TISSUE,0.00037257,0.2108,0.19312,1,1
4,GO MATURE B CELL DIFFERENTIATION,0.002631,0.21079,0.22555,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.018693,0.21042,0.14339,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,5.2344e-05,0.20973,0.21458,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.3878e-06,0.20945,0.251,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.7385e-05,0.20943,0.24765,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,5.1446e-05,0.20931,0.23366,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,4.4771e-05,0.20915,0.27986,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,6.8888e-05,0.20895,0.21952,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00046165,0.2089,0.20818,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,4.6578e-06,0.2087,0.19313,1,1
4,GO DNA DEAMINATION,0.0015249,0.20848,0.29321,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,1.5865e-05,0.20843,0.22874,1,1
4,GO OSTEOBLAST PROLIFERATION,0.00054518,0.20842,0.22462,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00049802,0.20833,0.19185,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,1.4207e-05,0.20823,0.18769,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0039481,0.20775,0.17331,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00016901,0.20765,0.18343,1,1
4,GO DIOL METABOLIC PROCESS,5.5127e-05,0.20765,0.22916,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00022927,0.20763,0.16417,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0018508,0.20762,0.22787,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0028492,0.20737,0.17158,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0007901,0.20658,0.1783,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.012798,0.20655,0.19237,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,4.5558e-05,0.2062,0.21559,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.009139,0.20608,0.15231,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,2.1621e-05,0.20594,0.17983,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0067673,0.20593,0.1817,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0001803,0.2059,0.19949,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.0010259,0.20566,0.22051,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.015674,0.20537,0.17393,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,1.6158e-05,0.20508,0.20822,1,1
4,GO ORGANELLE MEMBRANE FUSION,5.7582e-06,0.20473,0.18544,1,1
4,GO TISSUE REMODELING,6.7724e-05,0.20457,0.21482,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,9.6562e-05,0.20442,0.23505,1,1
4,GO PLATELET AGGREGATION,0.00018923,0.20392,0.21966,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.027401,0.20388,0.14538,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0066039,0.20346,0.26347,1,1
4,GO LYTIC VACUOLE ORGANIZATION,2.0879e-07,0.2034,0.22906,1,1
4,GO RESPONSE TO GROWTH HORMONE,0.00011033,0.20319,0.21818,1,1
4,GO BONE REMODELING,8.4424e-05,0.20304,0.20708,1,1
4,GO GLYCOSYLATION,1.8053e-06,0.20285,0.19271,1,1
4,GO PLATELET DEGRANULATION,0.0011836,0.2028,0.18603,1,1
4,GO B CELL PROLIFERATION,0.00026858,0.20221,0.17837,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.042197,0.20212,0.11975,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00029976,0.20198,0.17522,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00042128,0.20194,0.19197,1,1
4,GO REGULATION OF WOUND HEALING,0.00014839,0.2009,0.21328,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.00012594,0.20079,0.1913,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00048316,0.20076,0.17001,1,1
4,GO SNARE COMPLEX ASSEMBLY,3.3214e-05,0.20051,0.23176,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00083767,0.20045,0.21162,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.0047198,0.20042,0.17782,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,2.0879e-07,0.2004,0.20357,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.1623e-05,0.20003,0.19637,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.022446,0.20002,0.16079,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00058763,0.19996,0.25353,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.00045468,0.19972,0.1959,1,1
4,GO METHIONINE METABOLIC PROCESS,0.0020646,0.19955,0.14831,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0025277,0.19944,0.17741,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0010558,0.1993,0.17634,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,2.011e-05,0.19927,0.18752,1,1
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0016806,0.19904,0.24731,1,1
4,GO LIVER MORPHOGENESIS,0.00021511,0.19852,0.25005,1,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.049212,0.19851,0.17124,1,1
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.010279,0.19828,0.16937,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00030928,0.19772,0.25962,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.0034243,0.19749,0.16734,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00019229,0.19745,0.2314,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.3739e-05,0.19709,0.18248,1,1
4,GO REGULATION OF ACTIN NUCLEATION,1.9749e-05,0.19702,0.22175,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.020385,0.19694,0.15258,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,1.6994e-06,0.19686,0.22627,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0061347,0.19659,0.20391,1,1
4,GO BONE RESORPTION,2.3661e-05,0.19652,0.20698,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,4.9228e-07,0.19644,0.20239,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0010408,0.19643,0.17717,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0005211,0.19642,0.1968,1,1
4,GO DEFENSE RESPONSE TO FUNGUS,8.7316e-05,0.19617,0.16946,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,1.4454e-06,0.19609,0.18312,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00021857,0.19589,0.21044,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0005056,0.19589,0.20598,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00087508,0.19584,0.16609,1,1
4,GO TRANSCYTOSIS,0.003166,0.19558,0.15519,1,1
4,GO FUCOSYLATION,0.0045438,0.19497,0.14542,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00045468,0.19448,0.22664,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00080175,0.19447,0.18888,1,1
4,GO HEART TRABECULA MORPHOGENESIS,0.0098086,0.19411,0.13774,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.00011596,0.19363,0.22818,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.011949,0.19315,0.15956,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00027284,0.19305,0.19078,1,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00086244,0.19264,0.22428,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00015583,0.19248,0.26276,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.020605,0.19242,0.18371,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00029976,0.19239,0.1901,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.033948,0.19238,0.12106,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,4.1456e-06,0.19177,0.21333,1,1
4,GO PHAGOSOME MATURATION,2.4972e-05,0.19097,0.19799,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00092737,0.19093,0.24982,1,1
4,GO MICROVILLUS ASSEMBLY,0.017125,0.19078,0.17139,1,1
4,GO HAIR CELL DIFFERENTIATION,0.0038478,0.19049,0.15844,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0046018,0.19033,0.15371,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,6.5837e-06,0.19031,0.22523,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,1.536e-06,0.19026,0.19063,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00062378,0.19025,0.21355,1,1
4,GO HEART TRABECULA FORMATION,0.0063654,0.19011,0.21771,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.003166,0.1901,0.2034,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0013255,0.18988,0.1657,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.013093,0.18948,0.16213,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,3.628e-05,0.18942,0.18534,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0018006,0.18929,0.26897,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.0021505,0.18888,0.17052,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00037257,0.18833,0.16603,1,1
4,GO LEUKOCYTE MIGRATION,8.3013e-05,0.18826,0.17889,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,0.00013673,0.18762,0.19843,1,1
4,GO REGULATION OF B CELL ACTIVATION,0.00029511,0.18758,0.16398,1,1
4,GO CERAMIDE METABOLIC PROCESS,1.3693e-05,0.18732,0.17381,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,5.0323e-06,0.1872,0.19346,1,1
4,GO SIGNAL PEPTIDE PROCESSING,3.3214e-05,0.18683,0.24396,1,1
4,GO MAST CELL MEDIATED IMMUNITY,0.00017741,0.18671,0.2323,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,5.1446e-05,0.18648,0.22588,1,1
4,GO ICOSANOID METABOLIC PROCESS,0.0005618,0.18637,0.177,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0013443,0.18635,0.17301,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.00015331,0.18629,0.214,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00013232,0.1861,0.188,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.0022701,0.18607,0.16051,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.00073415,0.18589,0.18084,1,1
4,GO MEMBRANE FUSION,5.8698e-06,0.18588,0.18218,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0054192,0.1858,0.1226,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.026013,0.18578,0.14962,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0005056,0.18577,0.22871,1,1
4,GO DIET INDUCED THERMOGENESIS,5.5127e-05,0.18573,0.21802,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00022927,0.18561,0.17864,1,1
4,GO TRANSPOSITION,0.0013069,0.18546,0.24317,1,1
4,GO TRANSFERRIN TRANSPORT,2.9514e-07,0.18509,0.21008,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0087156,0.18502,0.15888,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0022095,0.18497,0.19112,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0030839,0.18494,0.15653,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00025215,0.1848,0.18169,1,1
4,GO NERVE DEVELOPMENT,0.001704,0.18475,0.18496,1,1
4,GO CYTOPLASM ORGANIZATION,0.0040509,0.18471,0.1786,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0058389,0.18449,0.14411,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0013443,0.18442,0.16372,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.001704,0.18425,0.20248,1,1
4,GO INSULIN SECRETION,7.105e-06,0.18421,0.18138,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00017176,0.18417,0.24395,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.004964,0.18415,0.15849,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0005618,0.18368,0.17448,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00092737,0.18342,0.21251,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00035024,0.18318,0.16053,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00018323,0.18305,0.17947,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00062378,0.183,0.1941,1,1
4,GO DETECTION OF BIOTIC STIMULUS,0.037882,0.18291,0.12277,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,6.3249e-05,0.18272,0.15333,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0016575,0.1827,0.17648,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0033799,0.18268,0.1469,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.2271e-06,0.18261,0.19407,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00017741,0.18248,0.16788,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00036124,0.18234,0.24576,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.015329,0.18221,0.10998,1,1
4,GO GAP JUNCTION ASSEMBLY,0.01499,0.18205,0.17091,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0074579,0.182,0.16682,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.001483,0.1817,0.16099,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0063654,0.18158,0.1351,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,6.2169e-06,0.18144,0.20163,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00032408,0.18144,0.19222,1,1
4,GO GROOMING BEHAVIOR,0.0050269,0.18073,0.16376,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.9711e-06,0.18054,0.18777,1,1
4,GO HUMORAL IMMUNE RESPONSE,0.00036124,0.18036,0.13948,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.010279,0.18024,0.27219,1,1
4,GO RESPONSE TO LEPTIN,0.00018923,0.17997,0.18653,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.0046604,0.17935,0.12831,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001483,0.17922,0.20633,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0078263,0.17906,0.24094,1,1
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0062108,0.17897,0.15604,1,1
4,GO RESPONSE TO THYROID HORMONE,0.022928,0.17861,0.15947,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0054192,0.17849,0.12064,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,9.819e-05,0.17822,0.17903,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.0002117,0.17819,0.16257,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0049019,0.17766,0.1495,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0063654,0.17727,0.13267,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.00053704,0.17698,0.14506,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.001235,0.17694,0.16178,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.00024045,0.17692,0.17915,1,1
4,GO REGULATION OF HEART RATE,0.00016629,0.17686,0.18093,1,1
4,GO POLYOL CATABOLIC PROCESS,0.00040235,0.17675,0.16275,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,1.7071e-05,0.17666,0.1974,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.001955,0.17661,0.13896,1,1
4,GO MICROVILLUS ORGANIZATION,0.00036686,0.17648,0.27646,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,1.1165e-05,0.17636,0.18216,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.2057e-05,0.17608,0.22173,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.001776,0.17598,0.20153,1,1
4,GO CHEMOKINE PRODUCTION,0.01499,0.17596,0.12367,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.00016629,0.17586,0.1698,1,1
4,GO PODOSOME ASSEMBLY,0.01585,0.17576,0.15532,1,1
4,GO NEURON MATURATION,0.004156,0.17574,0.16113,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0024281,0.17549,0.20323,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.01585,0.17545,0.12609,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0059852,0.17534,0.18341,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.00025617,0.17533,0.18332,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.0040509,0.17528,0.17633,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00014129,0.17518,0.18562,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0031247,0.17471,0.14239,1,1
4,GO DIGESTION,4.31e-06,0.17455,0.20571,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00010323,0.17435,0.17718,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.048285,0.17432,0.13264,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.001776,0.17361,0.14518,1,1
4,GO EXOCYTIC PROCESS,0.00012594,0.1735,0.19376,1,1
4,GO PLASMINOGEN ACTIVATION,0.01829,0.17348,0.15914,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0011836,0.17345,0.16126,1,1
4,GO LIPID EXPORT FROM CELL,0.0021505,0.17295,0.13623,1,1
4,GO STEROID METABOLIC PROCESS,0.00016629,0.17281,0.14943,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.018898,0.17254,0.14425,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0005789,0.1725,0.18082,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0022701,0.17247,0.22379,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.0023957,0.17243,0.22266,1,1
4,GO ZINC ION HOMEOSTASIS,0.017125,0.1724,0.19084,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0038478,0.17234,0.12821,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0027381,0.17226,0.13115,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0028492,0.17214,0.19275,1,1
4,GO SKIN DEVELOPMENT,0.00081356,0.17213,0.15371,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0089251,0.17191,0.13764,1,1
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0068504,0.17116,0.21408,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.00082553,0.17108,0.18162,1,1
4,GO RESPONSE TO METAL ION,4.9361e-06,0.17107,0.1647,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00022565,0.17095,0.17445,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,4.7172e-05,0.17093,0.15916,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0016122,0.17078,0.14224,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.018898,0.1707,0.14172,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.0013255,0.17048,0.13519,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0007901,0.17045,0.15403,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0046604,0.17035,0.16773,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,5.2344e-05,0.17023,0.1858,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00014839,0.17023,0.18158,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0013826,0.16998,0.15251,1,1
4,GO NUCLEOTIDE TRANSPORT,0.00011596,0.16998,0.15163,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.011949,0.16984,0.16867,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0030436,0.16973,0.14405,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.0010113,0.16946,0.1749,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00064263,0.16943,0.13658,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0020929,0.16922,0.16722,1,1
4,GO MULTIVESICULAR BODY SORTING PATHWAY,1.8701e-05,0.1692,0.17904,1,1
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.012367,0.16865,0.17566,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.032938,0.16859,0.11535,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.059879,0.16831,0.097595,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0040509,0.16821,0.13586,1,1
4,GO RESPONSE TO AMPHETAMINE,0.0051547,0.16816,0.17902,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00042128,0.16777,0.20053,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00027284,0.16774,0.1633,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0033799,0.16762,0.14175,1,1
4,GO BONE CELL DEVELOPMENT,0.02945,0.16762,0.13021,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.012798,0.16759,0.11513,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.1138e-06,0.1675,0.1864,1,1
4,GO PROTEIN HYDROXYLATION,0.011544,0.16744,0.18281,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0094686,0.16719,0.19702,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.03902,0.16714,0.1069,1,1
4,GO SKELETAL MUSCLE ADAPTATION,0.0016806,0.16707,0.18006,1,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00095459,0.16703,0.1664,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.001955,0.16678,0.15157,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00021857,0.16671,0.16785,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00070238,0.16639,0.14971,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,4.1751e-05,0.16613,0.18103,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.018898,0.16598,0.17108,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.0002443,0.16583,0.19958,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00061456,0.16571,0.17317,1,1
4,GO PROTEIN DEGLYCOSYLATION,0.00048316,0.1655,0.21364,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0024941,0.16538,0.15238,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00068191,0.16525,0.18329,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,3.5022e-05,0.16505,0.19537,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.01995,0.16483,0.10589,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.059879,0.16411,0.10156,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0010558,0.16391,0.1603,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0023957,0.16349,0.14473,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,0.00048316,0.16345,0.16252,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0010558,0.1633,0.16496,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0011021,0.16275,0.18164,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0001179,0.16256,0.18206,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00029052,0.16224,0.15747,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0098086,0.16206,0.17092,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.00058763,0.16201,0.14518,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00054518,0.1619,0.13903,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0032928,0.16154,0.13413,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00061456,0.16137,0.27897,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.013546,0.16129,0.16414,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.021509,0.16106,0.1303,1,1
4,GO VIRAL GENOME REPLICATION,0.0018508,0.161,0.15698,1,1
4,GO RESPONSE TO AMINE,0.054074,0.16099,0.091032,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0061347,0.16071,0.15977,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0011341,0.16071,0.18412,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0014624,0.16069,0.1752,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.027401,0.16055,0.17367,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,8.5858e-05,0.16046,0.17234,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0010259,0.16038,0.13513,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.014332,0.16027,0.11856,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0013255,0.1601,0.19044,1,1
4,GO MANNOSYLATION,0.00040857,0.16009,0.15927,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00062378,0.15989,0.16742,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0007901,0.15962,0.15571,1,1
4,GO PEPTIDE HORMONE SECRETION,4.1751e-05,0.15924,0.16878,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0024609,0.15921,0.14291,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00016361,0.15919,0.15155,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.003654,0.15919,0.14375,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00088789,0.15914,0.12629,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0024941,0.15831,0.15834,1,1
4,GO ACTION POTENTIAL,0.00036686,0.1582,0.16398,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0003557,0.15816,0.21729,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0020367,0.15815,0.15031,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.001071,0.1581,0.16613,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.059879,0.15793,0.18928,1,1
4,GO RESPONSE TO FUNGUS,4.9694e-05,0.15776,0.16316,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.043866,0.15749,0.16618,1,1
4,GO CATECHOLAMINE SECRETION,0.00040857,0.15724,0.27375,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.0022095,0.15694,0.12148,1,1
4,GO PH REDUCTION,2.0853e-05,0.15659,0.15224,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,6.1119e-05,0.15651,0.17328,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0072795,0.15639,0.14071,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.002702,0.15634,0.16244,1,1
4,GO REGULATION OF TRANSPOSITION,0.0060595,0.15584,0.22645,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0137,0.15576,0.13712,1,1
4,GO NECROTIC CELL DEATH,0.001118,0.15566,0.16065,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.017894,0.15538,0.12222,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,1.8363e-05,0.15535,0.18153,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.00016361,0.15523,0.14076,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0010558,0.15506,0.16617,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.011022,0.15497,0.15019,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.046474,0.15446,0.12605,1,1
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.043444,0.15439,0.12937,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0046018,0.15429,0.15331,1,1
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00010852,0.15383,0.17862,1,1
4,GO RESPONSE TO TUMOR CELL,0.016938,0.15381,0.14959,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0018256,0.15358,0.11599,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.010522,0.15318,0.10943,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00039622,0.15304,0.13737,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,9.6562e-05,0.15293,0.16929,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.00082553,0.15269,0.17489,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.011949,0.15265,0.15672,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.022209,0.1525,0.15506,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0053519,0.15244,0.12975,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00033955,0.1521,0.13775,1,1
4,GO NEURAL NUCLEUS DEVELOPMENT,0.0046604,0.15185,0.17306,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0060595,0.15184,0.10101,1,1
4,GO SODIUM ION HOMEOSTASIS,0.0020092,0.15176,0.12726,1,1
4,GO SECONDARY METABOLIC PROCESS,0.0046018,0.15167,0.15393,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,8.0256e-05,0.15138,0.1346,1,1
4,GO LEUKOCYTE PROLIFERATION,0.001776,0.15138,0.13419,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.034984,0.15136,0.097357,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0005056,0.15115,0.16951,1,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.025743,0.15094,0.15814,1,1
4,GO REGULATION OF INSULIN SECRETION,5.7059e-05,0.15063,0.15948,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0062108,0.1506,0.14237,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,0.00026858,0.15055,0.13848,1,1
4,GO MEMBRANE HYPERPOLARIZATION,0.016938,0.15044,0.12329,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0015463,0.15021,0.17742,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0093576,0.15018,0.12066,1,1
4,GO RESPONSE TO STEROL,0.0032078,0.15014,0.15901,1,1
4,GO FOAM CELL DIFFERENTIATION,0.0011836,0.14993,0.18098,1,1
4,GO NEUTROPHIL MIGRATION,0.0018508,0.14992,0.12836,1,1
4,GO EXOCYTOSIS,3.8246e-05,0.14987,0.1593,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.012945,0.14983,0.13823,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.019312,0.14981,0.13759,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0024941,0.14979,0.15719,1,1
4,GO LIPID LOCALIZATION,4.2487e-05,0.14967,0.16076,1,1
4,GO STEROL TRANSPORT,0.0020092,0.14963,0.15308,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00087508,0.14954,0.1551,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0076401,0.14944,0.13594,1,1
4,GO EPIDERMIS DEVELOPMENT,0.0011836,0.14921,0.14477,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00015583,0.14897,0.21705,1,1
4,GO REGULATION OF T CELL CHEMOTAXIS,0.0044864,0.14891,0.12625,1,1
4,GO REGULATION OF T CELL MIGRATION,0.0015038,0.14874,0.16875,1,1
4,GO CELL JUNCTION ASSEMBLY,0.011151,0.14868,0.11122,1,1
4,GO AMINE TRANSPORT,0.00020835,0.1485,0.23167,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00011218,0.14839,0.14376,1,1
4,GO MUSCLE HYPERTROPHY,0.00021511,0.14828,0.17322,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00035024,0.14827,0.15083,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.002702,0.14821,0.1735,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,9.9844e-05,0.14811,0.14831,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.0019285,0.14789,0.1616,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0046018,0.14787,0.15163,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.015674,0.14782,0.12987,1,1
4,GO REGULATION OF RUFFLE ASSEMBLY,0.015674,0.14778,0.13009,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00034485,0.1477,0.13945,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0083098,0.14756,0.12069,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0013826,0.14754,0.14686,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0011021,0.14747,0.13353,1,1
4,GO BONE MINERALIZATION,0.0090315,0.14734,0.12751,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00048316,0.14722,0.15824,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.023173,0.14708,0.13396,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.0044298,0.14706,0.12946,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0013633,0.14706,0.18296,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00047589,0.14701,0.14712,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0075485,0.14688,0.14616,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.026838,0.14676,0.12099,1,1
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00067188,0.14672,0.1564,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.00058763,0.14667,0.20898,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0033361,0.14652,0.14089,1,1
4,GO DENDRITE EXTENSION,7.2497e-05,0.14579,0.25116,1,1
4,GO PIGMENTATION,0.0071918,0.14579,0.10189,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.0030038,0.14557,0.13714,1,1
4,GO GRANULOCYTE MIGRATION,0.0014624,0.14534,0.13443,1,1
4,GO RESPONSE TO CALCIUM ION,0.00029976,0.14493,0.15154,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,6.1119e-05,0.14474,0.15896,1,1
4,GO RESPONSE TO CADMIUM ION,0.0062877,0.14451,0.16533,1,1
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0013443,0.14449,0.13583,1,1
4,GO POSITIVE REGULATION OF MYELINATION,0.00083767,0.14449,0.14462,1,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0037016,0.14388,0.13765,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.050154,0.14379,0.087085,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0024941,0.14378,0.15946,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0037498,0.14371,0.17505,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.003654,0.14369,0.14423,1,1
4,GO ORGANELLE FUSION,6.4341e-05,0.14314,0.14082,1,1
4,GO PROTEIN PROCESSING,3.3214e-05,0.14305,0.16366,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.013243,0.14301,0.13352,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.013093,0.14276,0.12109,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.00023294,0.14274,0.12396,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.0046604,0.14266,0.12342,1,1
4,GO LYSOSOME LOCALIZATION,0.00072342,0.1426,0.15206,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.00013232,0.14254,0.14708,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0056255,0.14242,0.20185,1,1
4,GO REGULATION OF HORMONE LEVELS,7.5001e-05,0.14236,0.14051,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00026024,0.14229,0.14745,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.0038977,0.14195,0.11031,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.054582,0.14182,0.12802,1,1
4,GO ACTIN NUCLEATION,7.8124e-06,0.14156,0.1763,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00092737,0.14153,0.15763,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.011022,0.14128,0.11703,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0019285,0.14097,0.13777,1,1
4,GO STEROL METABOLIC PROCESS,0.0005133,0.14089,0.14154,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0137,0.14083,0.10953,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.00074504,0.14073,0.15093,1,1
4,GO CARBOHYDRATE TRANSPORT,1.8363e-05,0.14053,0.14758,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0030839,0.14034,0.13242,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.02521,0.13999,0.14576,1,1
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.017699,0.13977,0.14375,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00016901,0.13968,0.11859,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0016575,0.13966,0.15847,1,1
4,GO ARACHIDONIC ACID SECRETION,0.0080166,0.13951,0.13164,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,3.9872e-06,0.13892,0.14175,1,1
4,GO GDP METABOLIC PROCESS,0.010769,0.13891,0.19168,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0083098,0.1389,0.090612,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.003654,0.13885,0.11892,1,1
4,GO B CELL HOMEOSTASIS,0.0088198,0.1384,0.13999,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0022701,0.13837,0.16697,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.3948e-05,0.13836,0.13842,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.00081356,0.13818,0.15581,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0067673,0.13806,0.1615,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0012705,0.13751,0.14658,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0018256,0.13727,0.12591,1,1
4,GO MEMBRANE REPOLARIZATION,0.0087156,0.13712,0.13405,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0003557,0.13699,0.14513,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.035336,0.13668,0.11163,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.00015583,0.13635,0.15461,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.013856,0.13624,0.1477,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0011341,0.13619,0.16027,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.0056255,0.13603,0.12452,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0020646,0.13574,0.14558,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,8.0256e-05,0.13537,0.15708,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.026561,0.13527,0.109,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.031311,0.13526,0.13257,1,1
4,GO REGULATION OF CELLULAR PH,1.0361e-05,0.13518,0.13491,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.00094089,0.13502,0.16861,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.014013,0.13467,0.10994,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0037016,0.13428,0.13441,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.019735,0.13409,0.13516,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0096941,0.13407,0.12765,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.0084096,0.13401,0.1458,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.047827,0.13397,0.10333,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.0024281,0.13387,0.19643,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0059852,0.13382,0.18069,1,1
4,GO VIRION ASSEMBLY,0.00084997,0.13375,0.11038,1,1
4,GO INFLAMMATORY RESPONSE,0.00070238,0.13317,0.13331,1,1
4,GO REGULATION OF MUSCLE CONTRACTION,0.001776,0.13298,0.11598,1,1
4,GO ENDOCRINE PROCESS,0.0037016,0.13295,0.13309,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00019857,0.1328,0.16486,1,1
4,GO VACUOLE ORGANIZATION,2.8814e-05,0.13256,0.14733,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0043737,0.13256,0.12724,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.00026858,0.13246,0.13254,1,1
4,GO CALCIUM ION IMPORT,0.0062877,0.13203,0.11028,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.0023957,0.13183,0.12329,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0089251,0.13135,0.1487,1,1
4,GO CELLULAR PIGMENTATION,0.017315,0.13033,0.097878,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0048405,0.13033,0.14088,1,1
4,GO AMINE METABOLIC PROCESS,6.7105e-06,0.13016,0.14421,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.031953,0.12996,0.12911,1,1
4,GO PLATELET MORPHOGENESIS,0.02128,0.1298,0.13775,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.055093,0.12964,0.080872,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.015674,0.12962,0.12161,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.0013826,0.12926,0.1285,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0048405,0.12921,0.13438,1,1
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.029754,0.12886,0.20996,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0068504,0.12878,0.12014,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.016205,0.12877,0.13397,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00046165,0.12857,0.14523,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0028118,0.12856,0.1063,1,1
4,GO REGULATION OF CELL ACTIVATION,0.006444,0.12848,0.10395,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.01849,0.12839,0.14469,1,1
4,GO SECRETION,5.0563e-05,0.12833,0.13496,1,1
4,GO ACUTE PHASE RESPONSE,0.0015249,0.1281,0.14154,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0088198,0.12801,0.10493,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0010558,0.1276,0.15503,1,1
4,GO UBIQUINONE METABOLIC PROCESS,0.0032928,0.12748,0.12073,1,1
4,GO T CELL PROLIFERATION,0.0029256,0.12725,0.13487,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.024428,0.12701,0.12791,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0019285,0.12673,0.15617,1,1
4,GO REGULATION OF EXOCYTOSIS,0.00029976,0.12671,0.15129,1,1
4,GO CELLULAR RESPONSE TO STARVATION,0.00019541,0.12612,0.13799,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.024428,0.12585,0.10502,1,1
4,GO REGULATION OF HEAT GENERATION,0.015501,0.12534,0.15625,1,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.0096941,0.12527,0.14711,1,1
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.019523,0.12504,0.11988,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.010769,0.12432,0.10865,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.5001e-05,0.12426,0.16042,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,3.2631e-05,0.12391,0.16693,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.032607,0.12383,0.10957,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.027686,0.12377,0.11951,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00060545,0.12361,0.16333,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.012367,0.12333,0.095262,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00081356,0.12329,0.11814,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0034243,0.12303,0.1559,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.043866,0.12255,0.10992,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.023668,0.12233,0.17007,1,1
4,GO REGULATION OF PH,1.1165e-05,0.12226,0.1313,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0072795,0.12214,0.097205,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.010769,0.1221,0.11314,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.0017277,0.12188,0.13601,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0022095,0.12175,0.10865,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0054872,0.12173,0.087309,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0078263,0.12129,0.11375,1,1
4,GO RELAXATION OF MUSCLE,0.009139,0.12123,0.14124,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.02945,0.1201,0.10302,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.001568,0.11995,0.12577,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.01829,0.11924,0.16453,1,1
4,GO T CELL SELECTION,0.0039992,0.11923,0.11481,1,1
4,GO MACROPHAGE ACTIVATION,0.0032501,0.11889,0.12853,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.003166,0.11875,0.16498,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.0027747,0.1185,0.12321,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.0035146,0.11813,0.11803,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0021798,0.11797,0.14534,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0137,0.11789,0.11104,1,1
4,GO REGULATION OF FERTILIZATION,0.0034692,0.11761,0.12664,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.052083,0.11715,0.095572,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0028118,0.11714,0.14076,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0022701,0.11675,0.13706,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.033271,0.1165,0.085621,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,4.3236e-05,0.1163,0.14361,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.014494,0.11602,0.12646,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0057669,0.11577,0.13262,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0072795,0.11549,0.12389,1,1
4,GO POSITIVE T CELL SELECTION,0.017125,0.1151,0.10517,1,1
4,GO CARNITINE SHUTTLE,0.053071,0.11479,0.10553,1,1
4,GO IRON ION TRANSPORT,5.9056e-05,0.11428,0.12617,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.0094686,0.1142,0.093422,1,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.014823,0.11369,0.14586,1,1
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.02174,0.11361,0.14334,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.013856,0.113,0.12353,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.00049053,0.11299,0.10769,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.055093,0.11296,0.078222,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.051111,0.11288,0.092679,1,1
4,GO PROTEIN PALMITOYLATION,0.047827,0.11283,0.1032,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.007921,0.11282,0.09279,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0090315,0.11278,0.10251,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.00026858,0.1123,0.14461,1,1
4,GO RESPONSE TO ZINC ION,0.022928,0.11229,0.15681,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0046604,0.11213,0.10122,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0034243,0.1121,0.11976,1,1
4,GO T CELL ACTIVATION,0.0060595,0.11191,0.10894,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.03429,0.11184,0.14709,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.018693,0.11179,0.092484,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.014494,0.11167,0.12047,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.037139,0.11166,0.11023,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0092477,0.11133,0.10245,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.013394,0.11121,0.13338,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0073682,0.11075,0.10041,1,1
4,GO PROTEIN MATURATION,0.00011986,0.10998,0.12503,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.057179,0.10963,0.090132,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0083098,0.10943,0.10414,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0051547,0.1087,0.16165,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00096848,0.10817,0.13779,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.036409,0.10809,0.11149,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0078263,0.10806,0.11004,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00010852,0.10804,0.12614,1,1
4,GO RESPONSE TO TESTOSTERONE,0.027686,0.10775,0.10301,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.011e-05,0.10754,0.1354,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.020385,0.10746,0.10204,1,1
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.012367,0.10671,0.11631,1,1
4,GO LIPID DROPLET ORGANIZATION,0.007921,0.10634,0.10325,1,1
4,GO REGULATION OF OSSIFICATION,0.026013,0.10621,0.095985,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0014022,0.10616,0.12343,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.032278,0.10616,0.1213,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0044864,0.10604,0.12237,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00021857,0.10603,0.12216,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.016027,0.10603,0.10053,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.053071,0.1059,0.093488,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.014823,0.10586,0.16581,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.0090315,0.10553,0.10227,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.046031,0.10539,0.11241,1,1
4,GO CHOLESTEROL EFFLUX,0.027973,0.10535,0.098199,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0011836,0.10527,0.1819,1,1
4,GO RESPONSE TO COCAINE,0.028264,0.10526,0.11157,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0043737,0.10499,0.096519,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0052197,0.10492,0.13018,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.011151,0.10477,0.12842,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.0013069,0.10438,0.12431,1,1
4,GO DETECTION OF STIMULUS,4.3236e-05,0.10422,0.12041,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.0043184,0.10417,0.11301,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015038,0.10413,0.10941,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.002702,0.10372,0.12402,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.03902,0.10362,0.094567,1,1
4,GO PHOTOTRANSDUCTION,0.003654,0.10359,0.06981,1,1
4,GO CYTOKINETIC PROCESS,0.0015249,0.10357,0.12719,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00075607,0.10334,0.10382,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00090088,0.10272,0.11804,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0085105,0.10171,0.11227,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0054192,0.10157,0.13287,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.046474,0.10118,0.10933,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.0043737,0.10115,0.11901,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.01251,0.10109,0.10115,1,1
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.016027,0.099619,0.13543,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.060988,0.099583,0.11124,1,1
4,GO RESPONSE TO ALKALOID,0.003166,0.098944,0.11961,1,1
4,GO PROTEIN DESTABILIZATION,0.0018256,0.0987,0.12296,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.01016,0.098516,0.1003,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.0084096,0.098228,0.1358,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00073415,0.097858,0.1111,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0029645,0.097842,0.10133,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.038258,0.09761,0.096664,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.015159,0.097575,0.097111,1,1
4,GO SELECTIVE AUTOPHAGY,0.0060595,0.096669,0.098908,1,1
4,GO AGING,0.014332,0.096358,0.078179,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.049212,0.095914,0.097609,1,1
4,GO GOLGI RIBBON FORMATION,0.036048,0.095784,0.11106,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.027973,0.095631,0.1123,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.046031,0.095477,0.099325,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00045468,0.095475,0.10237,1,1
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.0071918,0.094193,0.10913,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.012227,0.092908,0.11687,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0021215,0.092798,0.099055,1,1
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0068504,0.092238,0.12656,1,1
4,GO ENDOSOME ORGANIZATION,0.0019819,0.091681,0.11422,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.034984,0.091565,0.14685,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.045155,0.091561,0.1099,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.026013,0.091481,0.077077,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.0059852,0.090813,0.1006,1,1
4,GO NADP METABOLIC PROCESS,0.039795,0.089699,0.10965,1,1
4,GO LYMPH NODE DEVELOPMENT,0.021973,0.089564,0.10833,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.037882,0.087891,0.07737,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.020828,0.087023,0.11125,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.012945,0.086731,0.09048,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.001422,0.086199,0.11468,1,1
4,GO POLYOL METABOLIC PROCESS,0.016386,0.085476,0.080584,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.003654,0.085271,0.085812,1,1
4,GO GOLGI ORGANIZATION,0.0021505,0.08509,0.097718,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.040187,0.084808,0.11832,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.059331,0.084549,0.064939,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.040981,0.083448,0.08148,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.011411,0.083354,0.080788,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.023173,0.082834,0.071334,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.040981,0.081783,0.075654,1,1
4,GO BICARBONATE TRANSPORT,0.01585,0.081262,0.10918,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0024609,0.080926,0.11296,1,1
4,GO CHOLESTEROL STORAGE,0.041789,0.079207,0.14402,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.0080166,0.079148,0.071365,1,1
4,GO REGULATION OF TOR SIGNALING,0.004964,0.077913,0.10299,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0048405,0.077902,0.10657,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.016568,0.076915,0.089775,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.003166,0.074949,0.095276,1,1
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.052575,0.074584,0.0867,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.040582,0.073676,0.091965,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.014823,0.073067,0.098745,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.034636,0.07105,0.073382,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0090315,0.068916,0.072324,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.016205,0.061466,0.091712,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.033948,0.060014,0.074975,1,1
4,GO BLASTOCYST DEVELOPMENT,0.012798,0.058034,0.069469,1,1
4,GO ORGANELLE DISASSEMBLY,0.0034243,0.057782,0.087995,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.016205,0.057573,0.069466,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.023919,0.057149,0.071894,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.015159,0.054884,0.091429,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.055093,0.050414,0.059084,1,1
4,GO ORGANELLE INHERITANCE,0.037139,0.050319,0.079488,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.037509,0.04931,0.10067,1,1
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.016752,0.21354,0.18193,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.022446,0.16968,0.1386,1,1
6,GO REGULATION OF SYNAPSE MATURATION,1.9989e-07,0.70198,0.57028,1,1
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,3.9941e-08,0.67842,0.67332,1,1
6,GO SYNAPSE MATURATION,1.4454e-06,0.63456,0.51936,1,1
6,GO VOCALIZATION BEHAVIOR,1.9465e-08,0.63364,0.62568,1,1
6,GO COMMISSURAL NEURON AXON GUIDANCE,4.8673e-09,0.63121,0.62939,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,7.333e-07,0.60563,0.57731,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,4.5822e-08,0.60011,0.65702,1,1
6,GO ANATOMICAL STRUCTURE REGRESSION,2.7452e-06,0.59679,0.46213,1,1
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,4.1815e-08,0.5964,0.59076,1,1
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.8723e-07,0.59012,0.58603,1,1
6,GO PREPULSE INHIBITION,4.5233e-07,0.58051,0.51009,1,1
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,8.9166e-06,0.56806,0.54557,1,1
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,2.3933e-10,0.56398,0.6031,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,1.6514e-08,0.56288,0.55966,1,1
6,GO SYNAPTIC MEMBRANE ADHESION,2.5934e-07,0.56033,0.49858,1,1
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,2.5164e-08,0.55529,0.55273,1,1
6,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,5.5127e-05,0.54617,0.46019,1,1
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,7.0522e-08,0.54487,0.51725,1,1
6,GO CARDIAC VENTRICLE FORMATION,5.02e-08,0.53949,0.5413,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,4.5684e-06,0.53844,0.48655,1,1
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,4.1815e-08,0.53305,0.5734,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,4.719e-07,0.53053,0.52051,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.7922e-07,0.52173,0.45712,1,1
6,GO POSTSYNAPSE ASSEMBLY,2.6981e-08,0.51624,0.52812,1,1
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.3039e-08,0.51533,0.54889,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,5.8262e-07,0.51515,0.39429,1,1
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,8.8282e-08,0.50817,0.45463,1,1
6,GO INNER DYNEIN ARM ASSEMBLY,1.2716e-05,0.49972,0.46539,1,1
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,1.734e-06,0.49639,0.44609,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,3.0295e-08,0.49535,0.47046,1,1
6,GO NEURON CELL CELL ADHESION,7.3772e-08,0.49425,0.57075,1,1
6,GO PROSTATE GLAND MORPHOGENESIS,2.1234e-05,0.49161,0.38374,1,1
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.3468e-07,0.48963,0.49847,1,1
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.1034e-07,0.48288,0.46332,1,1
6,GO RETINAL ROD CELL DIFFERENTIATION,8.1361e-07,0.48263,0.41643,1,1
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,3.2146e-06,0.48039,0.42304,1,1
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,1.3999e-08,0.47252,0.48235,1,1
6,GO NEURONAL ION CHANNEL CLUSTERING,1.5674e-06,0.4684,0.47341,1,1
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,3.1479e-07,0.46421,0.37411,1,1
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,2.5424e-05,0.46144,0.43943,1,1
6,GO FACIAL NERVE MORPHOGENESIS,2.7804e-05,0.46068,0.41628,1,1
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.8416e-06,0.45935,0.55058,1,1
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,1.3693e-05,0.45619,0.43029,1,1
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,1.8573e-08,0.45616,0.43748,1,1
6,GO LIMB BUD FORMATION,2.0776e-06,0.45585,0.44881,1,1
6,GO NOSE DEVELOPMENT,7.7166e-08,0.45493,0.51307,1,1
6,GO POSITIVE REGULATION OF NEURON MIGRATION,1.1165e-05,0.45133,0.40558,1,1
6,GO SOMATIC STEM CELL DIVISION,4.0657e-06,0.4504,0.43214,1,1
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00014362,0.44899,0.37284,1,1
6,GO CARDIAC CHAMBER FORMATION,1.1794e-07,0.44602,0.4681,1,1
6,GO SPINAL CORD PATTERNING,1.069e-09,0.44584,0.50125,1,1
6,GO REGULATION OF NEUROBLAST PROLIFERATION,1.3761e-09,0.44558,0.41953,1,1
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.3196e-05,0.44517,0.38457,1,1
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.6823e-09,0.44439,0.42273,1,1
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,1.5293e-05,0.44328,0.39275,1,1
6,GO CELL DIFFERENTIATION IN HINDBRAIN,1.3085e-09,0.44125,0.40418,1,1
6,GO NEURON FATE SPECIFICATION,2.5756e-08,0.43731,0.50144,1,1
6,GO REGULATION OF NEURON MIGRATION,7.3476e-09,0.43142,0.43239,1,1
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.7195e-09,0.42965,0.41518,1,1
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,4.719e-07,0.42951,0.37323,1,1
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,1.2792e-06,0.42869,0.49138,1,1
6,GO FORELIMB MORPHOGENESIS,6.205e-09,0.4252,0.39803,1,1
6,GO THALAMUS DEVELOPMENT,6.5906e-08,0.42502,0.41609,1,1
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,5.2344e-05,0.42473,0.35182,1,1
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,1.1307e-08,0.42079,0.37864,1,1
6,GO CELL PROLIFERATION IN HINDBRAIN,2.5164e-08,0.41999,0.41045,1,1
6,GO CEREBELLAR CORTEX MORPHOGENESIS,3.019e-11,0.41984,0.40992,1,1
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00013673,0.41959,0.31622,1,1
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.9989e-07,0.41896,0.47776,1,1
6,GO SYNAPTIC VESICLE CLUSTERING,6.0991e-06,0.41506,0.49875,1,1
6,GO MALE SEX DETERMINATION,1.1034e-07,0.41481,0.39987,1,1
6,GO CEREBELLAR CORTEX FORMATION,1.6001e-09,0.41432,0.39282,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,9.6538e-08,0.41424,0.41591,1,1
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,3.357e-07,0.41415,0.4236,1,1
6,GO DIVALENT METAL ION EXPORT,1.2281e-06,0.41265,0.39616,1,1
6,GO OTIC VESICLE DEVELOPMENT,4.2271e-06,0.41003,0.38993,1,1
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.0036e-08,0.40843,0.37835,1,1
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.0811e-07,0.4073,0.42052,1,1
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,4.1552e-07,0.40717,0.43796,1,1
6,GO INNERVATION,3.9102e-06,0.4067,0.46803,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.3671e-08,0.4032,0.44135,1,1
6,GO MAST CELL MIGRATION,7.6283e-05,0.40306,0.41228,1,1
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,3.7605e-06,0.4018,0.3301,1,1
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.00018323,0.40152,0.35988,1,1
6,GO ATRIAL SEPTUM MORPHOGENESIS,1.0424e-06,0.39874,0.4359,1,1
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,1.5037e-07,0.39838,0.39617,1,1
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0018006,0.39831,0.28083,1,1
6,GO REGULATION OF RECEPTOR CLUSTERING,5.6085e-05,0.39717,0.35914,1,1
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,1.734e-06,0.39564,0.38108,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,4.6359e-05,0.39523,0.34578,1,1
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,5.2303e-06,0.39456,0.37427,1,1
6,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,8.4262e-06,0.39424,0.37859,1,1
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,1.0861e-06,0.39392,0.35667,1,1
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.064e-06,0.39317,0.38159,1,1
6,GO MICROTUBULE DEPOLYMERIZATION,3.5461e-06,0.39291,0.32147,1,1
6,GO NEURON FATE COMMITMENT,3.9035e-08,0.38997,0.40234,1,1
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,1.5994e-06,0.38854,0.38113,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.8161e-07,0.38759,0.39782,1,1
6,GO HEART VALVE FORMATION,2.0776e-06,0.38702,0.46622,1,1
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,7.8124e-06,0.38484,0.34422,1,1
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,3.8246e-05,0.38428,0.38384,1,1
6,GO CORONARY VASCULATURE MORPHOGENESIS,3.3435e-06,0.3842,0.38214,1,1
6,GO REGULATION OF GROWTH HORMONE SECRETION,1.6158e-05,0.38395,0.49655,1,1
6,GO TONGUE DEVELOPMENT,4.2271e-06,0.38388,0.35138,1,1
6,GO ACROSOME ASSEMBLY,1.1579e-08,0.38359,0.35895,1,1
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,8.8796e-05,0.38332,0.42961,1,1
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,2.7668e-07,0.38183,0.37682,1,1
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,7.7586e-05,0.3818,0.32098,1,1
6,GO CEREBELLAR CORTEX DEVELOPMENT,8.4871e-11,0.38122,0.37464,1,1
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,3.4773e-06,0.38116,0.41097,1,1
6,GO FOREBRAIN REGIONALIZATION,2.0398e-08,0.38098,0.42823,1,1
6,GO MICROTUBULE ANCHORING AT CENTROSOME,6.1583e-08,0.37834,0.34737,1,1
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,5.4701e-07,0.37769,0.37044,1,1
6,GO AXONAL FASCICULATION,5.4184e-05,0.37582,0.31449,1,1
6,GO CRANIAL NERVE MORPHOGENESIS,1.5576e-05,0.37564,0.32166,1,1
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.8198e-07,0.37528,0.40661,1,1
6,GO TONGUE MORPHOGENESIS,1.5293e-05,0.37502,0.39016,1,1
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,2.2015e-05,0.37223,0.32326,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,7.2414e-06,0.37165,0.36676,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00028155,0.37132,0.38132,1,1
6,GO RESPONSE TO L GLUTAMATE,2.3239e-05,0.37052,0.33203,1,1
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,3.9035e-08,0.3703,0.37612,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,2.3784e-07,0.36917,0.44143,1,1
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.996e-06,0.36659,0.36367,1,1
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,3.5794e-07,0.36539,0.42011,1,1
6,GO CENTRIOLE CENTRIOLE COHESION,6.5125e-09,0.36486,0.37405,1,1
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,4.9694e-05,0.36423,0.31077,1,1
6,GO GANGLION DEVELOPMENT,4.9694e-05,0.36372,0.3493,1,1
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,1.8053e-06,0.36187,0.31347,1,1
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,1.9175e-06,0.36131,0.48046,1,1
6,GO HISTONE H3 K9 DEMETHYLATION,4.3774e-08,0.36071,0.36543,1,1
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,1.734e-06,0.35905,0.29239,1,1
6,GO LEFT RIGHT AXIS SPECIFICATION,4.7488e-06,0.3588,0.33396,1,1
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0023637,0.35868,0.31998,1,1
6,GO ECTODERMAL PLACODE DEVELOPMENT,1.536e-06,0.35856,0.41662,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,3.9822e-07,0.35825,0.34227,1,1
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,3.0295e-08,0.35731,0.33731,1,1
6,GO CELLULAR RESPONSE TO VITAMIN D,4.1751e-05,0.35583,0.31715,1,1
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,3.0811e-07,0.35138,0.40798,1,1
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,3.3806e-05,0.35053,0.31257,1,1
6,GO RESPONSE TO ACETYLCHOLINE,2.0429e-07,0.35049,0.36554,1,1
6,GO HISTONE H3 K27 METHYLATION,2.0429e-07,0.34892,0.28491,1,1
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,2.2926e-08,0.34784,0.40247,1,1
6,GO LONG TERM SYNAPTIC DEPRESSION,3.4296e-07,0.34783,0.35645,1,1
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.003166,0.34623,0.2751,1,1
6,GO PROTEIN LOCALIZATION TO AXON,0.00013899,0.34608,0.38444,1,1
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.0078263,0.34548,0.20406,1,1
6,GO BRAIN MORPHOGENESIS,4.0033e-09,0.34539,0.33619,1,1
6,GO ATRIAL SEPTUM DEVELOPMENT,8.5867e-06,0.34506,0.32801,1,1
6,GO SPINAL CORD DEVELOPMENT,3.1896e-11,0.34477,0.37565,1,1
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,3.3806e-05,0.34409,0.31935,1,1
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,5.7582e-06,0.34386,0.33688,1,1
6,GO CELL PROLIFERATION IN FOREBRAIN,2.5868e-06,0.3425,0.32164,1,1
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,2.9332e-05,0.3424,0.29599,1,1
6,GO TELENCEPHALON REGIONALIZATION,1.7693e-06,0.34204,0.41582,1,1
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0005789,0.34202,0.31113,1,1
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.0004e-06,0.34181,0.31682,1,1
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,2.913e-06,0.34108,0.31546,1,1
6,GO NEURON CELLULAR HOMEOSTASIS,2.7804e-05,0.34084,0.31064,1,1
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,2.4972e-05,0.34022,0.36983,1,1
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,5.5864e-07,0.34006,0.34269,1,1
6,GO RESPONSE TO AUDITORY STIMULUS,4.1026e-05,0.33994,0.37606,1,1
6,GO REGULATION OF SYNAPSE ASSEMBLY,4.1552e-07,0.33961,0.30331,1,1
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00047589,0.33936,0.26084,1,1
6,GO COCHLEA MORPHOGENESIS,3.9872e-06,0.3392,0.32953,1,1
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,1.7385e-05,0.33874,0.30211,1,1
6,GO RECEPTOR CLUSTERING,8.8282e-08,0.33857,0.32131,1,1
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,7.1819e-07,0.33845,0.33774,1,1
6,GO DORSAL SPINAL CORD DEVELOPMENT,1.9136e-07,0.33819,0.38411,1,1
6,GO GLIAL CELL FATE COMMITMENT,0.00030928,0.33716,0.34261,1,1
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,1.1165e-05,0.33538,0.34949,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,6.895e-08,0.33379,0.32199,1,1
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00015083,0.33369,0.28099,1,1
6,GO NEURON RECOGNITION,2.5868e-06,0.33367,0.32494,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,1.471e-07,0.33339,0.32401,1,1
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0012886,0.33339,0.27535,1,1
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,2.9514e-07,0.33291,0.30103,1,1
6,GO CELL FATE SPECIFICATION,9.1793e-10,0.33258,0.33229,1,1
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,3.4796e-08,0.33188,0.34237,1,1
6,GO NEGATIVE REGULATION OF AXONOGENESIS,5.4356e-06,0.33145,0.28953,1,1
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,3.357e-07,0.33064,0.32863,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.5052e-06,0.33025,0.33,1,1
6,GO DORSAL VENTRAL AXIS SPECIFICATION,3.0302e-06,0.32982,0.34875,1,1
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,3.1312e-09,0.32874,0.2995,1,1
6,GO HISTONE H3 K9 METHYLATION,1.4112e-09,0.32848,0.32268,1,1
6,GO NUCLEAR MIGRATION,1.4163e-06,0.32817,0.31164,1,1
6,GO CARDIAC MYOFIBRIL ASSEMBLY,1.4472e-05,0.3281,0.28457,1,1
6,GO NEURON PROJECTION GUIDANCE,1.3999e-08,0.32745,0.32099,1,1
6,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00033955,0.32667,0.32102,1,1
6,GO INHIBITORY SYNAPSE ASSEMBLY,1.6654e-06,0.32663,0.43952,1,1
6,GO EMBRYONIC BRAIN DEVELOPMENT,3.9872e-06,0.32651,0.25347,1,1
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00029052,0.32642,0.30991,1,1
6,GO PROTEIN LOCALIZATION TO CILIUM,1.4677e-08,0.32571,0.32198,1,1
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00046165,0.32494,0.24266,1,1
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,3.9872e-06,0.32483,0.38206,1,1
6,GO NEURON PROJECTION ARBORIZATION,3.1479e-07,0.32457,0.35799,1,1
6,GO EXCITATORY SYNAPSE ASSEMBLY,2.2958e-06,0.32434,0.37968,1,1
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.3948e-05,0.32407,0.29186,1,1
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,2.1621e-05,0.32383,0.33757,1,1
6,GO NEURAL TUBE PATTERNING,1.3671e-08,0.32372,0.3083,1,1
6,GO TELENCEPHALON GLIAL CELL MIGRATION,1.2716e-05,0.32309,0.29015,1,1
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,5.5864e-07,0.32168,0.32694,1,1
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,3.3806e-05,0.32136,0.30079,1,1
6,GO NEUROBLAST PROLIFERATION,3.9064e-09,0.32031,0.34527,1,1
6,GO ACTIN FILAMENT BASED TRANSPORT,2.2958e-06,0.3203,0.31999,1,1
6,GO SEX DETERMINATION,5.4701e-07,0.31834,0.31205,1,1
6,GO REGULATION OF CENTRIOLE REPLICATION,4.5233e-07,0.31808,0.2978,1,1
6,GO ESTROUS CYCLE,1.2482e-05,0.3179,0.27972,1,1
6,GO MYELIN MAINTENANCE,0.0020092,0.3179,0.26601,1,1
6,GO CELL DIFFERENTIATION IN SPINAL CORD,4.0033e-09,0.31744,0.34415,1,1
6,GO NERVE DEVELOPMENT,1.2534e-06,0.31721,0.34092,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.4076e-07,0.31688,0.35095,1,1
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,3.7282e-08,0.31654,0.3035,1,1
6,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0087156,0.31636,0.23206,1,1
6,GO ACTIN CROSSLINK FORMATION,1.2886e-07,0.31571,0.36704,1,1
6,GO NEURAL RETINA DEVELOPMENT,7.892e-08,0.31556,0.31478,1,1
6,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.00022208,0.31504,0.33655,1,1
6,GO METENCEPHALON DEVELOPMENT,3.0296e-10,0.31458,0.34557,1,1
6,GO CRANIAL NERVE DEVELOPMENT,6.5837e-06,0.31411,0.30194,1,1
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.0905e-06,0.31341,0.28365,1,1
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,5.8049e-05,0.31312,0.2936,1,1
6,GO NEURON MIGRATION,7.8976e-09,0.31187,0.35572,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,9.5677e-09,0.31111,0.3452,1,1
6,GO NUCLEUS LOCALIZATION,2.3891e-06,0.3102,0.28852,1,1
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,9.9803e-06,0.30994,0.29687,1,1
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00019857,0.3099,0.26976,1,1
6,GO MRNA SPLICE SITE SELECTION,5.0922e-10,0.30951,0.36519,1,1
6,GO EPITHELIAL CELL MATURATION,3.4296e-07,0.30888,0.32277,1,1
6,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0023637,0.30867,0.24762,1,1
6,GO DENDRITIC SPINE MORPHOGENESIS,2.3784e-07,0.30831,0.32253,1,1
6,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.001118,0.30783,0.19301,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.0922e-10,0.30754,0.3264,1,1
6,GO PRESYNAPSE ORGANIZATION,1.3325e-06,0.3075,0.30255,1,1
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.007921,0.30746,0.29186,1,1
6,GO STARTLE RESPONSE,1.7071e-05,0.30545,0.33799,1,1
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.9558e-07,0.30509,0.33516,1,1
6,GO REGULATION OF COLLATERAL SPROUTING,4.3236e-05,0.30467,0.32203,1,1
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,2.2824e-05,0.30464,0.31141,1,1
6,GO MECHANOSENSORY BEHAVIOR,0.0032928,0.30443,0.35123,1,1
6,GO SIALYLATION,3.2146e-06,0.30344,0.35344,1,1
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,3.3435e-06,0.30301,0.41096,1,1
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,4.2271e-06,0.30291,0.24382,1,1
6,GO NEURAL CREST FORMATION,9.6562e-05,0.30192,0.2845,1,1
6,GO OUTER DYNEIN ARM ASSEMBLY,2.7312e-05,0.30178,0.35365,1,1
6,GO RESPONSE TO POTASSIUM ION,1.9393e-05,0.30128,0.31679,1,1
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,2.4861e-06,0.30087,0.3634,1,1
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.5684e-06,0.30041,0.30425,1,1
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00042128,0.30035,0.25867,1,1
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,7.105e-06,0.30021,0.29868,1,1
6,GO POSTSYNAPSE ORGANIZATION,1.1307e-08,0.2999,0.33405,1,1
6,GO SYNAPSE ORGANIZATION,6.1583e-08,0.29906,0.29164,1,1
6,GO MYOBLAST MIGRATION,0.0007901,0.29873,0.28325,1,1
6,GO CGMP METABOLIC PROCESS,0.001483,0.2987,0.27052,1,1
6,GO DENTATE GYRUS DEVELOPMENT,2.7804e-05,0.29861,0.39724,1,1
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,7.2964e-10,0.29794,0.32149,1,1
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,5.1351e-07,0.29782,0.29447,1,1
6,GO PHOTORECEPTOR CELL MAINTENANCE,6.5906e-08,0.29698,0.27236,1,1
6,GO GROWTH HORMONE SECRETION,1.7071e-05,0.29655,0.39002,1,1
6,GO HINDBRAIN MORPHOGENESIS,4.8359e-10,0.29637,0.29907,1,1
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,7.6446e-07,0.29629,0.30001,1,1
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00016361,0.29608,0.25168,1,1
6,GO SYNAPTIC VESICLE DOCKING,0.0025277,0.29567,0.2866,1,1
6,GO INTRACILIARY RETROGRADE TRANSPORT,1.6654e-06,0.29527,0.35439,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.2328e-07,0.29472,0.28131,1,1
6,GO HINDBRAIN DEVELOPMENT,5.2253e-10,0.29445,0.30232,1,1
6,GO HISTONE H3 K36 METHYLATION,7.71e-09,0.29444,0.35086,1,1
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.8318e-07,0.29435,0.25301,1,1
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,9.7991e-09,0.29434,0.30867,1,1
6,GO HIPPO SIGNALING,2.011e-05,0.29413,0.27159,1,1
6,GO AXONEME ASSEMBLY,2.4305e-07,0.29383,0.34438,1,1
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.4409e-05,0.29358,0.26194,1,1
6,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00082553,0.29257,0.3002,1,1
6,GO NEPHRON TUBULE FORMATION,4.1751e-05,0.29244,0.30379,1,1
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,7.6283e-05,0.2924,0.2908,1,1
6,GO SPERMATID NUCLEUS DIFFERENTIATION,1.5753e-08,0.29189,0.28904,1,1
6,GO URETER DEVELOPMENT,4.7999e-05,0.2917,0.38112,1,1
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,6.5837e-06,0.29145,0.29558,1,1
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,1.6129e-08,0.29143,0.28941,1,1
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.8716e-08,0.29138,0.34089,1,1
6,GO ADULT HEART DEVELOPMENT,6.3249e-05,0.29094,0.2618,1,1
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00027284,0.28967,0.22751,1,1
6,GO PROTEIN LOCALIZATION TO SYNAPSE,2.2958e-06,0.2896,0.29253,1,1
6,GO INTRACILIARY TRANSPORT,1.6782e-07,0.28939,0.31898,1,1
6,GO VENTRAL SPINAL CORD DEVELOPMENT,1.6129e-08,0.28875,0.30949,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00084997,0.28875,0.20849,1,1
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,5.6245e-08,0.28866,0.31393,1,1
6,GO POST ANAL TAIL MORPHOGENESIS,1.3693e-05,0.28776,0.26565,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,5.7051e-07,0.28719,0.27506,1,1
6,GO NON MOTILE CILIUM ASSEMBLY,9.7998e-07,0.28719,0.26021,1,1
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,4.3946e-06,0.28709,0.31152,1,1
6,GO REGULATION OF STEM CELL PROLIFERATION,2.2926e-08,0.28698,0.28949,1,1
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0014624,0.28664,0.20535,1,1
6,GO THYROID GLAND DEVELOPMENT,4.5684e-06,0.28659,0.2931,1,1
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0030038,0.28633,0.2797,1,1
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.4334e-08,0.28611,0.32618,1,1
6,GO V D J RECOMBINATION,4.6578e-06,0.28591,0.307,1,1
6,GO HISTONE H3 K9 MODIFICATION,2.3853e-09,0.28558,0.28979,1,1
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,4.719e-07,0.28504,0.29056,1,1
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,8.5867e-06,0.28503,0.28438,1,1
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,4.249e-10,0.28496,0.32628,1,1
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,1.3056e-06,0.28462,0.30183,1,1
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00024045,0.28414,0.26914,1,1
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0005618,0.2838,0.3571,1,1
6,GO AXON DEVELOPMENT,2.6981e-08,0.28374,0.28732,1,1
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,6.8885e-07,0.28361,0.3056,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS,0.00043435,0.283,0.30946,1,1
6,GO COCHLEA DEVELOPMENT,3.4796e-08,0.28247,0.3299,1,1
6,GO REGULATION OF SYNAPTIC PLASTICITY,1.1086e-06,0.28062,0.26939,1,1
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,1.6129e-08,0.28023,0.29622,1,1
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00091404,0.28023,0.24923,1,1
6,GO ASTRAL MICROTUBULE ORGANIZATION,3.2094e-09,0.27983,0.34571,1,1
6,GO SYNAPSE ASSEMBLY,1.3468e-07,0.27968,0.31164,1,1
6,GO RESPONSE TO VITAMIN A,0.00033955,0.27902,0.23421,1,1
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,1.2032e-06,0.27896,0.30005,1,1
6,GO MESENCHYMAL CELL PROLIFERATION,2.9859e-05,0.27879,0.28623,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,1.6062e-07,0.27852,0.24786,1,1
6,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0044864,0.27849,0.2046,1,1
6,GO REGULATION OF CILIUM ASSEMBLY,8.2543e-08,0.27836,0.25442,1,1
6,GO PROTEIN DEMETHYLATION,2.7668e-07,0.27781,0.27519,1,1
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.00027284,0.27697,0.20693,1,1
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,6.5837e-06,0.27675,0.25515,1,1
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,8.1138e-06,0.27666,0.27556,1,1
6,GO REGULATION OF GLIAL CELL PROLIFERATION,1.5014e-05,0.27607,0.25984,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,8.8389e-07,0.27602,0.27088,1,1
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,2.1624e-06,0.27589,0.33034,1,1
6,GO PANCREAS DEVELOPMENT,1.2886e-07,0.27574,0.30476,1,1
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.0422e-09,0.27558,0.30469,1,1
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,4.2444e-07,0.27539,0.26797,1,1
6,GO MOTILE CILIUM ASSEMBLY,9.03e-05,0.27532,0.307,1,1
6,GO RETROGRADE AXONAL TRANSPORT,1.0958e-05,0.27505,0.27716,1,1
6,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.034984,0.27471,0.19135,1,1
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.00020178,0.27464,0.25495,1,1
6,GO TUBE FORMATION,1.3174e-07,0.27462,0.23064,1,1
6,GO DENDRITIC SPINE DEVELOPMENT,1.5037e-07,0.27458,0.29011,1,1
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,5.0278e-07,0.2743,0.22889,1,1
6,GO RESPONSE TO NICOTINE,2.0429e-07,0.27401,0.29895,1,1
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,1.9465e-08,0.27379,0.3097,1,1
6,GO CELLULAR COMPONENT MAINTENANCE,3.4296e-07,0.27358,0.27053,1,1
6,GO DENDRITE SELF AVOIDANCE,0.00012388,0.27302,0.25633,1,1
6,GO OLIGODENDROCYTE DEVELOPMENT,1.8701e-05,0.27281,0.23779,1,1
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.7078e-07,0.2722,0.26283,1,1
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,2.2775e-07,0.27217,0.25983,1,1
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,1.1579e-08,0.27215,0.27972,1,1
6,GO LEARNING,9.8716e-08,0.27195,0.28349,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00012594,0.27183,0.23173,1,1
6,GO SEROTONIN TRANSPORT,0.00044103,0.27113,0.24528,1,1
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00081356,0.27043,0.25174,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00036124,0.27025,0.28408,1,1
6,GO LONG TERM SYNAPTIC POTENTIATION,1.5576e-05,0.2698,0.25004,1,1
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,3.3806e-05,0.26965,0.27823,1,1
6,GO EMBRYONIC BODY MORPHOGENESIS,2.7804e-05,0.26954,0.27873,1,1
6,GO METANEPHROS MORPHOGENESIS,1.9749e-05,0.26935,0.27219,1,1
6,GO CARDIAC ATRIUM DEVELOPMENT,1.5293e-05,0.2686,0.26665,1,1
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,3.0905e-06,0.26741,0.26517,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,1.0554e-07,0.26707,0.23735,1,1
6,GO REGULATION OF HEART MORPHOGENESIS,0.00022565,0.26699,0.2325,1,1
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,4.1552e-07,0.26699,0.30864,1,1
6,GO APPENDAGE MORPHOGENESIS,1.5372e-07,0.26682,0.26807,1,1
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,8.8282e-08,0.26677,0.27146,1,1
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.1806e-05,0.26577,0.28431,1,1
6,GO OVARIAN FOLLICLE DEVELOPMENT,1.0322e-07,0.26567,0.30475,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,7.333e-07,0.26558,0.25648,1,1
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00040857,0.26553,0.24422,1,1
6,GO REGULATION OF DENDRITE MORPHOGENESIS,2.8925e-08,0.26513,0.30295,1,1
6,GO POTASSIUM ION HOMEOSTASIS,7.9617e-06,0.26505,0.26735,1,1
6,GO CARDIAC ATRIUM MORPHOGENESIS,7.105e-06,0.26503,0.29298,1,1
6,GO CELL PART MORPHOGENESIS,2.188e-08,0.26453,0.27366,1,1
6,GO REGULATION OF EXTENT OF CELL GROWTH,2.4837e-07,0.26446,0.29764,1,1
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,3.0302e-06,0.26436,0.2724,1,1
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,5.7536e-08,0.26426,0.28041,1,1
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,2.9078e-09,0.26412,0.30535,1,1
6,GO DIENCEPHALON DEVELOPMENT,5.6487e-06,0.26406,0.26626,1,1
6,GO SEROTONIN SECRETION,0.00013232,0.26394,0.28837,1,1
6,GO CHLORIDE ION HOMEOSTASIS,0.00037835,0.26393,0.26384,1,1
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,4.5558e-05,0.26354,0.26826,1,1
6,GO HISTONE H3 K9 TRIMETHYLATION,1.7721e-08,0.26322,0.2753,1,1
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,7.5001e-05,0.2631,0.21274,1,1
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.1621e-05,0.26306,0.287,1,1
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,7.333e-07,0.26302,0.30511,1,1
6,GO COLLATERAL SPROUTING,3.8246e-05,0.2624,0.28049,1,1
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.00040235,0.26225,0.27921,1,1
6,GO LOCALIZATION WITHIN MEMBRANE,9.404e-07,0.26217,0.2439,1,1
6,GO NEGATIVE REGULATION OF GLIOGENESIS,1.2328e-07,0.26212,0.31534,1,1
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,7.4873e-07,0.26204,0.24983,1,1
6,GO HEART FORMATION,0.00018323,0.26125,0.2484,1,1
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,3.1004e-08,0.26088,0.25589,1,1
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00015083,0.26031,0.22198,1,1
6,GO HINDLIMB MORPHOGENESIS,0.00013673,0.2603,0.24187,1,1
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,8.4424e-05,0.26017,0.20782,1,1
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00055343,0.26009,0.24669,1,1
6,GO NOREPINEPHRINE SECRETION,7.7586e-05,0.26004,0.29437,1,1
6,GO RENAL VESICLE DEVELOPMENT,0.0001803,0.25998,0.25104,1,1
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,2.9859e-05,0.2599,0.24741,1,1
6,GO CARDIAC SEPTUM MORPHOGENESIS,0.00017457,0.25975,0.24388,1,1
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,3.5427e-10,0.25969,0.29434,1,1
6,GO CENTRIOLE ASSEMBLY,1.4076e-07,0.25937,0.28016,1,1
6,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.002631,0.25864,0.23731,1,1
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,5.3747e-08,0.2586,0.30278,1,1
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00038422,0.25829,0.2754,1,1
6,GO REGULATION OF CYCLASE ACTIVITY,7.8124e-06,0.25823,0.23804,1,1
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.2032e-06,0.25814,0.2569,1,1
6,GO PROXIMAL DISTAL PATTERN FORMATION,0.00023667,0.25795,0.25148,1,1
6,GO NEURON MATURATION,2.4861e-06,0.25778,0.26272,1,1
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.1588e-05,0.2577,0.28526,1,1
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.895e-08,0.25717,0.24934,1,1
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,3.9872e-06,0.25716,0.24233,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,6.8885e-07,0.25693,0.25463,1,1
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0011836,0.25674,0.3495,1,1
6,GO NEGATIVE REGULATION OF DNA REPLICATION,6.8396e-06,0.25664,0.23361,1,1
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,1.8793e-06,0.25649,0.25884,1,1
6,GO MICROTUBULE BUNDLE FORMATION,3.7282e-08,0.25647,0.29424,1,1
6,GO EMBRYONIC DIGIT MORPHOGENESIS,5.6487e-06,0.25622,0.21914,1,1
6,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.011151,0.25611,0.18924,1,1
6,GO RESPONSE TO LEUCINE,4.7172e-05,0.25567,0.28443,1,1
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,6.337e-06,0.25508,0.24367,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.001422,0.25502,0.21616,1,1
6,GO CILIUM ORGANIZATION,3.6293e-09,0.25494,0.25946,1,1
6,GO CORPUS CALLOSUM DEVELOPMENT,3.094e-05,0.25465,0.31305,1,1
6,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0032928,0.25431,0.26592,1,1
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00065224,0.25429,0.26243,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,3.5646e-05,0.2541,0.2057,1,1
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,4.6578e-06,0.25394,0.23816,1,1
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.00037835,0.25367,0.2394,1,1
6,GO EPITHELIAL CELL MORPHOGENESIS,0.0095807,0.25236,0.23354,1,1
6,GO REGULATION OF NEURON DIFFERENTIATION,1.8573e-08,0.25228,0.26034,1,1
6,GO REPLICATION FORK PROCESSING,2.0478e-05,0.25183,0.23027,1,1
6,GO MUSCLE FIBER DEVELOPMENT,1.5674e-06,0.25171,0.24226,1,1
6,GO VENTRICULAR SYSTEM DEVELOPMENT,2.5066e-09,0.2513,0.29946,1,1
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0032501,0.25105,0.24527,1,1
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.1304e-06,0.25082,0.26998,1,1
6,GO REGULATION OF DENDRITE DEVELOPMENT,2.2926e-08,0.25078,0.28383,1,1
6,GO MICROTUBULE ANCHORING,1.6321e-06,0.25074,0.24369,1,1
6,GO APICAL PROTEIN LOCALIZATION,1.4207e-05,0.25067,0.266,1,1
6,GO CELLULAR COMPONENT MORPHOGENESIS,2.3467e-08,0.25057,0.25901,1,1
6,GO EMBRYONIC HEMOPOIESIS,6.7105e-06,0.25018,0.27037,1,1
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031414,0.25016,0.21933,1,1
6,GO SOMITE DEVELOPMENT,1.3468e-07,0.24999,0.23838,1,1
6,GO G0 TO G1 TRANSITION,4.7125e-10,0.24982,0.2808,1,1
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,5.8856e-08,0.24975,0.22771,1,1
6,GO STEM CELL DIVISION,0.00011033,0.24972,0.22428,1,1
6,GO FOREBRAIN DEVELOPMENT,1.0422e-09,0.24954,0.27424,1,1
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,8.8389e-07,0.24945,0.279,1,1
6,GO LATERAL VENTRICLE DEVELOPMENT,4.1751e-05,0.24936,0.29945,1,1
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,9.4407e-08,0.24888,0.23053,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.1316e-06,0.24885,0.30407,1,1
6,GO NEURAL TUBE DEVELOPMENT,2.8886e-07,0.24875,0.22454,1,1
6,GO HIPPOCAMPUS DEVELOPMENT,2.3274e-07,0.24869,0.24976,1,1
6,GO RESPONSE TO ELECTRICAL STIMULUS,5.4184e-05,0.2486,0.25658,1,1
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,1.1165e-05,0.24849,0.28461,1,1
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,4.8839e-05,0.24818,0.24656,1,1
6,GO SPERM AXONEME ASSEMBLY,1.5865e-05,0.24816,0.25553,1,1
6,GO NEGATIVE REGULATION OF AXON EXTENSION,1.0958e-05,0.24815,0.27623,1,1
6,GO REGULATION OF TRANSPOSITION,0.0024281,0.24733,0.22317,1,1
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,5.7059e-05,0.24714,0.22023,1,1
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0012527,0.24704,0.29229,1,1
6,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0022396,0.24693,0.19634,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.5293e-05,0.2469,0.21516,1,1
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,7.6657e-06,0.24685,0.2286,1,1
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.8723e-07,0.24667,0.24796,1,1
6,GO SYNAPTIC VESICLE EXOCYTOSIS,2.2416e-05,0.24637,0.26845,1,1
6,GO NEUROTRANSMITTER SECRETION,9.6129e-06,0.24635,0.27254,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,6.2046e-07,0.24585,0.22846,1,1
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,6.3249e-05,0.24539,0.36469,1,1
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,4.5558e-05,0.24536,0.22213,1,1
6,GO IRON COORDINATION ENTITY TRANSPORT,0.00013899,0.24471,0.24208,1,1
6,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.020828,0.24466,0.20445,1,1
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00026024,0.24466,0.18585,1,1
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,8.8389e-07,0.24453,0.2568,1,1
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,8.8282e-08,0.2444,0.28075,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,2.188e-08,0.24372,0.24552,1,1
6,GO ADULT BEHAVIOR,6.0205e-08,0.24372,0.29362,1,1
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00031907,0.24365,0.30047,1,1
6,GO EPITHELIAL CELL FATE COMMITMENT,0.0005618,0.24356,0.33741,1,1
6,GO NEURAL CREST CELL DIFFERENTIATION,0.00015083,0.24349,0.21142,1,1
6,GO BONE MORPHOGENESIS,0.00069207,0.24196,0.18831,1,1
6,GO SKELETAL SYSTEM MORPHOGENESIS,1.8419e-06,0.24174,0.21264,1,1
6,GO DORSAL VENTRAL PATTERN FORMATION,1.3085e-09,0.24172,0.29729,1,1
6,GO CONVERGENT EXTENSION,0.00032916,0.24166,0.22156,1,1
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.0527e-08,0.24165,0.24594,1,1
6,GO NEURAL PRECURSOR CELL PROLIFERATION,8.7237e-10,0.24146,0.28202,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,7.8124e-06,0.24146,0.23922,1,1
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,8.0256e-05,0.24118,0.22553,1,1
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,1.7706e-05,0.24117,0.22237,1,1
6,GO MITOTIC RECOMBINATION,0.000286,0.24058,0.20556,1,1
6,GO STRIATUM DEVELOPMENT,0.00022208,0.2405,0.23988,1,1
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,1.5293e-05,0.24044,0.27233,1,1
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.0756e-05,0.24038,0.2315,1,1
6,GO PEPTIDYL LYSINE DIMETHYLATION,3.5038e-07,0.24028,0.23042,1,1
6,GO NEGATIVE REGULATION OF DNA BINDING,1.2434e-08,0.24009,0.25389,1,1
6,GO DENDRITIC TRANSPORT,1.2482e-05,0.23989,0.32158,1,1
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,9.9844e-05,0.23981,0.24293,1,1
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,3.5022e-05,0.23972,0.23344,1,1
6,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.016205,0.23957,0.24823,1,1
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,3.2146e-06,0.23913,0.20868,1,1
6,GO PEPTIDYL LYSINE TRIMETHYLATION,7.1819e-07,0.23898,0.21318,1,1
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,2.5066e-09,0.23862,0.25386,1,1
6,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,2.913e-06,0.23858,0.22862,1,1
6,GO EPITHELIAL TUBE FORMATION,2.7078e-07,0.23853,0.21998,1,1
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,2.8001e-06,0.23841,0.25414,1,1
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,2.7312e-05,0.2384,0.24506,1,1
6,GO REGULATION OF TUBULIN DEACETYLATION,0.00011218,0.23834,0.26493,1,1
6,GO NEURON DEVELOPMENT,1.9926e-08,0.23828,0.24866,1,1
6,GO SEGMENTATION,3.6162e-06,0.23826,0.20472,1,1
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0017277,0.23821,0.22437,1,1
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,4.7963e-08,0.2382,0.25358,1,1
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,1.3468e-07,0.23814,0.21645,1,1
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,2.2139e-09,0.23806,0.29236,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,2.0881e-08,0.23798,0.2394,1,1
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,2.1375e-08,0.23783,0.25109,1,1
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,8.8796e-05,0.2375,0.26226,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,4.5558e-05,0.23664,0.21256,1,1
6,GO MICROTUBULE BASED MOVEMENT,2.7614e-08,0.23662,0.22609,1,1
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,7.9617e-06,0.23661,0.24854,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,3.2146e-06,0.23632,0.24112,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,8.9047e-09,0.23632,0.24067,1,1
6,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00041488,0.2363,0.24435,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00069207,0.23607,0.27879,1,1
6,GO GLIAL CELL PROLIFERATION,0.00013232,0.23602,0.20348,1,1
6,GO STEM CELL PROLIFERATION,2.1338e-07,0.23558,0.24435,1,1
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,6.2169e-06,0.2355,0.23357,1,1
6,GO EXPLORATION BEHAVIOR,0.0015038,0.23548,0.22022,1,1
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0080166,0.23545,0.21098,1,1
6,GO NEURON DIFFERENTIATION,7.71e-09,0.23517,0.25043,1,1
6,GO REGULATION OF CHROMATIN BINDING,5.1351e-07,0.23483,0.28933,1,1
6,GO DERMATAN SULFATE METABOLIC PROCESS,0.025743,0.23474,0.17719,1,1
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.9069e-08,0.23462,0.2524,1,1
6,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0042636,0.23419,0.183,1,1
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00048316,0.23374,0.24137,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0005618,0.23362,0.27256,1,1
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,4.2444e-07,0.23359,0.23198,1,1
6,GO TRANSPORT ALONG MICROTUBULE,1.439e-07,0.23317,0.21356,1,1
6,GO SMOOTHENED SIGNALING PATHWAY,6.8348e-09,0.23316,0.25702,1,1
6,GO MYOTUBE CELL DEVELOPMENT,8.9166e-06,0.2331,0.23703,1,1
6,GO TRNA CATABOLIC PROCESS,0.021053,0.23307,0.19322,1,1
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.00054518,0.23303,0.27919,1,1
6,GO KIDNEY MORPHOGENESIS,4.4807e-06,0.23297,0.22352,1,1
6,GO NEPHRON MORPHOGENESIS,1.3442e-05,0.23275,0.21248,1,1
6,GO KINETOCHORE ORGANIZATION,0.00027284,0.23275,0.21872,1,1
6,GO APPENDAGE DEVELOPMENT,5.1351e-07,0.2325,0.23343,1,1
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,4.9069e-08,0.23226,0.26356,1,1
6,GO BEHAVIORAL RESPONSE TO COCAINE,0.0013069,0.23208,0.31808,1,1
6,GO EMBRYONIC EYE MORPHOGENESIS,8.4262e-06,0.23208,0.26403,1,1
6,GO ORGANIC CATION TRANSPORT,0.000286,0.23178,0.19544,1,1
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,9.6129e-06,0.23173,0.2653,1,1
6,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,3.8924e-05,0.23141,0.25008,1,1
6,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00048316,0.23114,0.30395,1,1
6,GO EMBRYONIC ORGAN MORPHOGENESIS,2.8262e-08,0.2311,0.24079,1,1
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00063314,0.23081,0.20736,1,1
6,GO OVULATION CYCLE PROCESS,9.4341e-06,0.23068,0.21752,1,1
6,GO DOSAGE COMPENSATION,2.8305e-05,0.23059,0.20649,1,1
6,GO CELLULAR RESPONSE TO VITAMIN,0.00033955,0.23055,0.25576,1,1
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,3.4003e-08,0.23053,0.23272,1,1
6,GO NEUROGENESIS,1.3039e-08,0.23037,0.23602,1,1
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,4.4771e-05,0.23027,0.26197,1,1
6,GO NOREPINEPHRINE TRANSPORT,0.00037835,0.23018,0.25378,1,1
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0011341,0.23,0.21338,1,1
6,GO AXIS ELONGATION,0.00019229,0.2296,0.22978,1,1
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00014599,0.22905,0.20459,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,1.1165e-05,0.22903,0.26333,1,1
6,GO CHONDROCYTE PROLIFERATION,0.0059852,0.2285,0.19276,1,1
6,GO SYNAPTIC TRANSMISSION GABAERGIC,3.1494e-05,0.22842,0.21179,1,1
6,GO REGULATION OF DEVELOPMENTAL GROWTH,1.1282e-07,0.22831,0.21426,1,1
6,GO ROOF OF MOUTH DEVELOPMENT,1.7385e-05,0.2282,0.20915,1,1
6,GO MICROTUBULE BASED TRANSPORT,1.5372e-07,0.22808,0.22153,1,1
6,GO TELENCEPHALON DEVELOPMENT,2.3268e-09,0.22799,0.26675,1,1
6,GO BASIC AMINO ACID TRANSPORT,0.017894,0.22781,0.14739,1,1
6,GO TRACHEA DEVELOPMENT,0.0025961,0.22763,0.21228,1,1
6,GO ANIMAL ORGAN FORMATION,0.00013451,0.22761,0.19424,1,1
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00016901,0.22748,0.17869,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,3.5606e-08,0.22747,0.21779,1,1
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,4.6578e-06,0.22738,0.23845,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00012186,0.22732,0.24517,1,1
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,4.4285e-07,0.22723,0.24216,1,1
6,GO INNER EAR MORPHOGENESIS,3.357e-07,0.2272,0.26466,1,1
6,GO REGULATION OF BEHAVIOR,1.3948e-05,0.22695,0.2058,1,1
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,2.9514e-07,0.22693,0.25279,1,1
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0010408,0.22652,0.1827,1,1
6,GO SECONDARY PALATE DEVELOPMENT,4.9694e-05,0.22647,0.27806,1,1
6,GO PROSTATE GLAND GROWTH,0.0025961,0.22632,0.23032,1,1
6,GO GENITALIA MORPHOGENESIS,0.0022701,0.22626,0.30804,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,2.402e-08,0.22606,0.20073,1,1
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.4972e-05,0.226,0.25129,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.010895,0.22549,0.16606,1,1
6,GO SYNAPTIC SIGNALING,1.9558e-07,0.22534,0.25993,1,1
6,GO REGULATION OF RECEPTOR INTERNALIZATION,6.4699e-07,0.22481,0.22959,1,1
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,3.4553e-09,0.22476,0.23831,1,1
6,GO ENERGY HOMEOSTASIS,0.00025617,0.2247,0.21895,1,1
6,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00057029,0.22463,0.2977,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00084997,0.22447,0.1839,1,1
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00011033,0.22432,0.19921,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,9.2585e-06,0.22415,0.30108,1,1
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,4.6578e-06,0.22367,0.24234,1,1
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,3.8246e-05,0.22352,0.301,1,1
6,GO HEAD DEVELOPMENT,1.4471e-09,0.22342,0.24224,1,1
6,GO SINGLE STRAND BREAK REPAIR,1.9393e-05,0.22342,0.21071,1,1
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.7706e-05,0.22341,0.27343,1,1
6,GO MAINTENANCE OF ORGANELLE LOCATION,4.9694e-05,0.22331,0.20824,1,1
6,GO REGULATION OF ANIMAL ORGAN FORMATION,0.00015583,0.22328,0.24203,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1.4741e-05,0.22326,0.2041,1,1
6,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0061347,0.22307,0.16038,1,1
6,GO L GLUTAMATE IMPORT,0.011544,0.22287,0.14525,1,1
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,5.8049e-05,0.22283,0.22296,1,1
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00070238,0.22278,0.26951,1,1
6,GO TRANSPOSITION,0.0016806,0.22275,0.21672,1,1
6,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00043435,0.22274,0.24938,1,1
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,1.7309e-08,0.22258,0.25847,1,1
6,GO REGULATION OF HEAT GENERATION,7.0072e-05,0.22256,0.27146,1,1
6,GO CILIUM MOVEMENT,5.0278e-07,0.22245,0.2308,1,1
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00029511,0.22233,0.24777,1,1
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,1.5674e-06,0.22208,0.23473,1,1
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,5.8049e-05,0.22199,0.21448,1,1
6,GO LEFT RIGHT PATTERN FORMATION,0.00013232,0.22164,0.23029,1,1
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.9393e-05,0.22129,0.21966,1,1
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,4.5822e-08,0.22121,0.2036,1,1
6,GO REGULATION OF APPETITE,1.1588e-05,0.22098,0.18565,1,1
6,GO EAR MORPHOGENESIS,1.6994e-06,0.22093,0.22782,1,1
6,GO RETINOIC ACID METABOLIC PROCESS,0.00061456,0.22085,0.24629,1,1
6,GO REGULATION OF FATTY ACID BETA OXIDATION,0.001704,0.2207,0.1913,1,1
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.6321e-06,0.22069,0.21461,1,1
6,GO DNA DOUBLE STRAND BREAK PROCESSING,3.8924e-05,0.22069,0.2243,1,1
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00030449,0.22059,0.20606,1,1
6,GO SULFATION,0.0050904,0.21955,0.16882,1,1
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.00036686,0.21945,0.20201,1,1
6,GO REPRODUCTIVE BEHAVIOR,3.1494e-05,0.21937,0.23338,1,1
6,GO REGULATION OF MRNA PROCESSING,1.5386e-08,0.21936,0.22434,1,1
6,GO HISTONE H4 DEACETYLATION,0.00010852,0.21906,0.20254,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,1.3442e-05,0.21872,0.2046,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.001235,0.21833,0.22568,1,1
6,GO OUTFLOW TRACT MORPHOGENESIS,0.00071283,0.21817,0.20788,1,1
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,1.4207e-05,0.21814,0.23658,1,1
6,GO MIDGUT DEVELOPMENT,0.016027,0.21798,0.18581,1,1
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,2.65e-07,0.2179,0.23272,1,1
6,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0024609,0.21771,0.20177,1,1
6,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0057669,0.21768,0.22071,1,1
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.00036686,0.21766,0.20844,1,1
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,2.0776e-06,0.21742,0.2544,1,1
6,GO ENDOCRINE PANCREAS DEVELOPMENT,1.6761e-05,0.21706,0.23458,1,1
6,GO EPITHELIAL TUBE MORPHOGENESIS,1.0756e-05,0.21703,0.18836,1,1
6,GO PROTEIN PALMITOYLATION,1.4472e-05,0.21701,0.23463,1,1
6,GO HEART VALVE DEVELOPMENT,0.001071,0.21669,0.18611,1,1
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,4.3355e-07,0.21653,0.22236,1,1
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,3.4773e-06,0.21636,0.22859,1,1
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,4.8416e-06,0.2163,0.218,1,1
6,GO REGULATION OF ORGANELLE ASSEMBLY,2.2926e-08,0.21572,0.20163,1,1
6,GO REGULATION OF SISTER CHROMATID COHESION,1.5994e-06,0.21535,0.24659,1,1
6,GO CELLULAR RESPONSE TO X RAY,5.0563e-05,0.2153,0.18565,1,1
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,5.2359e-09,0.21501,0.26373,1,1
6,GO UTERUS DEVELOPMENT,0.00040857,0.21481,0.22902,1,1
6,GO ECTODERM DEVELOPMENT,4.7999e-05,0.2145,0.18274,1,1
6,GO SPERMATID DIFFERENTIATION,6.4434e-08,0.21384,0.20963,1,1
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,3.6567e-07,0.21383,0.22279,1,1
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00014839,0.21357,0.24261,1,1
6,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0070192,0.21333,0.18439,1,1
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,5.6085e-05,0.21328,0.22306,1,1
6,GO MESONEPHROS DEVELOPMENT,0.00016098,0.21325,0.201,1,1
6,GO MITOTIC SPINDLE ORGANIZATION,7.0072e-05,0.21319,0.18023,1,1
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,1.2792e-06,0.21311,0.22346,1,1
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,6.586e-10,0.21304,0.2421,1,1
6,GO REGULATION OF HISTONE METHYLATION,1.2759e-09,0.21281,0.24173,1,1
6,GO EYE MORPHOGENESIS,4.8198e-07,0.21258,0.2199,1,1
6,GO HISTONE H4 K16 ACETYLATION,1.6761e-05,0.21245,0.19415,1,1
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00024819,0.21243,0.18254,1,1
6,GO PROSTATE GLAND DEVELOPMENT,0.0018256,0.21204,0.18196,1,1
6,GO REGULATION OF MICROTUBULE BASED PROCESS,1.6782e-07,0.2117,0.20986,1,1
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00013016,0.21156,0.22393,1,1
6,GO SPERM MOTILITY,1.5372e-07,0.21149,0.21677,1,1
6,GO SEX DIFFERENTIATION,1.1282e-07,0.21121,0.19497,1,1
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0057669,0.21106,0.16723,1,1
6,GO SENSORY ORGAN MORPHOGENESIS,3.5038e-07,0.21076,0.21391,1,1
6,GO KINETOCHORE ASSEMBLY,0.0017517,0.21007,0.18346,1,1
6,GO LOCOMOTORY BEHAVIOR,8.6579e-07,0.20996,0.26514,1,1
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.00012186,0.20974,0.2194,1,1
6,GO EMBRYONIC ORGAN DEVELOPMENT,3.0811e-07,0.20973,0.20899,1,1
6,GO MEMBRANE DISASSEMBLY,0.0054872,0.2095,0.17911,1,1
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,5.1351e-07,0.20945,0.22168,1,1
6,GO SENSORY SYSTEM DEVELOPMENT,3.9941e-08,0.20943,0.21824,1,1
6,GO SUBPALLIUM DEVELOPMENT,0.0080166,0.20933,0.202,1,1
6,GO MECHANORECEPTOR DIFFERENTIATION,2.3239e-05,0.20898,0.26924,1,1
6,GO OLIGODENDROCYTE DIFFERENTIATION,4.8198e-07,0.20891,0.24975,1,1
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,1.2716e-05,0.20881,0.20672,1,1
6,GO NEURAL CREST CELL MIGRATION,0.00010852,0.20876,0.26307,1,1
6,GO FUCOSYLATION,0.0020646,0.20862,0.17698,1,1
6,GO WHITE FAT CELL DIFFERENTIATION,1.2253e-05,0.20838,0.23626,1,1
6,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00015583,0.20838,0.21218,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0012705,0.20816,0.13636,1,1
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,8.5858e-05,0.20804,0.25758,1,1
6,GO OVULATION CYCLE,1.4741e-05,0.20786,0.20613,1,1
6,GO FEMALE SEX DIFFERENTIATION,2.8886e-07,0.20778,0.22575,1,1
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,4.8839e-05,0.20778,0.24292,1,1
6,GO GAMETE GENERATION,5.3617e-10,0.20767,0.20653,1,1
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0005789,0.20763,0.24878,1,1
6,GO LUNG CELL DIFFERENTIATION,0.0015038,0.20762,0.27177,1,1
6,GO REGULATION OF GONAD DEVELOPMENT,0.001422,0.20722,0.19268,1,1
6,GO CELL PROJECTION ASSEMBLY,2.3274e-07,0.20708,0.19179,1,1
6,GO HISTONE H4 K5 ACETYLATION,5.5127e-05,0.20694,0.1862,1,1
6,GO NEUROTRANSMITTER TRANSPORT,1.7071e-05,0.20655,0.25271,1,1
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.6386e-06,0.20642,0.2138,1,1
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,7.7586e-05,0.20639,0.21446,1,1
6,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.01016,0.2063,0.1484,1,1
6,GO CARDIAC SEPTUM DEVELOPMENT,0.00053704,0.20624,0.19103,1,1
6,GO RESPONSE TO FOOD,3.0395e-05,0.20615,0.18238,1,1
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,5.0563e-05,0.20596,0.24383,1,1
6,GO G2 DNA DAMAGE CHECKPOINT,8.1361e-07,0.20592,0.22582,1,1
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.001071,0.20571,0.19281,1,1
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,3.6162e-06,0.20557,0.2099,1,1
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00031414,0.20552,0.17279,1,1
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,9.2118e-07,0.20551,0.22127,1,1
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.1621e-05,0.20541,0.22611,1,1
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0018006,0.20526,0.17863,1,1
6,GO PATTERN SPECIFICATION PROCESS,7.5266e-09,0.20502,0.23471,1,1
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,5.7582e-06,0.20489,0.23764,1,1
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0059852,0.20479,0.2771,1,1
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,3.5461e-06,0.20457,0.21961,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,3.2784e-06,0.20431,0.24153,1,1
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.00071283,0.20425,0.22005,1,1
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,3.5022e-05,0.20424,0.23453,1,1
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0007786,0.20418,0.19564,1,1
6,GO SCHWANN CELL DIFFERENTIATION,3.1494e-05,0.20416,0.21268,1,1
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.0037016,0.20383,0.19811,1,1
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,4.4285e-07,0.20374,0.21697,1,1
6,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00026858,0.20373,0.17591,1,1
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,2.8271e-07,0.20356,0.2121,1,1
6,GO CALCINEURIN MEDIATED SIGNALING,2.1621e-05,0.20337,0.21088,1,1
6,GO SERTOLI CELL DEVELOPMENT,0.0027747,0.20316,0.19441,1,1
6,GO CELL JUNCTION ORGANIZATION,3.2784e-06,0.20284,0.21301,1,1
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00043435,0.20253,0.23814,1,1
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,1.0322e-07,0.20253,0.20563,1,1
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.2482e-05,0.20229,0.23382,1,1
6,GO REGULATION OF CHROMATIN ASSEMBLY,6.0991e-06,0.20218,0.22146,1,1
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,6.4434e-08,0.20214,0.22177,1,1
6,GO SCHWANN CELL DEVELOPMENT,9.4959e-05,0.20211,0.22147,1,1
6,GO RECOMBINATIONAL REPAIR,1.4207e-05,0.20206,0.18379,1,1
6,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.041383,0.20163,0.16924,1,1
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,4.31e-06,0.20119,0.20415,1,1
6,GO MALE SEX DIFFERENTIATION,1.0756e-05,0.20117,0.17506,1,1
6,GO REGULATION OF CILIUM MOVEMENT,5.1304e-06,0.20095,0.22794,1,1
6,GO VENTRICULAR SEPTUM DEVELOPMENT,0.00017741,0.20074,0.1969,1,1
6,GO DEVELOPMENTAL INDUCTION,0.00015838,0.20032,0.20517,1,1
6,GO EPIDERMIS MORPHOGENESIS,0.01585,0.20019,0.14567,1,1
6,GO ENDOCARDIUM DEVELOPMENT,0.00030928,0.19997,0.23083,1,1
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,3.5646e-05,0.19993,0.21795,1,1
6,GO STRESS GRANULE ASSEMBLY,0.00043435,0.19979,0.18672,1,1
6,GO MALE GAMETE GENERATION,6.586e-10,0.19979,0.20441,1,1
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.6352e-05,0.19942,0.22711,1,1
6,GO REGULATION OF RESPONSE TO FOOD,2.8814e-05,0.19941,0.20655,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,7.6657e-06,0.19875,0.19658,1,1
6,GO CATECHOLAMINE UPTAKE,0.0020092,0.19863,0.21947,1,1
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,3.6162e-06,0.19858,0.25305,1,1
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.001235,0.19855,0.17414,1,1
6,GO MEMBRANE DOCKING,2.0776e-06,0.1983,0.18215,1,1
6,GO CAMERA TYPE EYE MORPHOGENESIS,5.4701e-07,0.19821,0.22717,1,1
6,GO GERM CELL DEVELOPMENT,7.1121e-10,0.1982,0.22747,1,1
6,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.030368,0.19808,0.13275,1,1
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,9.4341e-06,0.19802,0.18697,1,1
6,GO CENTROSOME DUPLICATION,1.3599e-06,0.19775,0.23245,1,1
6,GO NON RECOMBINATIONAL REPAIR,9.4959e-05,0.19758,0.15874,1,1
6,GO NEURAL TUBE FORMATION,2.342e-06,0.19722,0.20592,1,1
6,GO ADIPOSE TISSUE DEVELOPMENT,1.3196e-05,0.19721,0.22109,1,1
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.00011596,0.19718,0.21141,1,1
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.00013016,0.19674,0.2246,1,1
6,GO HISTONE H2A UBIQUITINATION,3.5794e-07,0.19671,0.21196,1,1
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,6.4341e-05,0.1967,0.21571,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,6.895e-08,0.19662,0.20392,1,1
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,9.4959e-05,0.196,0.17359,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,9.4341e-06,0.19578,0.17009,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,4.9361e-06,0.19576,0.21573,1,1
6,GO MICROTUBULE BASED PROCESS,1.0279e-08,0.19551,0.21481,1,1
6,GO CELL PROJECTION ORGANIZATION,1.3999e-08,0.19518,0.21964,1,1
6,GO PROTEIN LOCALIZATION TO CHROMATIN,7.9617e-06,0.19514,0.18689,1,1
6,GO POLYOL CATABOLIC PROCESS,0.0089251,0.19505,0.11933,1,1
6,GO GLIAL CELL DEVELOPMENT,9.3381e-05,0.19497,0.18412,1,1
6,GO ENSHEATHMENT OF NEURONS,3.3214e-05,0.19475,0.17794,1,1
6,GO CELL FATE COMMITMENT,1.3351e-08,0.19453,0.22607,1,1
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00036124,0.19451,0.21324,1,1
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00098255,0.19444,0.26243,1,1
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,6.7724e-05,0.19436,0.21281,1,1
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0041031,0.19385,0.16705,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,2.5868e-06,0.1935,0.18638,1,1
6,GO PROSTATIC BUD FORMATION,0.00159,0.19345,0.31161,1,1
6,GO PROTEIN ACETYLATION,2.6362e-08,0.1932,0.18895,1,1
6,GO MORPHOGENESIS OF AN EPITHELIUM,0.00018323,0.19301,0.14304,1,1
6,GO SOMITOGENESIS,1.1375e-05,0.19301,0.18388,1,1
6,GO SMOOTH MUSCLE CONTRACTION,0.00087508,0.19282,0.14081,1,1
6,GO REGULATION OF TORC1 SIGNALING,1.0554e-07,0.19276,0.24842,1,1
6,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0093576,0.19269,0.14341,1,1
6,GO GLAND MORPHOGENESIS,0.0065235,0.19261,0.16753,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,2.0853e-05,0.19239,0.18938,1,1
6,GO TRIPARTITE REGIONAL SUBDIVISION,0.02915,0.19239,0.14813,1,1
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00036124,0.19238,0.20032,1,1
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,1.5674e-06,0.19203,0.17606,1,1
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,8.9166e-06,0.19196,0.20488,1,1
6,GO REGULATION OF DNA REPAIR,1.7922e-07,0.19188,0.18929,1,1
6,GO ENDOCRINE SYSTEM DEVELOPMENT,7.3803e-06,0.19186,0.22427,1,1
6,GO P BODY ASSEMBLY,4.7488e-06,0.19162,0.19281,1,1
6,GO SKIN EPIDERMIS DEVELOPMENT,0.00026438,0.19155,0.17455,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.4741e-05,0.19152,0.19101,1,1
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,2.4528e-05,0.19129,0.18883,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00065224,0.19121,0.20002,1,1
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,8.5867e-06,0.19108,0.19547,1,1
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,4.6356e-09,0.19106,0.22771,1,1
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00013451,0.19102,0.20743,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0050269,0.19097,0.19246,1,1
6,GO RESPONSE TO STEROL,0.00039018,0.19077,0.19961,1,1
6,GO RENAL TUBULE DEVELOPMENT,0.0011668,0.19072,0.16339,1,1
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00069207,0.19068,0.20155,1,1
6,GO NEGATIVE REGULATION OF DNA REPAIR,0.00053704,0.1905,0.14509,1,1
6,GO RESPONSE TO UV B,0.012227,0.19046,0.17798,1,1
6,GO CHROMATIN SILENCING,7.3476e-09,0.19039,0.21453,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.0010408,0.1902,0.18414,1,1
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00010852,0.1902,0.2186,1,1
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,3.0905e-06,0.1902,0.17344,1,1
6,GO MAMMARY GLAND DEVELOPMENT,0.0021215,0.19019,0.1458,1,1
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,6.6066e-07,0.19015,0.18975,1,1
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,2.4452e-09,0.19012,0.20575,1,1
6,GO DNA RECOMBINATION,2.8305e-05,0.18977,0.15641,1,1
6,GO SPECIFICATION OF SYMMETRY,4.3774e-08,0.18976,0.19789,1,1
6,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.016938,0.18936,0.1374,1,1
6,GO REGULATION OF CELL CYCLE ARREST,7.3476e-09,0.18922,0.20302,1,1
6,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.043444,0.18919,0.13784,1,1
6,GO REGULATION OF FATTY ACID OXIDATION,0.00040857,0.18917,0.19283,1,1
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,6.0565e-09,0.18903,0.19275,1,1
6,GO RENAL FILTRATION,0.0104,0.18869,0.28123,1,1
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,4.9694e-05,0.18839,0.1734,1,1
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00013673,0.18839,0.18009,1,1
6,GO SECRETORY GRANULE ORGANIZATION,0.00025617,0.18826,0.18175,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,3.4098e-06,0.18817,0.22829,1,1
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00012594,0.18816,0.16555,1,1
6,GO FUCOSE METABOLIC PROCESS,0.0017517,0.18812,0.18188,1,1
6,GO INOSITOL METABOLIC PROCESS,0.0059116,0.18794,0.18116,1,1
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00040235,0.18778,0.24128,1,1
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.01585,0.18772,0.15673,1,1
6,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0092477,0.18766,0.20394,1,1
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0018508,0.18762,0.17656,1,1
6,GO REGULATION OF SPINDLE CHECKPOINT,3.5646e-05,0.1876,0.2195,1,1
6,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.016568,0.18757,0.19844,1,1
6,GO HETEROCHROMATIN ORGANIZATION,1.6994e-06,0.18743,0.18396,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,3.5794e-07,0.18735,0.20093,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,2.913e-06,0.18729,0.21099,1,1
6,GO NEGATIVE CHEMOTAXIS,0.0059116,0.18722,0.21886,1,1
6,GO MATING BEHAVIOR,0.00046165,0.18712,0.2051,1,1
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,3.4553e-09,0.18699,0.18679,1,1
6,GO REGULATION OF CGMP MEDIATED SIGNALING,0.039406,0.18695,0.15042,1,1
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,2.1621e-05,0.18684,0.24696,1,1
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,1.3196e-05,0.1868,0.21178,1,1
6,GO SEXUAL REPRODUCTION,1.2441e-09,0.18665,0.19289,1,1
6,GO REGULATION OF CIRCADIAN RHYTHM,1.2434e-08,0.18664,0.22002,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,2.1338e-07,0.18658,0.20083,1,1
6,GO SYNAPTIC VESICLE RECYCLING,1.9044e-05,0.18652,0.22246,1,1
6,GO DNA REPLICATION,2.4371e-06,0.18648,0.18731,1,1
6,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.02128,0.18623,0.18034,1,1
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,1.2027e-05,0.18618,0.22481,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,8.2864e-09,0.18617,0.19596,1,1
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0018256,0.18605,0.20996,1,1
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,9.5999e-07,0.18551,0.19024,1,1
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.3997e-05,0.18547,0.1671,1,1
6,GO DETECTION OF MECHANICAL STIMULUS,0.00053704,0.18545,0.2187,1,1
6,GO GLIAL CELL DIFFERENTIATION,3.2784e-06,0.18541,0.20907,1,1
6,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00018923,0.18526,0.20237,1,1
6,GO DEVELOPMENTAL GROWTH,1.5052e-06,0.18526,0.18872,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,5.0563e-05,0.1852,0.23197,1,1
6,GO POSITIVE REGULATION OF CELL DIVISION,1.0557e-05,0.1852,0.20269,1,1
6,GO PRESYNAPTIC ENDOCYTOSIS,1.4472e-05,0.18505,0.23087,1,1
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00015583,0.18486,0.26176,1,1
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00010852,0.18483,0.25263,1,1
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.014494,0.18469,0.14721,1,1
6,GO MULTICELLULAR ORGANISM GROWTH,9.7998e-07,0.18435,0.19242,1,1
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00026438,0.18433,0.19206,1,1
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,4.7172e-05,0.18429,0.22702,1,1
6,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0034243,0.184,0.15582,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.2253e-05,0.18391,0.18804,1,1
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,2.4091e-05,0.18384,0.16386,1,1
6,GO REGULATION OF CELL DIVISION,1.8793e-06,0.18373,0.18193,1,1
6,GO EPITHELIAL CELL DEVELOPMENT,0.00053704,0.18362,0.1706,1,1
6,GO SUBSTANTIA NIGRA DEVELOPMENT,3.2631e-05,0.18362,0.19404,1,1
6,GO SPINDLE ORGANIZATION,1.8363e-05,0.18359,0.17737,1,1
6,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014494,0.18353,0.14366,1,1
6,GO ENDOTHELIAL CELL DEVELOPMENT,0.013546,0.1833,0.14266,1,1
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00029511,0.18318,0.21605,1,1
6,GO POST EMBRYONIC DEVELOPMENT,3.5646e-05,0.18315,0.19746,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00012594,0.183,0.19467,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.00018323,0.18294,0.15729,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.5014e-05,0.18286,0.20797,1,1
6,GO MOLTING CYCLE,0.00024045,0.18285,0.1611,1,1
6,GO PEPTIDE HORMONE SECRETION,3.7605e-06,0.18285,0.20463,1,1
6,GO PEPTIDYL LYSINE ACETYLATION,3.9035e-08,0.18275,0.19291,1,1
6,GO HORMONE MEDIATED SIGNALING PATHWAY,3.152e-06,0.18265,0.17098,1,1
6,GO HISTONE H3 K4 METHYLATION,2.6362e-08,0.1826,0.23467,1,1
6,GO REGULATION OF RNA SPLICING,1.1858e-08,0.18259,0.20365,1,1
6,GO LUNG MORPHOGENESIS,0.0056958,0.18252,0.15617,1,1
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1.0169e-05,0.18237,0.16518,1,1
6,GO CHROMOSOME LOCALIZATION,0.00012186,0.18234,0.1495,1,1
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.00013016,0.18222,0.16418,1,1
6,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.001568,0.18213,0.23652,1,1
6,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00069207,0.18211,0.23423,1,1
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0012005,0.18192,0.20526,1,1
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,6.545e-05,0.18186,0.2316,1,1
6,GO PROTEIN ACYLATION,8.2864e-09,0.18181,0.19458,1,1
6,GO ASSOCIATIVE LEARNING,1.7071e-05,0.18177,0.19497,1,1
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,1.2058e-07,0.18172,0.17667,1,1
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.001235,0.1816,0.12831,1,1
6,GO REGULATION OF JUN KINASE ACTIVITY,0.00022565,0.18152,0.15655,1,1
6,GO REGULATION OF SPINDLE ASSEMBLY,0.0023637,0.18151,0.13397,1,1
6,GO DEMETHYLATION,1.3599e-06,0.18143,0.18145,1,1
6,GO SENSORY ORGAN DEVELOPMENT,3.6435e-08,0.18121,0.22313,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,3.1479e-07,0.1811,0.1965,1,1
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,9.0235e-07,0.18075,0.2159,1,1
6,GO CENTROSOME SEPARATION,0.00094089,0.18074,0.16376,1,1
6,GO RECEPTOR INTERNALIZATION,0.00045468,0.18059,0.14727,1,1
6,GO ADHERENS JUNCTION ASSEMBLY,0.0025617,0.18038,0.19202,1,1
6,GO EXTRACELLULAR TRANSPORT,0.00013673,0.18034,0.239,1,1
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.014013,0.18024,0.16653,1,1
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,5.3256e-05,0.18019,0.19645,1,1
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.010895,0.18002,0.15274,1,1
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.2281e-06,0.17995,0.20374,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,2.4528e-05,0.17975,0.19331,1,1
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0078263,0.17974,0.19284,1,1
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0018256,0.17922,0.21863,1,1
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00088789,0.17921,0.17701,1,1
6,GO HISTONE H4 ACETYLATION,9.2118e-07,0.17884,0.18744,1,1
6,GO RESPIRATORY SYSTEM DEVELOPMENT,0.00062378,0.17881,0.17498,1,1
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.001071,0.17876,0.17618,1,1
6,GO LYMPH VESSEL MORPHOGENESIS,0.026561,0.17861,0.14952,1,1
6,GO CLATHRIN COAT ASSEMBLY,0.017506,0.1786,0.13083,1,1
6,GO MRNA EXPORT FROM NUCLEUS,0.0005056,0.1785,0.13484,1,1
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.040582,0.17816,0.13418,1,1
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,1.3325e-06,0.17813,0.20014,1,1
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0035146,0.17803,0.175,1,1
6,GO CHROMATIN SILENCING AT TELOMERE,2.3891e-06,0.17795,0.20849,1,1
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.00019857,0.17776,0.17217,1,1
6,GO GLIOGENESIS,5.0323e-06,0.17773,0.19328,1,1
6,GO OOGENESIS,1.1858e-08,0.17767,0.21799,1,1
6,GO PEPTIDYL LYSINE METHYLATION,2.5066e-09,0.17756,0.23607,1,1
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.2716e-05,0.17756,0.19961,1,1
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00016901,0.17748,0.19135,1,1
6,GO MULTICELLULAR ORGANISM REPRODUCTION,5.4967e-09,0.17736,0.18054,1,1
6,GO RESPONSE TO NERVE GROWTH FACTOR,1.9393e-05,0.17735,0.20823,1,1
6,GO REGULATION OF VASCULOGENESIS,0.037509,0.17711,0.15667,1,1
6,GO REGULATION OF DNA RECOMBINATION,0.00028155,0.17676,0.15042,1,1
6,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0015038,0.17669,0.17221,1,1
6,GO ADULT LOCOMOTORY BEHAVIOR,0.00026858,0.17666,0.19445,1,1
6,GO ODONTOGENESIS,0.014823,0.17664,0.14146,1,1
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,5.4184e-05,0.17634,0.18137,1,1
6,GO GLAND DEVELOPMENT,0.00010497,0.1763,0.15603,1,1
6,GO MATING,4.6359e-05,0.1761,0.18315,1,1
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.023919,0.17607,0.12153,1,1
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.001704,0.17605,0.17006,1,1
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.00099681,0.17601,0.15205,1,1
6,GO TISSUE MORPHOGENESIS,0.0001862,0.17599,0.14,1,1
6,GO LACTATE METABOLIC PROCESS,0.0099244,0.17599,0.13832,1,1
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.01995,0.17557,0.13008,1,1
6,GO DOUBLE STRAND BREAK REPAIR,3.3214e-05,0.17555,0.16454,1,1
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00016098,0.17536,0.19037,1,1
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,5.8698e-06,0.17536,0.16907,1,1
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00023667,0.17531,0.18865,1,1
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0005056,0.17525,0.18839,1,1
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,9.795e-06,0.17492,0.17057,1,1
6,GO REGULATION OF CHROMOSOME SEGREGATION,3.1494e-05,0.17489,0.18122,1,1
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0047198,0.17481,0.1523,1,1
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,2.8262e-08,0.1748,0.17168,1,1
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.014494,0.17477,0.168,1,1
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.011813,0.17466,0.13127,1,1
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00059648,0.17454,0.14909,1,1
6,GO INTRACELLULAR MRNA LOCALIZATION,0.0013069,0.17439,0.18807,1,1
6,GO LIPID TRANSLOCATION,0.0039992,0.17438,0.17963,1,1
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.00047589,0.17418,0.19502,1,1
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00016361,0.1739,0.15982,1,1
6,GO GAMMA DELTA T CELL DIFFERENTIATION,0.024947,0.17387,0.24329,1,1
6,GO HEART MORPHOGENESIS,8.2686e-06,0.17385,0.19832,1,1
6,GO MEIOSIS I CELL CYCLE PROCESS,8.4262e-06,0.17381,0.18892,1,1
6,GO CELLULAR RESPONSE TO STEROL,9.819e-05,0.17372,0.23473,1,1
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0015463,0.17366,0.14685,1,1
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00014599,0.17357,0.15205,1,1
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00041488,0.17343,0.22931,1,1
6,GO REGULATION OF MRNA POLYADENYLATION,1.6457e-05,0.17298,0.19378,1,1
6,GO MITOTIC CHROMOSOME CONDENSATION,0.00027284,0.17288,0.22055,1,1
6,GO ANIMAL ORGAN MORPHOGENESIS,1.5576e-05,0.17286,0.16673,1,1
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00039018,0.17254,0.14391,1,1
6,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00052901,0.17242,0.25515,1,1
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0062877,0.17237,0.1964,1,1
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,3.5461e-06,0.17234,0.18575,1,1
6,GO DNA PACKAGING,1.0557e-05,0.17226,0.17865,1,1
6,GO MISMATCH REPAIR,5.9498e-07,0.17218,0.20099,1,1
6,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0018764,0.17126,0.21412,1,1
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,3.2894e-09,0.17126,0.21864,1,1
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00029052,0.17124,0.20423,1,1
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,7.3739e-05,0.17104,0.16474,1,1
6,GO ACTIVATION OF GTPASE ACTIVITY,0.00024819,0.17093,0.15474,1,1
6,GO TRANSMISSION OF NERVE IMPULSE,0.00075607,0.17092,0.2186,1,1
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00028155,0.17085,0.2255,1,1
6,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00072342,0.17077,0.17401,1,1
6,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0072795,0.17068,0.15299,1,1
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00031414,0.17055,0.13737,1,1
6,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.043866,0.17048,0.1249,1,1
6,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.027973,0.17034,0.10138,1,1
6,GO CHONDROCYTE DEVELOPMENT,0.0013826,0.17033,0.19515,1,1
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00031907,0.1703,0.14455,1,1
6,GO PROTEIN KINASE C SIGNALING,0.0066851,0.17019,0.18565,1,1
6,GO CYTOKINESIS,6.337e-06,0.16993,0.1598,1,1
6,GO CELL CYCLE ARREST,1.9175e-06,0.16982,0.16324,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0028492,0.16975,0.13857,1,1
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,3.1729e-08,0.1697,0.20197,1,1
6,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.011022,0.16965,0.11168,1,1
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0023957,0.16962,0.15732,1,1
6,GO CARDIAC CHAMBER MORPHOGENESIS,0.00075607,0.16957,0.17791,1,1
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,1.5293e-05,0.16937,0.19876,1,1
6,GO REGULATION OF CELL DIFFERENTIATION,3.9872e-06,0.16929,0.16196,1,1
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0011836,0.16923,0.23394,1,1
6,GO HISTONE H3 K4 TRIMETHYLATION,0.00091404,0.16922,0.16015,1,1
6,GO GLIAL CELL MIGRATION,0.018091,0.16902,0.12542,1,1
6,GO HISTONE METHYLATION,3.2094e-09,0.16897,0.23199,1,1
6,GO REGULATION OF PROTEIN DEACETYLATION,0.00059648,0.16896,0.15993,1,1
6,GO THYMUS DEVELOPMENT,5.8262e-07,0.16893,0.22823,1,1
6,GO DNA INTEGRITY CHECKPOINT,1.9558e-07,0.16886,0.1885,1,1
6,GO NEUROMUSCULAR PROCESS,6.8396e-06,0.16882,0.2208,1,1
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.0035605,0.16878,0.18048,1,1
6,GO ASYMMETRIC CELL DIVISION,0.0086125,0.16873,0.17768,1,1
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,8.1361e-07,0.16848,0.20939,1,1
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,8.1623e-05,0.16837,0.19949,1,1
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0020367,0.16829,0.1557,1,1
6,GO NUCLEOSOME ORGANIZATION,1.3196e-05,0.16827,0.17744,1,1
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,3.5038e-07,0.16827,0.19233,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.022686,0.16804,0.17818,1,1
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00024045,0.168,0.1593,1,1
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00091404,0.168,0.19095,1,1
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.1751e-05,0.16788,0.1662,1,1
6,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.016205,0.16777,0.18746,1,1
6,GO EPITHELIAL CELL PROLIFERATION,0.0066851,0.1677,0.12206,1,1
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0013069,0.16769,0.13266,1,1
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00022208,0.16718,0.15292,1,1
6,GO CANONICAL WNT SIGNALING PATHWAY,0.00037835,0.16715,0.13995,1,1
6,GO REGULATION OF PHOSPHATASE ACTIVITY,5.3562e-07,0.16709,0.18791,1,1
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00083767,0.16708,0.17718,1,1
6,GO DNA DEPENDENT DNA REPLICATION,6.2169e-06,0.16694,0.18543,1,1
6,GO CELL CELL SIGNALING,2.4861e-06,0.16687,0.16863,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00018323,0.16671,0.16525,1,1
6,GO DNA CONFORMATION CHANGE,2.4972e-05,0.16667,0.1657,1,1
6,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0038977,0.16663,0.14226,1,1
6,GO RNA DESTABILIZATION,0.00019541,0.16634,0.16039,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0027381,0.16609,0.16237,1,1
6,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.016752,0.16609,0.12819,1,1
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,6.2175e-05,0.16588,0.17662,1,1
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,8.8389e-07,0.16579,0.17759,1,1
6,GO REPRODUCTION,3.357e-07,0.1657,0.15946,1,1
6,GO REGULATION OF MRNA 3 END PROCESSING,3.4409e-05,0.16529,0.1796,1,1
6,GO NEURON PROJECTION REGENERATION,0.00013673,0.16523,0.21703,1,1
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0042095,0.16519,0.14377,1,1
6,GO MEMBRANE BIOGENESIS,0.00036124,0.16515,0.23147,1,1
6,GO MICROTUBULE NUCLEATION,0.0017277,0.16506,0.17112,1,1
6,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0028872,0.16499,0.20378,1,1
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.152e-06,0.16486,0.16293,1,1
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,2.3891e-06,0.16457,0.18548,1,1
6,GO GAMMA DELTA T CELL ACTIVATION,0.014013,0.16437,0.19197,1,1
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.016938,0.16436,0.25076,1,1
6,GO REGULATION OF NEURON MATURATION,0.014658,0.16432,0.1651,1,1
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0005618,0.16425,0.16055,1,1
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,1.6654e-06,0.16418,0.18705,1,1
6,GO ENDOTHELIUM DEVELOPMENT,0.0023637,0.16405,0.16251,1,1
6,GO FERTILIZATION,3.9822e-07,0.16396,0.16978,1,1
6,GO REGULATION OF DNA REPLICATION,3.4098e-06,0.16381,0.17639,1,1
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.5865e-05,0.16378,0.21441,1,1
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00034485,0.16349,0.13754,1,1
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00026438,0.16348,0.16231,1,1
6,GO NEUROTRANSMITTER REUPTAKE,0.0059852,0.16347,0.17396,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,5.8049e-05,0.16344,0.14705,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.001422,0.1632,0.18166,1,1
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0018508,0.16296,0.24155,1,1
6,GO REGULATION OF WNT SIGNALING PATHWAY,0.00015331,0.16273,0.14359,1,1
6,GO ACTIVATION OF JNKK ACTIVITY,0.0058389,0.16255,0.15838,1,1
6,GO REGULATION OF LYASE ACTIVITY,0.00025215,0.16253,0.18224,1,1
6,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.038637,0.16251,0.13958,1,1
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00046872,0.16238,0.27584,1,1
6,GO DEVELOPMENTAL MATURATION,1.996e-06,0.16218,0.18577,1,1
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0067673,0.16217,0.13991,1,1
6,GO MRNA PROCESSING,9.819e-05,0.16178,0.14207,1,1
6,GO AXIS SPECIFICATION,4.5684e-06,0.16169,0.19659,1,1
6,GO REGULATION OF CHROMOSOME SEPARATION,0.00030449,0.16145,0.16328,1,1
6,GO REGULATION OF SPINDLE ORGANIZATION,0.0013069,0.16129,0.13352,1,1
6,GO REGULATION OF DNA BINDING,1.7154e-07,0.16122,0.18218,1,1
6,GO EXIT FROM MITOSIS,0.0001179,0.16116,0.1599,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0012005,0.16074,0.15367,1,1
6,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00022565,0.16063,0.16889,1,1
6,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.00068191,0.16055,0.21651,1,1
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0022396,0.1602,0.15784,1,1
6,GO MYOBLAST DIFFERENTIATION,0.0083098,0.16002,0.10699,1,1
6,GO MULTI ORGANISM PROCESS,8.8282e-08,0.15984,0.16032,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.001776,0.15984,0.20727,1,1
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00010673,0.15968,0.16748,1,1
6,GO PROTEIN METHYLATION,1.7721e-08,0.15961,0.20477,1,1
6,GO SISTER CHROMATID COHESION,1.3693e-05,0.15951,0.19188,1,1
6,GO ORGANELLE LOCALIZATION,2.1621e-05,0.15946,0.14001,1,1
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0011836,0.15944,0.14753,1,1
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,3.5646e-05,0.15938,0.18914,1,1
6,GO NUCLEAR CHROMOSOME SEGREGATION,3.6877e-06,0.15925,0.17661,1,1
6,GO ACTIVATION OF MAPKKK ACTIVITY,0.01128,0.15922,0.17744,1,1
6,GO INTERSTRAND CROSS LINK REPAIR,6.5837e-06,0.15917,0.18729,1,1
6,GO NEUROTROPHIN SIGNALING PATHWAY,0.00099681,0.15915,0.16609,1,1
6,GO PROTEIN AUTO ADP RIBOSYLATION,0.012798,0.15913,0.19158,1,1
6,GO CELLULAR GLUCAN METABOLIC PROCESS,0.001442,0.15825,0.14113,1,1
6,GO HISTONE DEACETYLATION,0.00011406,0.15815,0.16807,1,1
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.2414e-06,0.15738,0.18592,1,1
6,GO DNA GEOMETRIC CHANGE,0.00011986,0.1571,0.1554,1,1
6,GO CHROMOSOME SEGREGATION,7.8124e-06,0.157,0.17506,1,1
6,GO REGULATION OF CHROMOSOME ORGANIZATION,1.3056e-06,0.15685,0.15794,1,1
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.021509,0.15678,0.18826,1,1
6,GO CELL CYCLE CHECKPOINT,1.7534e-07,0.15649,0.18641,1,1
6,GO HISTONE UBIQUITINATION,2.2505e-06,0.15649,0.16613,1,1
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0015249,0.15647,0.21997,1,1
6,GO MITOTIC CYTOKINESIS,0.0011021,0.15632,0.11753,1,1
6,GO BONE DEVELOPMENT,0.0020367,0.1563,0.13439,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,1.9044e-05,0.15619,0.20779,1,1
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00030928,0.15619,0.18518,1,1
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,1.9749e-05,0.1559,0.18339,1,1
6,GO MEIOTIC SPINDLE ORGANIZATION,0.0002117,0.15589,0.20702,1,1
6,GO CYTOSKELETON ORGANIZATION,3.6162e-06,0.15588,0.16209,1,1
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,1.475e-06,0.15586,0.17922,1,1
6,GO SKELETAL SYSTEM DEVELOPMENT,0.00029052,0.15568,0.13675,1,1
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0011503,0.15554,0.1895,1,1
6,GO RNA POLYADENYLATION,0.010041,0.15545,0.11734,1,1
6,GO NUCLEOSOME ASSEMBLY,6.3249e-05,0.15517,0.18986,1,1
6,GO MITOTIC SPINDLE ASSEMBLY,0.000662,0.15513,0.15453,1,1
6,GO CHROMATIN REMODELING,1.1316e-06,0.1551,0.18573,1,1
6,GO NEURON APOPTOTIC PROCESS,3.4773e-06,0.15507,0.16089,1,1
6,GO REGULATION OF INSULIN SECRETION,2.1234e-05,0.15506,0.1897,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,6.4341e-05,0.15502,0.18387,1,1
6,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0094686,0.15481,0.18951,1,1
6,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00037835,0.15478,0.17952,1,1
6,GO COVALENT CHROMATIN MODIFICATION,8.9487e-10,0.15463,0.20709,1,1
6,GO REGULATION OF GLUCOSE IMPORT,0.0005133,0.15447,0.15943,1,1
6,GO MUSCLE ORGAN MORPHOGENESIS,0.00039622,0.15441,0.15867,1,1
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.012798,0.15426,0.15069,1,1
6,GO TELOMERE CAPPING,8.1623e-05,0.15425,0.15109,1,1
6,GO CELL CELL SIGNALING BY WNT,9.6562e-05,0.15415,0.14475,1,1
6,GO DNA REPAIR,6.6578e-05,0.15393,0.13834,1,1
6,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.0073682,0.15383,0.16478,1,1
6,GO GOLGI RIBBON FORMATION,0.00037257,0.15347,0.19321,1,1
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,3.094e-05,0.15347,0.20527,1,1
6,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0020092,0.1534,0.15947,1,1
6,GO CHROMATIN ORGANIZATION,2.1064e-09,0.15329,0.20527,1,1
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00028155,0.15302,0.13557,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.9711e-06,0.15278,0.15159,1,1
6,GO REGULATION OF TELOMERE CAPPING,0.0035146,0.1527,0.12601,1,1
6,GO REGULATION OF CENTROSOME CYCLE,2.5884e-05,0.15269,0.18358,1,1
6,GO HORMONE TRANSPORT,4.7999e-05,0.15239,0.16638,1,1
6,GO METAPHASE PLATE CONGRESSION,0.00036124,0.15239,0.13742,1,1
6,GO HEAT GENERATION,0.00045468,0.15212,0.19169,1,1
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0005789,0.15167,0.14585,1,1
6,GO SPERM CAPACITATION,0.0074579,0.15133,0.14218,1,1
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0049019,0.15127,0.14223,1,1
6,GO INSULIN SECRETION,2.4972e-05,0.15117,0.19185,1,1
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.021053,0.15116,0.13565,1,1
6,GO MAINTENANCE OF CELL POLARITY,0.013093,0.1511,0.15897,1,1
6,GO CELL CYCLE PROCESS,2.6914e-06,0.1508,0.14762,1,1
6,GO RNA SPLICING,7.0072e-05,0.15064,0.14083,1,1
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.2175e-05,0.15058,0.1606,1,1
6,GO HISTONE H3 DEACETYLATION,1.9749e-05,0.15057,0.2037,1,1
6,GO ORGANELLE ASSEMBLY,2.3274e-07,0.15034,0.15966,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.0018508,0.15024,0.13579,1,1
6,GO SISTER CHROMATID SEGREGATION,4.7172e-05,0.15008,0.16552,1,1
6,GO INOSITOL LIPID MEDIATED SIGNALING,0.0063654,0.14999,0.12166,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00026858,0.14995,0.15231,1,1
6,GO VESICLE DOCKING,0.0021505,0.14971,0.14188,1,1
6,GO FEEDING BEHAVIOR,8.0256e-05,0.14961,0.17672,1,1
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00082553,0.14952,0.14466,1,1
6,GO CELL CYCLE G2 M PHASE TRANSITION,0.00074504,0.14951,0.12244,1,1
6,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.013394,0.14943,0.17326,1,1
6,GO ORGANELLE FISSION,4.7488e-06,0.14927,0.15349,1,1
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0015463,0.14915,0.14707,1,1
6,GO REGULATION OF CHROMATIN ORGANIZATION,1.1579e-08,0.14915,0.19173,1,1
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,7.7586e-05,0.14892,0.15294,1,1
6,GO HISTONE H3 K9 ACETYLATION,0.00011596,0.14886,0.17652,1,1
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,5.6245e-08,0.14885,0.15996,1,1
6,GO REGULATION OF MEMBRANE PERMEABILITY,0.0002443,0.14883,0.14049,1,1
6,GO POSITIVE REGULATION OF DNA REPLICATION,2.5424e-05,0.14864,0.1596,1,1
6,GO MITOTIC SISTER CHROMATID SEGREGATION,0.0001862,0.14856,0.15232,1,1
6,GO HISTONE DEUBIQUITINATION,0.00028155,0.14835,0.17127,1,1
6,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0054192,0.1483,0.10338,1,1
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00014129,0.14825,0.16905,1,1
6,GO REGULATION OF CELL CYCLE PROCESS,1.9175e-06,0.14816,0.14789,1,1
6,GO CHROMOSOME ORGANIZATION,8.0712e-08,0.1481,0.17454,1,1
6,GO CIRCADIAN RHYTHM,2.7452e-06,0.1481,0.16386,1,1
6,GO REGULATION OF FEEDING BEHAVIOR,0.00060545,0.14801,0.18919,1,1
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0050269,0.14795,0.13711,1,1
6,GO LABYRINTHINE LAYER DEVELOPMENT,0.0098086,0.14792,0.16328,1,1
6,GO EATING BEHAVIOR,0.00045468,0.14774,0.15409,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.015159,0.14747,0.11685,1,1
6,GO RHYTHMIC PROCESS,2.1807e-07,0.14729,0.17888,1,1
6,GO TORC1 SIGNALING,7.3803e-06,0.14718,0.19792,1,1
6,GO VIRAL RNA GENOME REPLICATION,0.020605,0.14715,0.10721,1,1
6,GO SINGLE FERTILIZATION,2.4861e-06,0.147,0.15972,1,1
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,1.2604e-07,0.14669,0.16333,1,1
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0034692,0.14668,0.1687,1,1
6,GO POSITIVE REGULATION OF CYTOKINESIS,8.8796e-05,0.14667,0.1805,1,1
6,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0078263,0.14666,0.14651,1,1
6,GO PROTEIN AUTOUBIQUITINATION,0.00012594,0.14666,0.13862,1,1
6,GO CELL DIVISION,2.342e-06,0.14661,0.16393,1,1
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.012798,0.14652,0.13397,1,1
6,GO ANIMAL ORGAN MATURATION,0.00014839,0.14648,0.20554,1,1
6,GO REGULATION OF HORMONE SECRETION,3.628e-05,0.14647,0.16964,1,1
6,GO NEUROTRANSMITTER UPTAKE,0.0092477,0.14638,0.1397,1,1
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0084096,0.1463,0.20435,1,1
6,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0049019,0.14617,0.19803,1,1
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0038478,0.14608,0.13351,1,1
6,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0035605,0.14602,0.12908,1,1
6,GO SPINDLE ASSEMBLY,8.3013e-05,0.14593,0.1575,1,1
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0085105,0.14584,0.12247,1,1
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00029052,0.14573,0.18515,1,1
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0020092,0.14567,0.13231,1,1
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0020929,0.14564,0.1198,1,1
6,GO RESPONSE TO COCAINE,3.758e-05,0.14546,0.21953,1,1
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0029645,0.14526,0.13576,1,1
6,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.024428,0.1452,0.11616,1,1
6,GO LIPOPROTEIN LOCALIZATION,0.008211,0.14518,0.14246,1,1
6,GO MAMMARY GLAND MORPHOGENESIS,0.0099244,0.145,0.15856,1,1
6,GO REGULATION OF OOGENESIS,0.00037257,0.14496,0.14601,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0019023,0.14459,0.14923,1,1
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,6.6578e-05,0.14454,0.16865,1,1
6,GO POSITIVE REGULATION OF DNA BINDING,0.00010497,0.14446,0.16093,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE,3.0302e-06,0.14445,0.14128,1,1
6,GO NEGATIVE REGULATION OF OSSIFICATION,0.020166,0.1443,0.11745,1,1
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0028492,0.14402,0.13724,1,1
6,GO LIPID PHOSPHORYLATION,5.1446e-05,0.14395,0.15872,1,1
6,GO FEAR RESPONSE,0.00017457,0.14371,0.18104,1,1
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,1.6158e-05,0.1436,0.1511,1,1
6,GO REGULATION OF HISTONE MODIFICATION,8.2543e-08,0.14352,0.18371,1,1
6,GO NEGATIVE REGULATION OF NEURON DEATH,1.7385e-05,0.1434,0.15377,1,1
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00016901,0.14339,0.18458,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.01829,0.14274,0.16135,1,1
6,GO CELLULAR RESPONSE TO UV,1.4741e-05,0.14273,0.16606,1,1
6,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0014022,0.14268,0.1829,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,5.5127e-05,0.14266,0.14698,1,1
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.059879,0.14265,0.080526,1,1
6,GO MITOTIC NUCLEAR DIVISION,4.7999e-05,0.14262,0.15547,1,1
6,GO POTASSIUM ION TRANSPORT,7.6283e-05,0.14238,0.19313,1,1
6,GO GANGLIOSIDE METABOLIC PROCESS,0.008211,0.14236,0.15366,1,1
6,GO MITOCHONDRIAL GENOME MAINTENANCE,0.00044103,0.14232,0.1574,1,1
6,GO REGULATION OF MITOCHONDRIAL FISSION,0.0073682,0.14231,0.11674,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00081356,0.1423,0.13351,1,1
6,GO NUCLEAR EXPORT,0.0025277,0.14207,0.11154,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0002443,0.14192,0.13839,1,1
6,GO REGULATION OF CELL CYCLE,3.6567e-07,0.14184,0.1484,1,1
6,GO MRNA METHYLATION,0.008211,0.14184,0.14009,1,1
6,GO MRNA TRANSPORT,0.00031414,0.14179,0.13095,1,1
6,GO JNK CASCADE,0.0057669,0.14178,0.10547,1,1
6,GO RNA EXPORT FROM NUCLEUS,0.0073682,0.14173,0.10607,1,1
6,GO MUSCLE CELL MIGRATION,0.036409,0.1417,0.11285,1,1
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00074504,0.14169,0.1381,1,1
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0027381,0.14153,0.12619,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.9136e-07,0.14097,0.16433,1,1
6,GO DNA METHYLATION OR DEMETHYLATION,7.6283e-05,0.14094,0.13134,1,1
6,GO NEGATIVE REGULATION OF BINDING,0.00011033,0.14094,0.13814,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,2.342e-06,0.14073,0.14761,1,1
6,GO HISTONE PHOSPHORYLATION,0.00042777,0.14069,0.14841,1,1
6,GO MIDBRAIN DEVELOPMENT,9.086e-06,0.14057,0.15714,1,1
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,1.2716e-05,0.14054,0.14179,1,1
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,1.5293e-05,0.14052,0.14485,1,1
6,GO MRNA 3 END PROCESSING,0.00065224,0.14051,0.14024,1,1
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00033955,0.14026,0.12975,1,1
6,GO REGULATION OF SENSORY PERCEPTION,0.0022095,0.13982,0.12291,1,1
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00088789,0.13956,0.13058,1,1
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.0072e-05,0.13952,0.17729,1,1
6,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.01585,0.13937,0.11204,1,1
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,1.536e-06,0.13928,0.16968,1,1
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,3.9872e-06,0.13921,0.14341,1,1
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,4.0314e-05,0.13898,0.16582,1,1
6,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.038637,0.1388,0.13692,1,1
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00098255,0.13869,0.13527,1,1
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0015249,0.13861,0.12565,1,1
6,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0032501,0.13861,0.17596,1,1
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00036124,0.13831,0.14123,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0042095,0.13795,0.10254,1,1
6,GO NEGATIVE REGULATION OF RNA SPLICING,3.0395e-05,0.13768,0.15062,1,1
6,GO MUSCLE TISSUE DEVELOPMENT,0.00011596,0.1375,0.13289,1,1
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0013826,0.13742,0.13767,1,1
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00070238,0.13734,0.14903,1,1
6,GO PROTEIN DEPHOSPHORYLATION,1.3948e-05,0.13721,0.13737,1,1
6,GO T CELL DIFFERENTIATION IN THYMUS,0.0019819,0.13691,0.13037,1,1
6,GO FEMALE GAMETE GENERATION,1.1794e-07,0.13681,0.17449,1,1
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.0012886,0.13655,0.10458,1,1
6,GO NEUROTRANSMITTER METABOLIC PROCESS,0.036772,0.13642,0.13026,1,1
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.03429,0.13609,0.13135,1,1
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,5.0563e-05,0.13598,0.15713,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,8.0256e-05,0.13579,0.12579,1,1
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,4.5558e-05,0.13579,0.14678,1,1
6,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.016027,0.13571,0.15674,1,1
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00099681,0.13569,0.1335,1,1
6,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.016386,0.13559,0.13193,1,1
6,GO RESPONSE TO X RAY,0.012653,0.13555,0.10692,1,1
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00015583,0.13553,0.13828,1,1
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.00088789,0.13551,0.11139,1,1
6,GO ONE CARBON METABOLIC PROCESS,0.022686,0.13527,0.10603,1,1
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,7.8124e-06,0.13523,0.18093,1,1
6,GO MUSCLE CELL DEVELOPMENT,0.0038478,0.1352,0.11856,1,1
6,GO DENDRITIC SPINE MAINTENANCE,0.0047198,0.13516,0.20148,1,1
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00020504,0.13485,0.13857,1,1
6,GO REGULATION OF DEPHOSPHORYLATION,1.4454e-06,0.13476,0.1679,1,1
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00092737,0.13459,0.1863,1,1
6,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0023009,0.13434,0.15833,1,1
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0086125,0.13432,0.10781,1,1
6,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.03429,0.13418,0.10752,1,1
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.001442,0.13418,0.11414,1,1
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00024045,0.13413,0.11839,1,1
6,GO CELL CYCLE,1.6321e-06,0.13407,0.14426,1,1
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0051547,0.13395,0.14379,1,1
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,2.4972e-05,0.13384,0.12972,1,1
6,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.040582,0.13375,0.099834,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.01995,0.13365,0.092092,1,1
6,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0033799,0.13356,0.18246,1,1
6,GO BROWN FAT CELL DIFFERENTIATION,0.0023637,0.13352,0.17101,1,1
6,GO GOLGI LOCALIZATION,0.046921,0.13352,0.078864,1,1
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.002631,0.13303,0.11673,1,1
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0005211,0.13273,0.14274,1,1
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,9.4959e-05,0.13265,0.13838,1,1
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0020367,0.13262,0.11239,1,1
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,5.9056e-05,0.13257,0.17524,1,1
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00025215,0.13241,0.11948,1,1
6,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.002702,0.13229,0.16051,1,1
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1.3948e-05,0.1322,0.14038,1,1
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0078263,0.13211,0.10703,1,1
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,9.819e-05,0.1321,0.1654,1,1
6,GO ANOIKIS,0.028556,0.13204,0.13425,1,1
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.1751e-05,0.13196,0.13693,1,1
6,GO ERROR PRONE TRANSLESION SYNTHESIS,2.0853e-05,0.1319,0.17598,1,1
6,GO REGULATION OF CENTROSOME DUPLICATION,9.9844e-05,0.13179,0.17984,1,1
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,7.1274e-05,0.13165,0.14626,1,1
6,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.004964,0.13145,0.12069,1,1
6,GO KERATINOCYTE PROLIFERATION,0.046031,0.1313,0.11972,1,1
6,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0030436,0.13116,0.17747,1,1
6,GO REGULATION OF STEM CELL DIVISION,0.018091,0.13108,0.14421,1,1
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0024941,0.13107,0.14304,1,1
6,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.024687,0.13073,0.11133,1,1
6,GO CELL VOLUME HOMEOSTASIS,0.0030436,0.13067,0.14005,1,1
6,GO REGULATION OF VASOCONSTRICTION,0.0028872,0.13053,0.14263,1,1
6,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0088198,0.13046,0.17959,1,1
6,GO INTRACELLULAR LIPID TRANSPORT,0.026838,0.13033,0.12209,1,1
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.8419e-06,0.13004,0.14827,1,1
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0049019,0.12987,0.10191,1,1
6,GO PROTEIN MONOUBIQUITINATION,0.00083767,0.12987,0.12583,1,1
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00039622,0.12966,0.11566,1,1
6,GO DETECTION OF VISIBLE LIGHT,5.5127e-05,0.12965,0.11491,1,1
6,GO OXIDATIVE DEMETHYLATION,0.0069343,0.12951,0.081359,1,1
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00015838,0.12949,0.18173,1,1
6,GO MITOTIC CELL CYCLE,8.3013e-05,0.12938,0.12978,1,1
6,GO DEPHOSPHORYLATION,2.0853e-05,0.12935,0.13407,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.057711,0.12928,0.097462,1,1
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.016027,0.1292,0.15052,1,1
6,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.011949,0.1289,0.099483,1,1
6,GO METANEPHRIC NEPHRON DEVELOPMENT,0.020385,0.12887,0.14912,1,1
6,GO VESICLE LOCALIZATION,0.0059116,0.12883,0.099656,1,1
6,GO POSITIVE REGULATION OF JNK CASCADE,0.023173,0.12871,0.10309,1,1
6,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.024173,0.12847,0.15038,1,1
6,GO EPITHELIUM DEVELOPMENT,0.0020646,0.12828,0.11963,1,1
6,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.010279,0.12818,0.13407,1,1
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,7.5001e-05,0.12813,0.14724,1,1
6,GO LACTATION,0.02128,0.128,0.10631,1,1
6,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0034243,0.12781,0.10731,1,1
6,GO POLYSACCHARIDE METABOLIC PROCESS,0.0050904,0.12771,0.11597,1,1
6,GO PLACENTA DEVELOPMENT,0.011544,0.12766,0.11701,1,1
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0035605,0.12737,0.18065,1,1
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0016122,0.12723,0.14937,1,1
6,GO UV DAMAGE EXCISION REPAIR,0.0016806,0.12685,0.15192,1,1
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0054192,0.12666,0.16067,1,1
6,GO REGULATION OF MITOTIC CELL CYCLE,5.0563e-05,0.12651,0.12491,1,1
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0039481,0.12628,0.13441,1,1
6,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.035691,0.12623,0.08854,1,1
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00026438,0.1262,0.12024,1,1
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.004964,0.12614,0.14297,1,1
6,GO REGULATION OF HAIR CYCLE,0.0018006,0.12609,0.16067,1,1
6,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.039795,0.12585,0.07351,1,1
6,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0092477,0.12556,0.11209,1,1
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0013826,0.12553,0.10887,1,1
6,GO REGULATION OF CELL AGING,0.0034243,0.12527,0.13113,1,1
6,GO GROOMING BEHAVIOR,0.019104,0.12527,0.15447,1,1
6,GO MUSCLE CELL DIFFERENTIATION,0.00035024,0.12518,0.13732,1,1
6,GO DNA METABOLIC PROCESS,6.0079e-05,0.12517,0.12321,1,1
6,GO CELLULAR RESPONSE TO STARVATION,0.00073415,0.12513,0.12739,1,1
6,GO NUCLEAR TRANSPORT,0.00073415,0.12501,0.11473,1,1
6,GO CELL CYCLE PHASE TRANSITION,0.00040235,0.1249,0.1152,1,1
6,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00017176,0.12482,0.13275,1,1
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,1.0791e-07,0.12468,0.1651,1,1
6,GO ENERGY RESERVE METABOLIC PROCESS,0.0021215,0.1246,0.13229,1,1
6,GO METANEPHROS DEVELOPMENT,0.008211,0.12448,0.13683,1,1
6,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0080166,0.12442,0.098398,1,1
6,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0032501,0.12376,0.11495,1,1
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0069343,0.12368,0.095685,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00011986,0.12347,0.14414,1,1
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.012367,0.12328,0.062953,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.060432,0.1232,0.084533,1,1
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.011151,0.12296,0.15698,1,1
6,GO HYPEROSMOTIC RESPONSE,0.0029256,0.12259,0.14924,1,1
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0016806,0.12209,0.13741,1,1
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00011406,0.12198,0.11471,1,1
6,GO SODIUM ION TRANSPORT,0.00069207,0.12183,0.14372,1,1
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00091404,0.12169,0.11891,1,1
6,GO PROTEIN K48 LINKED UBIQUITINATION,0.027401,0.12165,0.08806,1,1
6,GO PEPTIDYL AMINO ACID MODIFICATION,0.00016629,0.12153,0.11336,1,1
6,GO REGULATION OF SODIUM ION TRANSPORT,0.0012005,0.12146,0.1576,1,1
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.041789,0.12044,0.08313,1,1
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0037016,0.12012,0.10676,1,1
6,GO NEURON DEATH,0.00010673,0.12004,0.13579,1,1
6,GO RECEPTOR METABOLIC PROCESS,0.0033361,0.1199,0.11433,1,1
6,GO CHLORIDE TRANSPORT,0.0012177,0.11979,0.13254,1,1
6,GO IMPORT INTO NUCLEUS,0.0012705,0.11973,0.11054,1,1
6,GO ASTROCYTE DIFFERENTIATION,0.0052197,0.11934,0.13988,1,1
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0055559,0.11933,0.095934,1,1
6,GO RESPONSE TO AMINO ACID STARVATION,0.0013826,0.11933,0.14799,1,1
6,GO NEGATIVE REGULATION OF SIGNALING,0.0011503,0.11917,0.1112,1,1
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.010895,0.11916,0.13577,1,1
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,8.1138e-06,0.11895,0.14278,1,1
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.003654,0.11894,0.11178,1,1
6,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0073682,0.11885,0.10134,1,1
6,GO DETECTION OF LIGHT STIMULUS,0.00049053,0.11883,0.091824,1,1
6,GO RESPONSE TO UV,3.4409e-05,0.1188,0.14957,1,1
6,GO REGULATION OF HORMONE LEVELS,0.0013826,0.11879,0.11899,1,1
6,GO GOLGI ORGANIZATION,0.01829,0.11871,0.078208,1,1
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0021798,0.1187,0.12397,1,1
6,GO RESPONSE TO COLD,0.055609,0.11862,0.10544,1,1
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010769,0.11856,0.086105,1,1
6,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.018693,0.11856,0.13149,1,1
6,GO DETECTION OF ABIOTIC STIMULUS,3.628e-05,0.11856,0.15031,1,1
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.0019023,0.11847,0.13073,1,1
6,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.033948,0.11844,0.09814,1,1
6,GO PROTEIN AUTOPHOSPHORYLATION,0.0068504,0.11834,0.11292,1,1
6,GO REGULATION OF GLIAL CELL MIGRATION,0.0023637,0.11827,0.12784,1,1
6,GO LIPOPROTEIN METABOLIC PROCESS,0.011411,0.11825,0.0902,1,1
6,GO RNA DECAPPING,0.026286,0.11807,0.095016,1,1
6,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0032928,0.11767,0.10847,1,1
6,GO FAT CELL DIFFERENTIATION,0.0063654,0.11749,0.11804,1,1
6,GO PROTEOGLYCAN METABOLIC PROCESS,0.0071051,0.11739,0.13351,1,1
6,GO RESPONSE TO LIGHT STIMULUS,1.5865e-05,0.11694,0.12947,1,1
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.00033432,0.1166,0.13525,1,1
6,GO REGULATION OF DNA METABOLIC PROCESS,1.6158e-05,0.11628,0.13358,1,1
6,GO ACROSOME REACTION,0.0025617,0.11592,0.18156,1,1
6,GO CYTOSOLIC TRANSPORT,0.0052854,0.1159,0.10997,1,1
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.016027,0.11545,0.081242,1,1
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.049681,0.11535,0.067606,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00091404,0.11531,0.099463,1,1
6,GO REGULATION OF HISTONE DEACETYLATION,0.034984,0.11506,0.11426,1,1
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,8.7316e-05,0.115,0.12118,1,1
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.045155,0.1148,0.080943,1,1
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0056255,0.11479,0.13403,1,1
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.052575,0.11466,0.11108,1,1
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.007921,0.11455,0.093275,1,1
6,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00025215,0.1141,0.10487,1,1
6,GO REGULATION OF BINDING,0.00052901,0.11394,0.11958,1,1
6,GO EXCRETION,0.0088198,0.11386,0.12202,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,5.02e-08,0.11374,0.17115,1,1
6,GO POSITIVE REGULATION OF NEURON DEATH,0.01499,0.1137,0.10886,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0017517,0.1131,0.10494,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00069207,0.11309,0.10257,1,1
6,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0052197,0.11295,0.098476,1,1
6,GO METHYLATION,0.00018323,0.1129,0.12539,1,1
6,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0013069,0.11286,0.14976,1,1
6,GO POSITIVE REGULATION OF MITOPHAGY,0.053071,0.11283,0.08401,1,1
6,GO REGULATION OF CELL MATURATION,0.010522,0.1128,0.097316,1,1
6,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.03902,0.1127,0.11623,1,1
6,GO RETINA HOMEOSTASIS,0.00013232,0.11265,0.13127,1,1
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00037835,0.1126,0.14898,1,1
6,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0017277,0.11242,0.099816,1,1
6,GO STEM CELL DIFFERENTIATION,0.00035024,0.11232,0.11924,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0076401,0.11228,0.10462,1,1
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.055609,0.11197,0.16804,1,1
6,GO REGULATION OF HISTONE UBIQUITINATION,0.0042095,0.11183,0.11113,1,1
6,GO RNA 3 END PROCESSING,0.037882,0.11157,0.081281,1,1
6,GO RNA LOCALIZATION,0.017699,0.11147,0.08376,1,1
6,GO REGULATION OF MAPK CASCADE,0.05063,0.11136,0.077612,1,1
6,GO REGULATION OF PODOSOME ASSEMBLY,0.052575,0.11134,0.17081,1,1
6,GO SNRNA TRANSCRIPTION,0.012798,0.11108,0.082964,1,1
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0011668,0.11052,0.10649,1,1
6,GO DNA METHYLATION,0.00045468,0.11049,0.1316,1,1
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.027118,0.11022,0.10567,1,1
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.017894,0.11015,0.087053,1,1
6,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.023173,0.11008,0.086789,1,1
6,GO POSITIVE REGULATION OF SIGNALING,0.0061347,0.11002,0.094971,1,1
6,GO REGULATION OF TOR SIGNALING,0.00012186,0.10996,0.14479,1,1
6,GO RESPONSE TO ACTIVITY,0.0059852,0.10986,0.10377,1,1
6,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0072795,0.10981,0.11145,1,1
6,GO PYRUVATE METABOLIC PROCESS,0.023173,0.10969,0.097133,1,1
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.02945,0.10959,0.076567,1,1
6,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0017517,0.10919,0.12944,1,1
6,GO MITOCHONDRIAL FISSION,0.023419,0.10914,0.092071,1,1
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,3.3806e-05,0.10909,0.22633,1,1
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0046018,0.10891,0.098176,1,1
6,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00064263,0.1089,0.13654,1,1
6,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.011813,0.10873,0.09606,1,1
6,GO SECOND MESSENGER MEDIATED SIGNALING,0.00086244,0.10853,0.12117,1,1
6,GO PHOTOPERIODISM,0.00029511,0.10833,0.1663,1,1
6,GO REGULATION OF NUCLEAR DIVISION,2.2824e-05,0.10817,0.13847,1,1
6,GO POSITIVE REGULATION OF TOR SIGNALING,5.5127e-05,0.10805,0.16241,1,1
6,GO RHYTHMIC BEHAVIOR,0.0037016,0.10801,0.12872,1,1
6,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00015331,0.10767,0.097207,1,1
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0029645,0.10738,0.10308,1,1
6,GO PROTEIN INSERTION INTO MEMBRANE,0.017894,0.10715,0.086788,1,1
6,GO REGULATION OF CELL FATE SPECIFICATION,0.023919,0.10708,0.16421,1,1
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0065235,0.10635,0.10494,1,1
6,GO PROTEIN SUMOYLATION,0.0001179,0.10631,0.14371,1,1
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.047372,0.10623,0.1531,1,1
6,GO RESPONSE TO STARVATION,0.00090088,0.1061,0.12588,1,1
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0018256,0.10591,0.12253,1,1
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.010041,0.10574,0.075953,1,1
6,GO RESPONSE TO ACID CHEMICAL,0.0046018,0.10573,0.1091,1,1
6,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.03068,0.10548,0.075214,1,1
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0014022,0.10532,0.12341,1,1
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0022095,0.10502,0.10157,1,1
6,GO CELL CELL ADHESION,0.036048,0.10476,0.097436,1,1
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0017277,0.10459,0.10509,1,1
6,GO OSTEOBLAST DIFFERENTIATION,0.061549,0.10443,0.079111,1,1
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0054872,0.10432,0.11278,1,1
6,GO DNA DEMETHYLATION,0.007921,0.10432,0.13846,1,1
6,GO LIPID DROPLET ORGANIZATION,0.006444,0.10425,0.12483,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.036409,0.10402,0.069946,1,1
6,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.054074,0.104,0.12278,1,1
6,GO CELLULAR RESPONSE TO RADIATION,0.00011986,0.10399,0.1097,1,1
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.053071,0.10337,0.078177,1,1
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.013856,0.10289,0.17087,1,1
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.01849,0.10253,0.083537,1,1
6,GO PROTEIN LOCALIZATION TO VACUOLE,0.024173,0.10188,0.1027,1,1
6,GO ENDOCYTIC RECYCLING,0.0089251,0.10178,0.12151,1,1
6,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.014332,0.10162,0.07074,1,1
6,GO EXOCYTIC PROCESS,0.056128,0.10133,0.10805,1,1
6,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.05063,0.10117,0.075562,1,1
6,GO PROTEIN POLYUBIQUITINATION,0.01829,0.10113,0.079098,1,1
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.036409,0.10098,0.10126,1,1
6,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.016386,0.10095,0.10767,1,1
6,GO NCRNA TRANSCRIPTION,0.025743,0.10094,0.073848,1,1
6,GO PROTEIN HOMOOLIGOMERIZATION,0.0052197,0.10092,0.095721,1,1
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0061347,0.10076,0.16178,1,1
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.058247,0.10066,0.0999,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00086244,0.10034,0.11742,1,1
6,GO MACROMOLECULE DEACYLATION,0.00014839,0.099948,0.14633,1,1
6,GO DNA MODIFICATION,0.00095459,0.099604,0.098394,1,1
6,GO LYMPHOCYTE DIFFERENTIATION,0.039795,0.099507,0.072004,1,1
6,GO NUCLEOTIDE PHOSPHORYLATION,0.013243,0.099407,0.10691,1,1
6,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.013243,0.099119,0.10963,1,1
6,GO REGULATION OF PROTEIN SUMOYLATION,0.0023009,0.0991,0.13225,1,1
6,GO PSEUDOPODIUM ORGANIZATION,0.054582,0.099079,0.1683,1,1
6,GO ENDOSOMAL TRANSPORT,0.014332,0.099074,0.087558,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.016938,0.098972,0.12985,1,1
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0054192,0.098677,0.10177,1,1
6,GO SENSORY PERCEPTION,0.00021511,0.098524,0.12018,1,1
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.012227,0.0983,0.10443,1,1
6,GO PEPTIDYL CYSTEINE MODIFICATION,0.0032078,0.097882,0.11897,1,1
6,GO RESPONSE TO ETHER,0.052083,0.097386,0.10056,1,1
6,GO SODIUM ION HOMEOSTASIS,0.0083098,0.096806,0.13639,1,1
6,GO CELLULAR RESPONSE TO ATP,0.020605,0.096642,0.10824,1,1
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0022701,0.096635,0.095405,1,1
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00028155,0.0966,0.10977,1,1
6,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.017699,0.096547,0.091967,1,1
6,GO BILE ACID BIOSYNTHETIC PROCESS,0.034984,0.09653,0.10064,1,1
6,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0035146,0.095956,0.11318,1,1
6,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.012798,0.095723,0.090604,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.001776,0.095008,0.12455,1,1
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0048405,0.094829,0.10042,1,1
6,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0086125,0.094819,0.11152,1,1
6,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.020385,0.094614,0.10452,1,1
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.032938,0.093592,0.11119,1,1
6,GO REGULATION OF PROTEIN BINDING,0.047827,0.093582,0.08719,1,1
6,GO ACTIN CYTOSKELETON REORGANIZATION,0.011151,0.093519,0.10864,1,1
6,GO PROTEIN ADP RIBOSYLATION,0.040582,0.093498,0.10768,1,1
6,GO CALCIUM MEDIATED SIGNALING,0.018091,0.093357,0.074391,1,1
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0029256,0.093245,0.099974,1,1
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.059879,0.093187,0.075158,1,1
6,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.048285,0.092977,0.074915,1,1
6,GO INTERMEMBRANE LIPID TRANSFER,0.061549,0.092853,0.097862,1,1
6,GO INTRACELLULAR PROTEIN TRANSPORT,0.024947,0.092385,0.064479,1,1
6,GO TRANSLESION SYNTHESIS,0.013394,0.092368,0.091534,1,1
6,GO VACUOLAR TRANSPORT,0.016027,0.092359,0.092729,1,1
6,GO PROTEIN CATABOLIC PROCESS,0.052575,0.092082,0.064499,1,1
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.032607,0.091996,0.071378,1,1
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0063654,0.091836,0.063879,1,1
6,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.05063,0.091444,0.063547,1,1
6,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.013243,0.091296,0.093577,1,1
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.037509,0.090996,0.076741,1,1
6,GO PHOTOTRANSDUCTION,0.013546,0.09077,0.055016,1,1
6,GO CARBOHYDRATE PHOSPHORYLATION,0.050154,0.090711,0.098759,1,1
6,GO INTRACELLULAR TRANSPORT,0.011544,0.090402,0.073956,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00087508,0.09022,0.099662,1,1
6,GO MRNA METABOLIC PROCESS,0.011678,0.090065,0.07989,1,1
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.0046604,0.090041,0.090824,1,1
6,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.050154,0.089567,0.068988,1,1
6,GO CARNITINE SHUTTLE,0.01016,0.08956,0.17405,1,1
6,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.010895,0.08949,0.099934,1,1
6,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0049019,0.089225,0.07614,1,1
6,GO REGULATION OF MITOPHAGY,0.018898,0.088017,0.10905,1,1
6,GO INORGANIC ANION TRANSPORT,0.020605,0.085531,0.084197,1,1
6,GO PROTEIN COMPLEX OLIGOMERIZATION,0.013546,0.085049,0.083719,1,1
6,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.033271,0.082941,0.088353,1,1
6,GO SENSORY PERCEPTION OF SMELL,0.043866,0.082456,0.067484,1,1
6,GO CARBOHYDRATE HOMEOSTASIS,0.0086125,0.081878,0.10361,1,1
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.056128,0.081657,0.062035,1,1
6,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.058787,0.081614,0.077969,1,1
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0068504,0.08138,0.11006,1,1
6,GO DNA CATABOLIC PROCESS,0.0005211,0.081246,0.12143,1,1
6,GO NEGATIVE REGULATION OF SECRETION,0.011022,0.080922,0.087565,1,1
6,GO ORGAN INDUCTION,0.027401,0.0808,0.14267,1,1
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.022446,0.080663,0.10476,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.019523,0.080038,0.077547,1,1
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.049681,0.079806,0.078719,1,1
6,GO REGULATION OF ATP METABOLIC PROCESS,0.011678,0.079497,0.098277,1,1
6,GO CELLULAR SENESCENCE,0.0045438,0.078969,0.11131,1,1
6,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.020605,0.077378,0.064923,1,1
6,GO ESTABLISHMENT OF TISSUE POLARITY,0.010279,0.077158,0.093946,1,1
6,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.027973,0.07664,0.10138,1,1
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0038478,0.076481,0.13099,1,1
6,GO REGULATION OF MACROAUTOPHAGY,0.010895,0.07486,0.082283,1,1
6,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.05063,0.074689,0.069817,1,1
6,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.035691,0.074455,0.078733,1,1
6,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0081133,0.073023,0.09558,1,1
6,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.047827,0.069384,0.067821,1,1
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.023173,0.068273,0.099651,1,1
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.039795,0.068026,0.065193,1,1
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.033948,0.067525,0.073523,1,1
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.02915,0.066977,0.079768,1,1
6,GO REGULATION OF AUTOPHAGY,0.038637,0.066938,0.070535,1,1
6,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.02915,0.065737,0.06621,1,1
6,GO REGULATION OF PROTEIN TARGETING,0.061549,0.063876,0.071756,1,1
6,GO MACROAUTOPHAGY,0.046921,0.059944,0.06303,1,1
